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 Hypertension (HTN) is a critical public health issue estimated to contribute to 10% 
of deaths worldwide. Additionally, the salt sensitivity of blood pressure, an exaggerated 
pressor response to elevated dietary sodium intake, is estimated to be present in 
approximately 50% of the hypertensive population and 25% of the normotensive 
population. This is a critical problem as the average American consumes roughly three 
times the daily sodium intake recommended by the American Heart Association.  
Our laboratory has previously identified a critical role of Hypothalamic 
Paraventricular Nucleus (PVN) Gαi2 proteins in the maintenance of salt resistance and 
normotension in the rat. Salt resistant rats such as the Sprague-Dawley (SD) rat site-
specifically upregulate these proteins in response to elevated dietary sodium intake to 
facilitate sympathoinhibition, natriuresis, and normotension. In contrast, in the Dahl Salt 
Sensitive (DSS) rat, and in salt resistant rats in which this protein is experimentally 
downregulated, our laboratory has identified the development of renal nerve-dependent 
sympathoexcitation and salt-sensitive hypertension (ssHTN). However, the neural 
 
xi 
mechanisms whereby PVN Gαi2 proteins facilitate salt resistance are unclear. In addition, 
there is a robust literature in other rat models of HTN suggesting that both 
neuroinflammation in the PVN as well as an imbalance between PVN inhibitory 
GABAergic and excitatory glutamatergic signaling contribute to elevations in sympathetic 
outflow to promote HTN.  
 In this study, SD rats infused chronically with either targeted Gαi2 
oligodeoxynucleotides (ODNs) or control scrambled (SCR) ODNs and challenged with 
either normal (0.6% NaCl) or high-salt (4% NaCl) diets were used to demonstrate that 1) 
PVN microglial activation and associated pro-inflammatory cytokine production 
contribute to the development of Gαi2 protein dependent ssHTN, 2) sex-dependent PVN 
microglial-mediated neuroinflammation precedes and likely drives the development of 
sympathoexcitation following high dietary sodium administration in male but not female 
Gαi2 protein dependent ssHTN, and 3) PVN GABAergic and glutamatergic signaling is 
disrupted and imbalanced, favoring excitation over inhibition, following elevated dietary 
sodium intake in Gαi2 protein dependent ssHTN. Together, these findings shed light on the 
pathological neural processes that occur in the absence of PVN Gαi2 protein upregulation 
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CHAPTER ONE: Introduction 
Hypertension 
Overview and Epidemiology 
 
 Hypertension (HTN), or high blood pressure, is a critical public health issue, 
estimated to be the leading global cause of death, contributing to 10.4 million deaths 
worldwide per year (Unger et al., 2020). HTN is also the leading cause of chronic kidney 
disease, stroke, and myocardial infarction (Lloyd-Jones et al., 2010; Dariush Mozaffarian 
et al., 2016). Normal blood pressure is defined as a systolic blood pressure (SBP) of less 
than 120 mmHg and diastolic blood pressure (DBP) of less than 80 mmHg. While stage 1 
HTN was previously defined as SBP ≥ 140 mmHg and DBP ≥ 90 mmHg, the 2017 
American College of Cardiology (ACC)/ American Heart Association (AHA) Blood 
Pressure Guidelines redefined Stage 1 HTN as SBP of ≥ 130 mmHg or a DBP of ≥ 80 
mmHg, increasing the estimated prevalence of HTN to approximately 1 in 2 adults in the 
United States (Whelton et al., 2018). 
Essential Hypertension 
 HTN can be categorized according to etiology. HTN resulting from an identifiable 
secondary cause, such as Cushing’s Syndrome or renal artery stenosis, is known as 
secondary HTN, and account for approximately 5-10% of all cases of HTN (Unger et al., 
2020). In contrast, HTN without an identifiable cause is considered primary, or essential 
HTN, and constitutes the rest of the cases of diagnosed HTN. Current medical management 
of HTN includes the use of what are called first-line antihypertensives, and include thiazide 
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diuretics, angiotensin II type 1 receptor antagonists, angiotensin-converting enzyme 
inhibitors, and calcium channel blockers (Wright, Musini, & Gill, 2018). There is a well-
established body of literature demonstrating the benefit of reducing blood pressure in 
reducing HTN-related mortality and morbidity (Hardy et al., 2015; Rashid, Leonardi-Bee, 
& Bath, 2003). Moreover, the knowledge that reducing blood pressure reduces mortality 
has been highlighted by the very successful Systolic Blood Pressure Intervention Trial 
(SPRINT), which found a reduction of systolic blood pressure to <120 mmHg reduced 
cardiovascular-related and all-cause mortality at one year compared to standard treatment 
to a systolic blood pressure of <120 mmHg (Group et al., 2015). Effective blood pressure 
control in essential HTN is difficult to achieve, however, due to the variable and largely 
unidentified mechanisms contributing to the elevated blood pressure. 
 Human and animal studies of essential HTN have demonstrated that impairments 
may exist in one or several of the physiological body systems that contribute to the 
maintenance of blood pressure, including the renal, nervous, and endocrine systems 
(Oparil, Zaman, & Calhoun, 2003). There currently exist antihypertensive medications that 
target all of these systems, but which are prescribed without selectivity for the mechanisms 
specific to a hypertensive individual. Moreover, progress in generating novel 
antihypertensive medications has been stagnant in the 21st century (Shah & Stafford, 2017). 
Thus, there is a need to investigate the mechanisms contributing to essential HTN to 
identify novel therapeutic targets, as well as reduce HTN-related morbidity and mortality 
in the human population. 
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Salt-Sensitivity of Blood Pressure 
 Decades of research has highlighted an important role of dietary sodium intake in 
the pathogenesis of HTN (Frohlich & Varagic, 2004; Guyton, Coleman, Young, Lohmeier, 
& DeClue, 1980; Williams & Hollenberg, 1989). It is well documented that individuals 
who  consume low dietary salt intakes have, generally, normal blood pressures while those 
who consumption exceed recommended amounts of sodium have a higher incidence of 
HTN (Guyton et al., 1980).  
While those individuals who are salt-resistant possess mechanisms that facilitate 
sympathoinhibitory, natriuretic, and normotensive responses to an elevated dietary sodium 
intake (Brooks, Haywood, & Johnson, 2005; Lohmeier, Hildebrandt, & Hood, 1999; 
Osborn, Collister, & Guzman, 2008), those who display the phenotype of the salt-
sensitivity of blood pressure, an exaggerated pressor response to elevated dietary sodium 
intake, display sympathoexcitation and a rise in blood pressure that is maintained for the 
duration of the elevation of salt intake (Brooks et al., 2005; Fujita & Fujita, 2013; Stocker, 
Monahan, & Browning, 2013). Moreover, the salt-sensitivity of blood pressure phenotype 
appears to be present in ≈ 50% of hypertensive and ≈ 25% of normotensive individuals 
(Franco & Oparil, 2006), and thus, this phenotype may account for a significant proportion 
of individuals with essential HTN. The salt sensitivity of blood pressure is particularly 
relevant in the US population given that the average American is consuming approximately 
3.5 g of sodium per day, which is about three times the daily recommended sodium intake 
of 1.5 g per day by the AHA and 2 g per day recommended by the World Health 
Organization (WHO) (Appel et al., 2011; D. Mozaffarian et al., 2014; Whelton et al., 
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2012). It is likely that, given the role of sympathoexcitation in salt-sensitive hypertension 
(ssHTN), there are impairments occurring in the autonomic nervous system regulation of 
fluid and electrolyte homeostasis.  
Overview of Blood Pressure Regulation 
 Blood pressure is primarily determined by multiplying cardiac output and total 
peripheral resistance. Cardiac output is measured as heart rate (HR) multiplied by stroke 
volume, and reflects blood pumped by the heart per minute. Total peripheral resistance, the 
overall resistance to blood flow across the arteriolar vascular beds of the body, is 
principally determined by arteriolar radius and blood viscosity. The various factors that 
influence blood pressure are modulated through short-term (acute) and long-term (chronic) 
mechanisms to maintain a steady blood pressure and to accommodate challenges to fluid, 
electrolyte, and hemodynamic homeostasis.  
 
Figure 1.1: The primary determinants of Mean Arterial Pressure (MAP).  
A schematic diagram demonstrating the breakdown of physiological factors impacting mean 
arterial pressure. Figure generated with BioRender software.  
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Short Term Regulation of Blood Pressure 
 Blood pressure maintenance is critical to organ blood flow and oxygen delivery. 
Acute challenges to blood pressure, such as shifting from a prone to standing position or 
rapid activity (e.g., running), are counteracted with physiological mechanisms intended to 
maintain normal blood pressure. In order to facilitate this phenomenon, the body must be 
able to detect blood pressure. The most commonly discussed and well-studied acute blood 
pressure regulatory mechanism is the carotid arterial baroreflex, intended to provide 
moment-to-moment feedback about carotid arterial blood pressure to the brain to maintain 
normal blood pressure (Cowley, Liard, & Guyton, 1973). The carotid baroreceptors, which 
are sensitive to stretch, identify a blood pressure set point and when pressure, sensed as 
carotid arterial stretch, changes, they respond accordingly via signaling up afferent 
glossopharyngeal fibers to the brainstem to modulate sympathetic and parasympathetic 
tone to the heart (Andani & Khan, 2020; Hart & Charkoudian, 2011).  
 Under normal circumstances, the carotid arterial baroreflex, which integrates with 
the brain stem cardiovascular control centers, will facilitate increased parasympathetic tone 
and inhibit sympathetic tone to lower blood pressure in response to elevations in blood 
pressure and resultant increases in carotid arterial stretch (Hart & Charkoudian, 2011). In 
HTN, however, it has been demonstrated that resetting of the carotid arterial baroreflex and 
associated decreases in baroreflex sensitivity allow higher mean arterial pressures to persist 
without reflex inhibition of sympathetic tone (Carmichael, Carmichael, Kuwabara, 
Cunningham, & Wainford, 2016; Lanfranchi et al., 1998; Yamamoto, Eubank, Franzke, & 
Mifflin, 2013).  
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Long-Term Regulation of Blood Pressure 
 While the carotid arterial baroreflex plays an important role in preventing blood 
pressure from temporarily deviating from a given set point moment-to-moment, 
neurohumoral mechanisms are largely important in determining and maintaining the set 
point for blood pressure itself. As previously mentioned, the principal factors that influence 
mean arterial pressure are cardiac output and total peripheral resistance.  
 Sympathetic nervous system activity is a particularly important long-term regulator 
of blood pressure due to its ability to influence both of the aforementioned factors. This 
will be described further in Integrative Role of the Autonomic Nervous System in Fluid 
and Electrolyte Homeostasis (below), but in brief the sympathetic nervous system release 
of catecholamines can stimulate the heart and elevate HR (positive chronotropy) and stroke 
volume (positive inotropy), the vessels to directly induce vasoconstriction and thus 
influence resistance, and the kidneys to directly influence sodium resorption and renin 
secretion, which drives renin-angiotensin-aldosterone axis activity. The renin-angiotensin-
aldosterone system (RAAS) then acts further through its main effector angiotensin-II, 
which promotes further vasoconstriction, renal sodium resorption directly, and indirectly 
(via aldosterone), and vasopressin secretion from the posterior pituitary. Notably, both the 
sympathetic nervous system and the renin-angiotensin-aldosterone axis heavily influence 
fluid and electrolyte homeostasis by modulating sodium resorption at the kidney. This in 
itself highlights the role of electrolyte balance in promoting normotension, and implicates 
dysregulation of electrolyte homeostasis in HTN. 
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Integrative Role of the Autonomic Nervous System in Fluid and Electrolyte 
Homeostasis 
 Amongst the many mechanisms which are modulated to maintain electrolyte 
homeostasis in salt-resistance, the sympathetic division of the autonomic nervous system 
stands out in the HTN literature. While the heightened sympathetic outflow seen in HTN 
acts to increase blood pressure via vasoconstriction of arterioles, it also plays an important 
role in influencing sodium resorption in the kidney via action at adrenergic receptors 
(Frame, Puleo, et al., 2019; Mu et al., 2011; Tanoue et al., 2002). Overall hyperactivity of 
the sympathetic nervous system can heavily influence blood pressure by increasing sodium 
retention and disturbing fluid and electrolyte balance as a result.  
Overview of the Sympathetic Nervous System 
 The sympathetic nervous system is structured such that each sympathetic nerve is 
the result of a multi-neuronal arc in which a preganglionic neuron and a postganglionic 
neuron come together to innervate a given structure (Figure 1.2). Preganglionic neurons 
have a cell body located in the intermediolateral cell column (IML) of the spinal cord 
between the thoracic and upper lumbar regions. These preganglionic neurons then project 
their axons to a ganglion, usually the paravertebral sympathetic ganglion trunk, where a 
synapse forms onto the cell body of a postganglionic neuron. The postganglionic neuron 




Figure 1.2 Overview of the anatomy of the sympathetic nervous system. 
The sympathetic nervous system is comprised of preganglionic neurons residing in the lateral 
horn of grey matter between the upper thoracic and upper lumbar regions of the spinal cord, 
which project outward to the paravertebral sympathetic ganglion trunk or a lesser ganglion on 
either side of the spinal cord and synapse onto a postganglionic neuron, which then projects to the 
target tissue that it innervates. Reproduced from Anatomy & Physiology (College, 2020), 




 The sympathetic nervous system uses the neurotransmitter norepinephrine (NE) to 
signal at the target site via postganglionic axonal fibers, and stimulation of the adrenal 
medulla by preganglionic fibers additionally releases epinephrine directly into the 
circulating blood. NE and epinephrine are catecholamine neurotransmitters. NE has an 
equal affinity for beta and alpha adrenergic receptors, but a high selectivity for alpha-
adrenergic receptors, and then a lower selectivity for beta-adrenergic receptors, whereas 
epinephrine has no selectivity for a given adrenergic receptor, but a higher affinity for beta-
2 adrenergic receptors. NE actions at alpha-adrenergic receptors are site-specific, but 
include vasoconstriction in the arterioles (Brodde, 1990) and sodium resorption in the 
kidney (DiBona, 1985; Elhawary & Pang, 1994). Epinephrine acts to heavily influence the 
heart, and exerts strong chronotropic and inotropic effects (Bristow et al., 1990).  
 The critical role of the sympathetic nervous system in fluid and electrolyte 
homeostasis and the resultant maintenance of normal blood pressure is highlighted by the 
many studies demonstrating that HTN is associated with enhanced central nervous system 
sympathetic outflow and dysregulation of sodium balance (Foss, Fink, & Osborn, 2013; 
Stocker, Madden, & Sved, 2010; Stocker et al., 2013). 
The Role of Cardiovascular Control Centers in Blood Pressure Regulation 
 Although preganglionic sympathetic neurons are located in the IML of the spinal 
cord, the top-down control of the sympathetic nervous system is facilitated by neural 
control centers in the brain. For example, the brain stem, which facilitates the short-term 
control of blood pressure via descending pre-sympathetic projection neurons to the IML, 
is the control center integrating and controlling the carotid arterial baroreflex. In this 
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example, ascending information about acutely increased blood pressure sensed as 
increased arterial stretch synapses in the brain stem at the Nucleus Tractus Solitarii (NTS). 
The NTS then sends an excitatory projection to the Caudal Ventrolateral Medulla (CVLM), 
which when activated will inhibit the Rostral Ventrolateral Medulla (RVLM). Inhibition 
of the RVLM decreases cardiovascular sympathetic outflow, which is normally driven by 
activity of the RVLM. This reflex thus facilitates a decrease in blood pressure via a 
reduction in cardiac output (Machado, 2001).   
While brain stem centers reflexively contribute to the regulation of blood pressure 
via the input of sensory afferent nerves, they are also in communication with and influenced 
by higher brain centers such as the Paraventricular Nucleus (PVN) of the hypothalamus 
and the circumventricular organs, including the Subfornical Organ (SFO), Organum 
Vasculosum Lamina Terminalis (OVLT), and the Area Postrema (AP). Each of these 
regions performs a function in exerting top-down control of neural-cardiovascular 
autonomic integration. For example, the PVN is understood to be involved in the regulation 
of cardiovascular function via integration of peripheral sensory nerves, particularly the 
renal nerves (Caverson & Ciriello, 1988; Simon & Ciriello, 1989), and has been shown to 
influence both cardiac and renal function (Carmichael et al., 2020; Coote, 1995; Kannan, 
Hayashida, & Yamashita, 1989). The AP is well-connected to the NTS and in studies of 
cardiovascular function, AP lesions are demonstrated to alter neuronal activation markers 
in the NTS and other neural control regions (Kato et al., 2004). Like the AP, the SFO 
influences cardiovascular function. The SFO is understood to sense changes in central 
sodium in the cerebrospinal fluid through chemoreceptors, and influence autonomic 
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function via top-down control of the PVN and the brain stem nuclei to restore electrolyte 
homeostasis and maintain normal blood pressure (Hiyama & Noda, 2016; Hiyama, 
Watanabe, Okado, & Noda, 2004).  
Central Mechanisms in Blood Pressure Regulation 
 Since the 20th century, significant advancements in research techniques in 
neuroscience and physiology have helped researchers begin to identify the previously 
largely unknown mechanisms whereby the central nervous system influences blood 
pressure. Over the past several decades, as mentioned in the previous section, multiple 
brain sites have been identified as playing a role in both the normal regulation of blood 
pressure and in contributing to the dysfunction seen in HTN.  
 A significant amount of research has been done to understand central neural 
dysfunction in HTN, and many researchers have identified critical central targets of 
peripheral hormones such as angiotensin-II which contribute to hypertension (Marques-
Lopes et al., 2017; P. Shi et al., 2010), as well as the existence of centrally-derived 
angiotensinergic pathways in the brain and the existence of the central pro-renin receptor, 
which can both contribute to the excessive sympathetic activity seen in HTN (Mohsin et 
al., 2020; Souza et al., 2019; Xue, Zhang, & Johnson, 2020). Moreover, researchers have 
provided us with an understanding of the dynamic, bidirectional interactions between 
multiple brain regions such as the PVN and the SFO to coordinate homeostatic responses 
to fluid and electrolyte perturbations such as excessive salt intake in both salt-sensitive and 
salt-resistant animals (Dampney, Michelini, Li, & Pan, 2018; Stocker et al., 2013). 
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The Paraventricular Nucleus as an Integrative Cardiovascular Control Center 
 Of the many critical cardiovascular regulatory centers mentioned above, the PVN 
is an exceptionally important cardiovascular control center in the brain which exerts direct, 
top-down control over the sympathetic nervous system to regulate fluid and electrolyte 
homeostasis, cardiac function, and overall blood pressure, predominantly through its 
impact on renal sodium handling. Anatomically, the PVN is divided into a parvocellular 
preautonomic region, and a magnocellular neuroendocrine region (Swanson & Kuypers, 
1980; Swanson & Sawchenko, 1980).  
Afferent signals arriving at the PVN come from a variety of central and peripheral 
locales. For example, the SFO projects to the PVN to influence PVN control of sympathetic 
outflow in response to centrally sensed sodium (Ferguson, Latchford, & Samson, 2008). 
Moreover, the afferent renal sensory nerves have been demonstrated to influence PVN 
neuronal activation and under normal conditions facilitate a sympathoinhibitory reflex to 
perturbations in fluid and electrolyte homeostasis via both mechanosensitive and 
chemosensitive mechanisms to maintain normotension (Frame, Carmichael, Kuwabara, 
Cunningham, & Wainford, 2019; Ye et al., 2020).  
Tracer studies have shown that the PVN has two predominant subdivisions, with 
corresponding efferent projections. The magnocellular division of the PVN possess 
projections to the pituitary gland, reflecting its role in neuroendocrine control (Swanson & 
Kuypers, 1980), while the parvocellular divisions of the PVN project to various regions 
relevant in cardiovascular control, including the RVLM to influence cardiac sympathetic 
activity (Koba et al., 2018), and the thoracic spinal cord to influence global sympathetic 
13 
 
outflow via the IML (Swanson & Kuypers, 1980). The renal sympathetic efferent nerves 
have fibers directly originating in the inferior mesenteric ganglion (Figure 1.3), but which 
stem from centrally originating PVN neurons via a multisynaptic pathway beginning in the 
PVN and are a significant effector of PVN sympathetic control of blood pressure (Wang et 
al., 2013; J. H. Yang, Choi, & Gwon, 2013), influencing sodium handling via renal 
adrenergic receptors (DiBona, 1985; Elhawary & Pang, 1994). 
Multiple studies reflect the importance of PVN neuronal activity in modulating 
blood pressure, and further provide evidence that aberrant PVN function is important in 
the pathogenesis of HTN (Carmichael et al., 2020; Fujita & Fujita, 2016; Gabor & Leenen, 
2009; Jiang et al., 2018; Ribeiro, Panizza Hdo, Santos, Ferreira-Neto, & Antunes, 2015).  
 
Figure 1.3 Anatomical subcategories of Paraventricular Nucleus subnuclei. 
The principal subdivisions of the PVN contain neurons projecting to various regions. First, 
parvocellular subdivisions (MP, VLP, DP) contain neurons projecting to the median eminence 
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and spinal sympathetic centers. Second, magnocellular subdivisions (PM) contain neurons 
projecting to the pituitary to control hormonal release. 
 
Basic Structure and Function of GPCRs 
G-protein coupled receptors (GPCRs), seven-pass transmembrane proteins coupled 
to intracellular signal transduction proteins, represent a large class of membrane receptor 
proteins in the Central Nervous System (CNS) responsible for neurotransmission, and 
serve  several other physiological roles in the body (Rosenbaum, Rasmussen, & Kobilka, 
2009). Intracellularly, these receptors are bound to a G-protein α-subunit, and a 
heterodimerized βγ-subunit (Flock et al., 2017). At resting states, and without ligand 
binding, the α-subunit is bound to guanine-dinucleotide phosphate (GDP). Upon ligand 
binding, the α-subunit switches out its bound GDP for guanine trinucleotide phosphate 
(GTP) and becomes active, dissociating away from the receptor complex to act in a manner 
specific to its subtype. Additionally, upon ligand binding, the βγ-subunit dissociates to 
perform various context-dependent functions.  
 With respect to the subtypes of G-protein α-subunits, there are four classically 
recognized categories. Gα(s) subunits are stimulatory to the enzyme adenylate cyclase 
(AC) and increase concentrations of the intracellular secondary messenger cyclic 
adenosine monophosphate (cAMP). Gα(i/o) and Gα(z) subunits are inhibitory and inhibit 
AC to reduce cAMP levels. Lastly, Gα(q) proteins work to activate phospholipase C, which 
results in intracellular calcium signaling as a secondary messenger (Flock et al., 2017).  
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Gαi2 Proteins and Blood Pressure 
 While some of the central mechanisms involved in the regulation of blood pressure, 
as discussed above, have been identified, certain central pathways remain incompletely 
understood. Our laboratory has identified a novel role of PVN-specific GPCR-coupled 
Guanine Nucleotide–Binding Protein Alpha Inhibiting Activity Polypeptide 2 (Gαi2) 
proteins in mediating PVN responses to both acute and chronic perturbations to fluid and 
electrolyte homeostasis and in the maintenance of salt-resistance and normotension under 
these conditions.   
Gαi2 Proteins and Acute Blood Pressure Regulation 
 First, utilizing either control scrambled (SCR) or targeted Gαi2 antisense 
oligodeoxynucleotide (ODN) intracerebroventricular (ICV) administrations, which have 
been well-demonstrated to result in target-specific protein downregulation following 
oligodeoxynucleotide DNA- complementary mRNA hybridization (Hadjimarkou, Silva, 
Rossi, Pasternak, & Bodnar, 2002; Silva et al., 2000; Wainford & Kapusta, 2012), our 
laboratory has assessed the physiological role of PVN Gαi2 proteins in mediating responses 
to acute stimuli. In SCR ODN pretreated rats, ICV administration of the α2-adrenergic 
receptor agonist guanabenz evoked decreases in MAP and HR, as well as inducing diuresis 
and natriuresis. In contrast, Gαi2 ODN pretreated rats did not display the natriuretic or the 
hypotensive response, suggesting specificity of the Gαi2 protein in mediating central α2-
adrenergic receptor-dependent hypotensive and natriuretic pathways (Wainford & 
Kapusta, 2012).  
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 In further studies, acute physiological challenges were provided using a similar 
paradigm pretreating salt-resistant rats with either SCR or Gαi2 ODNs. For example, 
following a 5% body weight isotonic volume expansion, SCR pretreated rats displayed a 
robust sympathoinhibitory response seen as a decrease in measured renal sympathetic 
nerve activity, which facilitated natriuresis. Pretreatment with Gαi2 ODNs significantly 
attenuated this response, and demonstrated the role of PVN Gαi2  proteins in mediating 
sympathoinhibitory responses to acute vole expansions (Kapusta, Pascale, & Wainford, 
2012). Additionally, in a study conducted using a 3M sodium chloride bolus infusion, 
pretreatment with Gαi2 ODNs significantly impaired neuronal activation assessed via 
immunohistochemistry, natriuresis, suppression of plasma NE, and time to restore MAP to 
baseline (Carmichael et al., 2016). These studies together, among other acute paradigms 
our laboratory has performed, suggest a critical role of PVN Gαi2 proteins in responding 
to acute perturbations to both fluid and electrolyte homeostasis and in the acute regulation 
of blood pressure. 
Gαi2 Proteins and Chronic Blood Pressure Regulation 
 Our laboratory additionally demonstrated the role of PVN Gαi2 proteins in 
mediating sympathoinhibitory and normotensive responses to chronic challenges, such as 
an elevated high dietary sodium intake. Over several studies, we have identified that in 
SCR ODN infused salt-resistant rats, a chronic high-salt diet evokes site-specific 
upregulation of PVN Gαi2 proteins (Kapusta et al., 2012), decreases in plasma NE content 
indicative of sympathoinhibition (Kapusta, Pascale, Kuwabara, & Wainford, 2013; 
Kapusta et al., 2012), and normotension. In contrast, Gαi2 ODN infused rats fed a high salt 
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diet displayed elevations in plasma NE, indicative of sympathoexcitation, (Kapusta et al., 
2013; Kapusta et al., 2012) as well as sodium retention and elevated MAP, suggestive of 
the development of ssHTN (Kapusta et al., 2013).  
 A recent report from our laboratory further supports the role of Gαi2 proteins in 
mediating normotensive responses to elevations in dietary sodium intake, and extends our 
findings to suggest site-specificity of the role of Gαi2  proteins in salt-resistance by utilizing 
a PVN-specific infusion of Gαi2 ODNs to site-specifically induce knockdown. Even with 
the Gαi2 protein knockdown occurring solely in the PVN, Gαi2 ODN infused rats displayed 
significant elevations in plasma and renal NE, indicative of global and renal 
sympathoexcitation, and elevations in sodium retention and MAP suggesting the 
development of ssHTN to an equivalent magnitude as seen in whole-CNS Gαi2 protein 
knockdowns achieved via ICV ODN infusion (Carmichael et al., 2020).   
 Altogether, studies from our laboratory have demonstrated a critical role of PVN 
Gαi2 proteins in the neural signaling networks designed to respond to disturbed fluid and 
electrolyte balance. The presence of these proteins is necessary for proper 
sympathoinhibitory and natriuretic responses to acute volume loading, as well as to chronic 
elevations in dietary sodium intake. Additionally, the absence of these proteins results in a 
failure to properly facilitate these salt-resistant mechanisms and instead facilitates the 
development of ssHTN.  
The Role of Excitation-Inhibition Coupling in Hypertension 
 The central nervous system plays a clear, significant role in maintaining normal 
blood pressure as well as fluid and electrolyte homeostasis via facilitating alterations to 
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autonomic outflow in response to stimuli. In HTN, it has been demonstrated that 
appropriate changes to maintain normal blood pressure and fluid and electrolyte balance 
are not made (Carmichael et al., 2020; Ferreira-Junior et al., 2019; Korpal, Han, Schwenke, 
& Brown, 2017; Li & Pan, 2010; Stern et al., 2012; Wainford, 2014). In many of these 
studies, it has been shown that the failure to make these homeostatic changes likely 
represent alterations to firing in, and possibly alterations in the phenotypic composition of, 
neuronal populations in cardiovascular control centers. However, the literature is not 
entirely clear on the origin and homogeneity of these changes across different models of 
HTN.  
Basics of Neurotransmission 
 Neurons are classified in many ways, but predominantly according to the function 
role of the neurotransmitter they release. Neurons expressing gamma-amino-butyric acid 
(GABA), for example, are classified as the predominant inhibitory neuronal population in 
the CNS, as the release of GABA from their synaptic terminals exerts a suppressive effect 
on the firing of the receptive neuron(s) via a local hyperpolarizing effect (Ngo & Vo, 2019). 
Glutamate, in contrast, is the predominant excitatory neurotransmitter in the CNS, which 
when released at the synapse produces a local depolarizing effect on the receptive neuron, 
increasing the chance of a firing event occurring in that receptive neuron (Palmada & 
Centelles, 1998; Tapiero, Mathe, Couvreur, & Tew, 2002). Additional neurotransmitters 
in the brain are known as neuromodulatory, and through their respective receptors can 




 With respect to signaling in the PVN, many studies have highlighted the role of 
both GABAergic and glutamatergic neurons, amongst many neuromodulatory neuronal 
phenotypes such as adrenergic neurons, in the physiological regulation of blood pressure, 
with a particular focus on the normotensive role GABAergic neurons appear to play, along 
with the influence of noradrenergic signaling on sympathoinhibition (Ferreira-Junior et al., 
2019; Korpal et al., 2017; Nishihara, Takesue, & Hirooka, 2017; Patel, 1991; Takenaka et 
al., 1996; Wainford & Kapusta, 2012).  
GABAergic Signaling and Blood Pressure Regulation 
 GABA, as the principal inhibitory neurotransmitter in the nervous system, stands 
to play a significant role in dampening neuronal firing events that if unchecked would be 
pathological. As such, it is not entirely surprising to find that there is a well-studied 
reduction in GABAergic input to the PVN in many models of HTN and that many 
therapeutic interventions appear to normalize blood pressure via restoration of GABAergic 
input (Ferreira-Junior et al., 2019; Li & Pan, 2006; Nishihara et al., 2017). What remains 
unclear, and controversial across different studies, is the role of the GABA(A) receptor, a 
ligand-gated ion channel functioning to quickly hyperpolarize the postsynaptic cell via 
influx of chloride anions, versus the GABA(B) receptor, a metabotropic G-protein coupled 
receptor which serves to reduce intracellular cAMP concentrations as well as active 
inwardly rectifying potassium channels, amongst other functions to result in a slow 
hyperpolarization (Jembrek & Vlainic, 2015; Kuriyama, Hirouchi, & Nakayasu, 1993; 
Nakayasu, Kimura, & Kuriyama, 1995). GABA(B) receptors, in particular, are of interest 
as previous studies have identified them as coupled to Gαi-subunit proteins, and they have 
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been shown to localize to both presynaptic terminals to inhibit neurotransmitter release, as 
well as postsynaptic membranes to hyperpolarize neurons (Cheng, Wang, Schmid, & Han, 
2014; Jembrek & Vlainic, 2015).  
Glutamatergic Signaling and Blood Pressure Regulation 
 Like GABA, glutamate signaling, as the principal excitatory neurotransmitter in the 
brain, represents another important component of blood pressure regulation as a certain 
degree of excitatory tone drives sympathetic outflow necessary to maintain appropriate 
global vascular tone, as well as fluid and electrolyte balance at the kidney. A fine balance 
exists, however, and enhancement of glutamatergic tone, either intrinsically or through a 
reduction in GABAergic regulation of glutamatergic tone, can result in excessive 
sympathetic activity and elevated blood pressure (Gabor & Leenen, 2012b; Li & Pan, 2017) 
and is a documented feature of HTN.  
The Role of Neuroinflammation in Hypertension 
 In many models of hypertension, it is becoming increasingly clear that in addition 
to changes in neuronal function in cardiovascular control centers, there are disturbances to 
neural immune cells that in turn contribute to the development of salt-sensitive HTN. The 
brain possesses, amongst many cell types, two cell types which have been demonstrated to 
contribute in various ways to the development of multiple forms of HTN. Microglia, the 
resident innate-immune cells of the brain, may become activated or  reactive by a whole 
host of pathological stimuli and in turn drive inflammatory processes linked with the 
development of HTN (Biancardi, Stranahan, Krause, de Kloet, & Stern, 2016; Gilman, 
Mitchell, Daws, & Toney, 2019; Sharma et al., 2018; P. Shi et al., 2010). Additionally, 
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astrocytes, neural stem cell-derived glia which play a role in tissue homeostasis, 
neurotransmitter reuptake, vascular integrity, and more (Pekny, Wilhelmsson, & Pekna, 
2014; Verkhratsky & Nedergaard, 2018) have been demonstrated to respond to insults by 
producing cytokines and chemokines and generating their own processes which drive 
neural activity in HTN (Stern et al., 2016). 
Microglia, Astrocytes, and Neuroinflammation 
 Microglia, the innate immune cells of the brain, are key mediators of 
neuroinflammation. Microglia constantly survey the surrounding tissue in their respective 
domains to help maintain normal tissue function, clear debris and pathogens, and support 
neural function (Miron & Priller, 2020). When microglia encounter pathogens, or are 
otherwise stimulated via pro-inflammatory signal cascades, their morphology changes and 
they become reactive or activated. These activated microglia then behave as classic 
macrophage-like cells and engulf targets, produce and release pro-inflammatory cytokines 
(PIC) and reactive oxygen species, and produce an overall inflammatory 
microenvironment to resolve the issue (Rodriguez-Gomez et al., 2020). As such, microglia 
are key drivers of neuroinflammation.  
 In certain diseases, including HTN, it has been well documented that microglia may 
remain persistently active and propagate an inappropriate and chronic inflammatory 
response, ultimately making conditions worse through changing neuronal function or 
resorption of synapses (Biancardi et al., 2016; Galic, Riazi, & Pittman, 2012; Gerber et al., 
2018; Kaur, Sharma, & Deshmukh, 2019; X. Z. Shen et al., 2015). The production of PICs 
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has been demonstrated to alter neuronal firing and other intrinsic properties (Galic et al., 
2012), and active microglia may even engulf and phagocytize synapses (Roy et al., 2020).  
 Astrocytes are critical regulators of central nervous system homeostasis. Astrocytes 
maintain extracellular pH, reuptake excess neurotransmitters such as glutamate, and 
contribute end-foot processes to the blood brain barrier to protect the nervous system from 
toxins and pathogens (Verkhratsky & Nedergaard, 2018). In addition, astrocytes may 
become reactive in response to noxious stimuli (Pekny et al., 2014) and contribute to 
neuroinflammatory responses in multiple diseases, including HTN (Stern et al., 2016), via 
production of PICs as well as chemokines which recruit other immune cells such as 
microglia and macrophages to respond.  
Impacts of Cytokines on Neural Control Centers 
 Mechanistically, neuroinflammation has been linked to changes in neuronal activity 
via the production of certain PICs which can impact neuronal firing (Chen et al., 2017; 
Clarkson, Kahoud, McCarthy, & Howe, 2017).  Following injury or insult, activated 
microglia release local inflammatory mediators such as interleukins (IL) or tumor necrosis 
factor (TNF) which bind to receptors on neurons and intrinsically change firing properties. 
The significance of this in the context of neurogenic hypertension is that locally released 
cytokines may increase intrinsic firing rates of spinally projecting PVN neurons, or neurons 
in other cardiovascular control centers, to enhance sympathetic tone. Supporting this, 
several studies have confirmed through a multitude of interventions that significant 
neuroinflammation is present in hypertensive animals compared to normotensive controls 
(Du et al., 2017; Jiang et al., 2018; Segiet, Smykiewicz, Kwiatkowski, & Zera, 2019; P. 
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Shi et al., 2010), and that suppression of local inflammation or inflammatory signaling 
pathways in cardiovascular control centers dampens sympathetic outflow and the 
magnitude of HTN (Qi et al., 2019; P. Shi et al., 2010). These studies together implicate 
neuroinflammation not just as a minor component of HTN, but as a significant determinant 
of hypertensive magnitude and thus represent a mechanistic target to be further studied as 
well as considered for therapeutic intervention.                                                       
Sex-Specificity and Hypertension 
 In both human populations and in animal studies, research has identified an effect 
of sex on both the development, maintenance and magnitude of HTN. In human 
premenopausal females, who still produce estrogens and other sex steroid hormones, there 
is a resistance to HTN, as well as other cardiovascular diseases (Ashraf & Vongpatanasin, 
2006; Dubey, Oparil, Imthurn, & Jackson, 2002). Many studies have attempted to identify 
the mechanisms whereby estrogens exert their cardioprotective effects, and some have 
been delineated while others remain unknown.  
 With respect to the mechanisms influencing blood pressure, estrogens in females 
have been demonstrated to protect against excessive vasoconstriction (J. G. Kim et al., 
2018; Riedel et al., 2019), renal and cardiac oxidative injury (Ozdemir Kumral et al., 2016), 
coronary artery remodeling (Matrai et al., 2016), overactivation of the RAAS pathway (da 
Silva et al., 2019), and pro-inflammatory neuroimmune cell activity (Singh, Song, Dutta, 
Gonzalez, & Malik, 2020). Additionally, the literature has shown not only an 
antihypertensive effect of estrogens in animal studies, but also a prohypertensive effect of 
testosterone, the male sex steroid hormone (Mishra, More, Gopalakrishnan, & Kumar, 
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2019; Pingili et al., 2015), reinforcing the findings of human trials demonstrating that males 
are more susceptible to HTN than premenopausal women, and providing potential 
mechanisms. 
Sex and Inflammation 
 With respect to inflammation as a recently renewed topic of interest in studies of 
the mechanisms mediating HTN, there has also been the identification of a sex-dependency 
to inflammation as estrogens have been shown to exert a strong anti-inflammatory effect 
on immune cells. Studies in models of HTN, as well as in other diseases, have shown that 
estrogens act both in the CNS on microglia and astrocytes (Lee, Choi, Ju, & Yune, 2018; 
Singh et al., 2020) as well as on peripheral immune cells (Ni et al., 2019). While these 
studies aren’t as numerous as other studies in HTN, they are beginning to provide 
mechanistic insight into the ways in which estrogens protect against newly identified 
inflammatory pathways that cause damage to, and induce changes in, nearby cells in the 
brain and in the peripheral organs such as the kidney to worsen HTN. 
Sex and the PVN 
 The PVN, as discussed in the section Integrative Role of the Autonomic Nervous 
System in Fluid and Electrolyte Homeostasis (above), is a critical regulator of blood 
pressure via its output influencing both neuroendocrine and autonomic function. Research 
over the past several years, aimed at identifying mechanisms involved in observed sex 
differences in HTN, has sought to understand if there are anatomic differences in the PVN 
that may account for the heightened sympathetic tone seen in male but not female models 
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of HTN. Interestingly, several studies identified a lack of sex differences in the PVN with 
respect to neuronal distribution and receptor distribution, but were able to determine that 
the PVN is a specific site for high expression of sex steroid hormone receptors, particularly 
the Estrogen Receptor-β (Kanaya, Higo, & Ozawa, 2019; Stern & Zhang, 2003), which 
some functional studies suggest may play a role in dampening excessive excitation 
(Gingerich & Krukoff, 2006; Jonklaas & Buggy, 1984). These studies just highlight 
potential mechanisms, however, and the full influence of estrogens on the PVN remains 
unknown. 
Hypothesis and Specific Aims 
Hypothesis 
PVN Gαi2 proteins gate anti-inflammatory and neuronal inhibitory pathways, facilitating 
sympathoinhibitory and normotensive responses to elevated dietary sodium intake in salt-
resistant Sprague-Dawley (SD) rats.  
Specific Aims 
Specific Aim 1: To establish that PVN-specific Gαi2 proteins protect against the activation 
of sex- and sodium-dependent neuroinflammatory pathways in salt-resistant male SD rats. 
In brief, rats will be instrumented with an intracerebroventricular (ICV) cannula to infuse 
control or targeted oligodeoxynucleotides (ODN), placed on a normal (NS) or high (HS) 
salt diet, and several parameters will be assessed over a time course including sodium 
balance and blood pressure. At the end of these studies, animals will be euthanized and 
tissue harvested for analysis of brain immune cells and cytokines via 
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immunohistochemistry, plasma and urine hormones via ELISA, and protein expression via 
western blot.  
Specific Aim 2: To establish that PVN-specific Gαi2 proteins facilitate inhibitory 
neurotransmission and sympathoinhibitory responses to high sodium in male SD rats. 
In brief, rats will be instrumented with either an ICV or PVN cannula to infuse control or 
targeted ODNs and then placed on NS or HS diet. Rats will then be instrumented for the 
measurement of blood pressure and responses to PVN microinjections of various receptor 
antagonists. Finally, tissue will be harvested from euthanized rats for analysis of neuronal 











CHAPTER TWO: General Methods  
This chapter contains detailed descriptions of the surgical procedures, in-vivo 
studies, and molecular and analytical techniques used in Chapters 3–5. Chapters 3–5 each 
contain a brief, chapter-specific methods section which provide a context-specific 
overview referring to the methods detailed below. 
Animals 
Male and female Sprague-Dawley (SD) rats weighing 275–299 g and 200–225 g 
(approximately 3 months of age), respectively, were purchased from Envigo (Indianapolis, 
IN, USA). All animals were pair-housed prior to surgical intervention and single-housed 
post-intervention. Animals were housed at all times in a temperature-controlled (20-26°C) 
and humidity-controlled (30–70%) facility under a 12-hour light-dark cycle. Tap water and 
standard rodent diet (Teklad, Envigo, Indianapolis, IN, USA) or experimental high sodium 
diet (Teklad, Envigo, Indianapolis, IN, USA) (detailed in Table 2.1 below) ad libitum. All 
animals were randomly assigned to experimental groups and all study personnel were blind 
to group assignment. All animal protocols were approved by the Boston University 
Institutional Animal Care and Use Committee in accordance with the National Institutes of 
Health Guide for the Care and Use of Laboratory Animals (8th edition). 
 
Parameter Standard (Normal Salt or NS) 
Diet 
Experimental (High Salt or HS) 
Diet 
total NaCl content 0.6% (174 mEq Na+/kg) 4% (678 mEq Na+ /kg) 
Total K+ content 0.6% 0.8% 
Total Fiber 5%  3%  
Total Protein 18% 19% 
Crude Fat 5% 5% 




Intracerebroventricular Cannula and Subcutaneous Osmotic Minipump Implantation 
 Animals were first anesthetized with intraperitoneal (IP) Ketamine/Xylazine 
(Ketamine 30 mg/kg IP + Xylazine 3 mg/kg IP). An incision was then made on the ventral 
neck, rostral to the scapulae, and a pocket was made in the subscapular region. A 
subcutaneous (SC) osmotic minipump with an infusion rate of 6 μL/day and a max fill 
volume of approximately 200 μL (Model 2004, Alzet, Cupertino, CA, USA) was placed 
into the SC pocket. Then, the animal was placed in a stereotaxic headholder (Stoelting Co., 
Wood Dale, IL, USA) and implanted with a stainless steel cannula (P1 Technologies, 
Roanoke, VA, USA) into the right lateral cerebral ventricle utilizing coordinates from 
Paxinos and Watson The Rat Brain atlas (AP -0.3 mm from bregma, ML +1.3 mm from 
bregma, DV -4.5 mm from the skull surface) (Kapusta & Kenigs, 1999; Paxinos & Watson, 
2007). This cannula was connected via silastic tubing to the SC minipump, such that an 
infusion of either control scrambled (SCR) or targeted Gαi2 oligodeoxynucleotides (ODNs) 
would infuse at a rate of 25 μg/ 6 μL/ day. The cannula was cemented in place and the 
wound on the back of the neck was sutured closed.  
A National Center for Biotechnology Information Basic Local Alignment Search 
Tool was used to determine i.) that the SCR ODNs possessing the sequence (5′‐
GGGCGAAGTAGGTCTTGG‐3′) would not target any known brain mRNA in the rat 
brain (Rattus norvegicus) and ii.) that the targeted Gαi2 ODNs possessing the sequence (5′‐
CTTGTCGATCATCTTAGA‐3′) were sequence-specific to the mRNA for the rat Gαi2 
sequence, and would not result in unwanted knockdown of off-target mRNA. Moreover, 
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these sequences have been highly validated in prior studies from our lab and others 
(Carmichael et al., 2016; Carmichael et al., 2020; Rossi, Standifer, & Pasternak, 1995; 
Standifer, Rossi, & Pasternak, 1996; Wainford, Carmichael, Pascale, & Kuwabara, 2015; 
Wainford & Kapusta, 2012). 
PVN Cannula and Subcutaneous Osmotic Minipump Implantation 
 In a subset of studies outlines in Chapter 5, animals received an infusion of either 
control SCR ODNs or targeted Gαi2 ODNs, with the same sequences and validations as 
mentioned in the section Intracerebroventricular Cannula and Subcutaneous Osmotic 
Minipump Implantation, directly into the PVN to assess the impact of site-specific 
downregulation on cardiovascular function compared to whole CNS downregulation as 
occurs during ICV infusion, as previously described (Carmichael et al., 2020). Animals 
were anesthetized with intraperitoneal (IP) Ketamine/Xylazine (Ketamine 30 mg/kg IP + 
Xylazine 3 mg/kg IP). An incision was then made on the ventral neck, rostral to the 
scapulae, and a pocket was made in the subscapular region. Two osmotic minipumps, each 
with an infusion rate of 3.6 μL/day and a max fill volume of approximately 150 μL (Model 
2006; Alzet, Cupertino, CA, USA) were inserted into the SC pocket. The animal was then 
placed in a stereotax and stereotaxically implanted with a bilateral stainless steel cannula 
(P1 Technologies, Roanoke, VA, USA) into the PVN utilizing coordinates from Paxinos 
and Watson The Rat Brain atlas (AP -1.8 mm from bregma, ML ±0.5 mm from bregma, 
DV -8.0 mm from the skull surface) (Paxinos & Watson, 2007). Cannulation site was 
confirmed at the end of the study when microinjections of L-glutamate (15 nmol/side) were 
made into the PVN to elicit a pressor response. Animals lacking the pressor response were 
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considered mis-cannulations (Carmichael et al., 2020). The PVN cannulas were connected 
one per side via silastic tubing to the respective SC minipump, such that an infusion of 
either control SCR or targeted Gαi2 ODNs would infuse at a rate of 300 ng/ side / day. The 
cannula was cemented in place and the wound on the back of the neck was sutured closed.  
Chronic Radiotelemeter Implantation and MAP Measurement   
 In Chapter 3, we describe the radiotelemeter implantation that was performed and 
used to assess the chronic changes in MAP occurring in male SD rats following either 
targeted Gαi2 or control SCR ODN ICV infusion. Five days before ICV cannula 
implantation, animals were anesthetized with IP Ketamine/Xylazine (Ketamine 30 mg/kg 
IP + Xylazine 3 mg/kg IP) and the femoral triangle was shaved and an incision was made. 
A radiotelemetry device (PA‐C40; Data Sciences International, New Brighton, MN, USA) 
was implanted via a cannula into the abdominal aorta via the left femoral artery and the 
telemeter was stored in a SC pocket. The wound was closed and sutured and the animals 
received buprenorphine for 48 h after radiotelemetry probe implantation 
(0.05 mg kg−1 s.c.). Radiotelemetry data were collected via scheduled sampling for 10 s 
every 10 min in all groups of rats, stored and analyzed using Dataquest A.R.T. v.4.2 
software (Data Sciences International, St. Paul, MN, USA). 
Acute Femoral Artery and Vein Cannulation and MAP Measurement 
 In Chapters 4-5, we describe the MAP that was assessed via an acute cannulation 
protocol at the end of dietary sodium intake and ODN infusion studies. Animals were 
anesthetized with Sodium Brevital IP (Sodium Brevital 20 mg/kg IP + 10 mg/kg 
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Intravenous (IV) as needed). The left femoral triangle was shaved and then dissected to 
isolate the femoral vein. The left femoral vein was cannulated using a PE50 catheter for 
the infusion of IV anesthetics and IV isotonic saline, and the left femoral artery cannulated 
in the same manner for the measurement of MAP. Rats were placed in a plexiglass rat 
holder and an isotonic infusion of saline (20 μL/min IV) was given over a 2-hour recovery 
period allowing rats to return to full consciousness and stable renal and cardiovascular 
function. MAP and heart rate (HR) were recorded continuously via the femoral artery 
cannula using computer driven BIOPAC data acquisition software (MP150 and 
AcqKnowledge 3.8.2; BIOPAC Systems In., Goleta, CA, USA) connected to an external 
pressure transducer (P23XL; Viggo Spectramed Inc., Oxnard, CA, USA). 
Transcardial Perfusion  
 In certain studies for histologic examination of tissues, transcardial perfusion was 
used to procure fixed tissue for immunohistochemical, immunofluorescent, and in-situ 
hybridization staining techniques. Animals were deeply anesthetized with 
Ketamine/Xylazine IP (Ketamine 30 mg/kg IP + Xylazine 3 mg/kg IP). The thorax of the 
animal was then opened on a surgical tray and the animal was perfused through the heart 
with ice cold 0.1M phosphate-buffered saline (PBS) until the liver and kidneys cleared of 
blood and then perfused with ice cold 4% paraformaldehyde (PFA) until the tissue was 
fixed. Tissues were then extracted and post-fixed in 4% PFA for 24-48 hours before being 




In-vivo PVN Microinjection Studies 
 In a subset of animals in Chapter 5, PVN microinjections of GABAergic and 
glutamatergic agents were used to determine the impact of PVN Gαi2 protein 
downregulation on neuronal circuit function. Following acute femoral artery and vein 
cannulation and the 2-hour recovery period, a baseline MAP and HR was recorded for 20 
minutes, and then animals were microinjected with kynurenate (1.4μg/side, glutamatergic 
antagonist) or CGP52432 (3nmol/ side, GABA(B) antagonist) to determine basal activity 
of both glutamatergic (NMDA, AMPA, Kainate) and GABA(B) receptors, and the MAP 
and HR responses were recorded for 60 minutes following injections.  
Metabolic Balance Studies 
 In subgroups of animals, to assess the impact of central Gαi2 protein 
downregulation on sodium handling, metabolic balance studies were undertaken. Animals 
in these studies were first moved to and acclimated in metal meshwire bottom metabolic 
cages for a 48-h period before studies began. Following acclimation, animals were allotted 
a measured daily amount of food (~100 g) and water, and this was reset each day. 
Additionally, 24-hour urine was collected each day for sodium excretion measurement. To 
calculate sodium balance, sodium intake was determined from the known amount of food 
consumed, and then sodium excreted as measured via urinalysis was subtracted from 
sodium consumed to obtain a difference for each 24-hour period for 2-3 days of a NS diet 




Harvest of Plasma, Fresh Brain, and Fresh Kidneys 
 In subgroups of animals in which plasma and fresh frozen brain and kidney tissue 
were needed, rats were euthanized in accordance with our approved IACUC protocols via 
conscious decapitation using a standard rodent guillotine. Whole blood was collected in 
potassium-EDTA tubes and centrifuged at 3000 x g for 10 minutes at 4°C. Plasma was then 
aliquoted and stored at -80°C until further use. Fresh frozen brains and kidneys were 
harvested and were snap frozen and stored at -80°C until further use.  
Assessment of Plasma and Renal NE Levels, Plasma Renin Activity, and Urinary 
Angiotensinogen 
 Frozen plasma and fresh frozen kidney samples were used for the determination of 
plasma and renal NE levels via enzyme‐linked immunosorbent assay (ELISA) per 
manufacturer’s instructions. Plasma and Renal NE content were analyzed via ELISA 
(IB89552, IB89537 respectively; Immuno‐Biological Laboratories, Inc., Minneapolis, 
MN, USA) as previously described (Carmichael et al., 2020; Wainford et al., 2015). Plasma 
Renin Activity (PRA) was assessed via PRA ELISA (DB52011; Tecan, Mannerdorf, 
Switzerland) for the quantitative determination of PRA by the immunoassay of generated 
angiotensin I, according to the manufacturer's instructions. Urinary angiotensinogen 
(UAGT) in Chapter 3 was assessed from urine samples obtained from a 4 h urine collection 
period (09.00–13.00 h) in individual metabolic cages, during which time the animals had 
free access to food and water. UAGT was determined via ELISA (IB27412, Immuno‐
34 
 
Biological Laboratories, Inc.) according to the manufacturer's instructions.  
Cytokine mRNA studies  
From a subset of fresh frozen brains, a tissue punching tool was used to take 
bilateral PVN punches for RNA isolation. Total RNA was isolated using RNeasy kits 
(Qiagen, Hilden, Germany) according to the manufacturer's instructions, and 200 ng of 
purified RNA was quantified using a NanoDrop. Reverse transcription was performed 
using a high‐capacity complementary DNA RT kit to obtain coding DNA (Qiagen, Hilden, 
Germany). The IL‐1β, IL‐6, TNFα and IL‐10 mRNA (cDNA as a proxy for mRNA) levels 
were analyzed by quantitative real‐time PCR using targeted primers in a PRISM 7000 
sequence detection system (Applied Biosystems, Bedford, MA, USA) (P. Shi et al., 2010). 
Data were normalized to 18S ribosomal RNA, and the 2−ΔΔ CT method was used to calculate 
relative changes in gene expression for determination of relative fold change between 
groups.  
Assessment of PVN Gαi2 Protein Levels 
 In certain studies, we elected to assess PVN Gαi2 protein levels. First, in Chapter 
3, we elected to do so in animals receiving co-infusion of minocycline with ODNs to 
validate that minocycline’s function in reducing MAP was not due to interference with the 
ability of the targeted Gαi2 ODN to infuse the animal. Second, in Chapter 4, we elected to 
measure levels in the brains of female SD rats to confirm the efficacy of our targeted ODN 
as we have not previously done so in females. Fresh frozen brains were taken to a cryostat 
and sliced to the anterior level of the PVN. Then, a brain punching tool (Stoelting Co., 
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Wood Dale, IL, USA) was used to harvest PVN punches from each brain. Tissue lysates 
were made and protein levels quantified using a BCA assay according to the manufacturer's 
instructions (Thermo Scientific, Waltham, MA, USA) against standards provided. Lysates 
were resolved on a 10% SDS–PAGE gel in studies in Chapter 3, and a 7.5% SDS-PAGE 
gel in studies in Chapter 4, and transferred to nitrocellulose membranes (catalogue no. 456‐
1033; Bio‐Rad, Hercules, CA, USA). Gαi2 levels were determined as previously published 
by our laboratory using commercially available antibodies from Santa Cruz 
Biotechnologies (Santa Cruz, CA, USA), against Gαi2 (see Table 2.2, Santa Cruz 
Biotechnology catalogue no. sc‐13534, 1:200, RRID:AB_627644) (Carmichael et al., 
2020; Kapusta et al., 2013; Wainford et al., 2015). Protein levels were normalized to total 
protein via Coomassie Blue‐stained gels. Chemiluminescent immunoreactive bands were 
detected by a horseradish peroxidase‐conjugated secondary antibody; data were imaged 
and semi‐quantified using Bio‐Rad Quantity One and ImageJ image analysis software. 
Immunohistochemistry of Brain Tissues 
 For the detection of microglia, astrocytes, and cytokines in brain sections, fixed 
brain tissues were taken and sliced coronally at 40μm between approximately Bregma -1.6 
and Bregma -2.2, the anterior and posterior limits of the PVN respectively, on a cryostat 
and stored in cryoprotectant solution (30% weight/volume sucrose, 30% ethylene glycol, 
and 1% polyvinyl-pyrrolidone in 0.1M PBS).  
Free-floating slices were then selected for immunohistochemistry as previously 
described (Carmichael et al., 2016; Carmichael et al., 2020). First slices were washed in 
0.1 M PBS at room temperature on an orbital shaker, then endogenous peroxidase activity 
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was removed with incubation for 30 minutes in 1% hydrogen peroxide at room temperature 
on an orbital shaker. Slices were then blocked with 3% horse serum and permeabilized in 
0.25% Triton-X at room temperature on an orbital shaker. The tissue was incubated in 
primary antibodies dissolved in PBS diluent (0.25% Triton-X and 3% horse serum in 0.1M 
PBS, primary antibody specifics detailed in Table 2.2) for 2 hours on an orbital shaker at 
room temperature and then for 48 hours at 4°C. Slices were washed, and then incubated in 
secondary antibodies (see specific antibody in Table 2.2) dissolved in PBS diluent at room 
temperature on an orbital shaker for 2 hours. Slices were then washed and incubated for 
one hour in a biotin-streptavidin signal enhancer (VectaStain Kit; Vector Laboratories), 
washed, and exposed to 3-3-diaminobenzidine and nickel sulfate solution for staining. 
Slices were finally wet mounted in 0.1M PBS onto gelatin-subbed slides (Southern 
Biotechnology, Birmingham, AL, USA) and cover-slipped with Permount toluene 
mounting solution (UN1294 toluene solution; Fisher Chemical, Waltham, MA, USA), and 
stored until imaging. 
Immunofluorescence of Brain Tissues 
 Similarly to immunohistochemistry, immunofluorescence was used for the 
detection of cytokines in the brain. Slices obtained via the same coronal sectioning process, 
sliced at 40μm, and stored in cryoprotectant solution (30% weight/volume sucrose, 30% 
ethylene glycol, and 1% polyvinyl-pyrrolidone in 0.1M PBS) were selected for 
immunofluorescence. Free-floating slices were then washed in 0.1M PBS on an orbital 
shaker at room temperature, permeabilized with 0.25% Triton-X and blocked with 3% 
horse serum at room temperature on an orbital shaker, washed again in 0.1M PBS, and 
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incubated in primary antibodies (see Table 2.2 for specific antibodies) against cytokines 
for 2 hours at room temperature on an orbital shaker, and then for 48 hours at 4°C on an 
orbital shaker. Slices were then washed, and incubated in Alexa-fluor-conjugated 
secondary antibodies (see Table 2.2 for specific antibodies) diluted in PBS diluent in the 
dark at room temperature for 2 hours on an orbital shaker. Slices were finally washed and 
wet-mounted  on  gelatin-subbed  slides  in  0.1M  PBS, and  cover-slipped with  Prolong  
Target antigen Vendor or Source Catalog # 
Working 
concentration 











IL-6 (mouse anti-rat primary) Santa Cruz Biotech Sc-28343 1:100 
IL-1β (mouse anti-rat primary) Santa Cruz Biotech Sc-32294 1:100 
TNFα (mouse anti rat primary) Santa Cruz Biotech Sc-133192 1:100 
Mouse IgG (goat anti-mouse, 
alexa-fluor 488 conjugated 
secondary, immunofluorescence) 
Invitrogen/Fisher Sci A11001 1:200 
IL-10 (rabbit polyclonal to 
synthetic antigen) 
Abbiotec 250713 1:100 
Rabbit IgG (goat anti-rabbit IgG 
biotinylated secondary, 
histochemistry) 
Invitrogen 31820 1:100 
GFAP (goat anti-rat primary) Abcam Ab53554 1:60-1:500 





Gαi2 protein (mouse anti-rat 
primary) 
Santa Cruz Biotech Sc-13534 1:200 
Mouse IgG (goat anti-mouse, 
HRP conjugated secondary, 
western blot) 
Abcam Ab6789 1:2000 
  




Diamond anti-fade mounting media (Fisher- P36961, Fisher Scientific, Waltham, MA, 
USA) and stored in the dark until imaging. 
In-situ Hybridization of Brain Slices 
 For the co-localization of the Gnai2 mRNA with vGlut2 and Gad1 in the PVN to 
determine the percent distribution of neuronal phenotypes expressing the Gαi2 protein, in-
situ hybridization was performed as recently described by our laboratory (Chaudhary & 
Wainford, 2021). Coronally sliced sections of fixed brains were cut on a cryostat at 20 μm 
and stored in cryoprotectant until tissue processing. In situ hybridization was performed 
using the Manual RNAscope Assay Fluorescent multiplex kit (ACD 32850, Hayward, CA, 
USA). Optimization and specificity were determined using 3-Plex positive (ACD 320891, 
Hayward, CA, USA) and negative (ACD 320871, Hayward, CA, USA) controls. First, 
sections were rinsed with 1X PBS and mounted on superfrost plus slides (Fisher 1255015, 
Fisher Scientific, Waltham, MA, USA). Slides were then washed in RNase free water 
(Fisher 10-977-015, Fisher Scientific, Waltham, MA, USA) for 5 minutes and dehydrated 
through serial concentrations of ethanol, air dried, permeabilized using hydrogen peroxide 
(ACD 322335, Hayward, CA, USA) to block endogenous peroxidase activity and protease 
III (ACD 322337, Hayward, CA, USA). Slices were then hybridized using specific target 
probes for 2 hours at 40°C. Readily available C2 probes Gad1 (ACD 316401-C2, Hayward, 
CA, USA) and Slc17a6(vGLUT2, ACD 317011-C2, Hayward, CA, USA) were used along 
with a custom-designed targeted C1 Gnai2 probe (NPR-0001497; ACD 805201) detecting 
specific Gai2 target RNA. The custom probe was designed using the National Center for 
Biotechnology Information Gene ID 81664 for Rattus norvegicus Gnai2. For hybridization 
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channels C1 (1X concentration) and C2 (50X concentration), and for the multiplex probe 
mixture at 1X concentration, the C2 probes were diluted at 1:50 in the C1 probe.  
Following probe hybridization, tissue section slides were rinsed twice with 1X 
wash buffer (ACD 310091; 50X diluted in RNase free water, Hayward, CA, USA) at room 
temperature for 2 minutes each time. The signal amplification was performed using an 
RNA scope set of amplifiers (ACD 320851, Hayward, CA, USA) (Amp 1, 30 minutes at 
40°C; Amp 2, 15 minutes at 40°C; Amp 3, 30 minutes at 40°C; and Amp 4A, 15 min at 
40°C). Washing steps with 1X wash buffer (2 minutes at room temperature x2) were 
included between Amplification steps. Slides were then coated with Prolong Diamond anti-
fade mounting media (Fisher-P36961) to preserve fluorescent signals. 
Microscopy and Image Analysis 
 All brain section staining protocols were imaged on a Keyence BZ‐9000 
fluorescence microscope (BZ-9000, BIOREVO, Keyence, Tokyo, Japan) which possesses 
DAPI (excitation: 360 ± 20 nm; absorption: 460 ± 25 nm), GFP (excitation: 470 ± 20 nm; 
absorption: 535 ± 25 nm), and Texas Red (excitation: 560 ± 20 nm; absorption: 630 ± 30 
nm) filters. The microscope was set to bright field utilizing a standard halogen lamp for 
immunohistochemistry, and set to fluorescence for immunofluorescence and in-situ 
hybridization.  For immunohistochemistry of microglia stained by Cd 11b/c, astrocytes 
stained by GFAP, and cytokines IL-1β, IL-10, IL-6, and TNFα, images were captured on 
brightfield at standard microscope configurations and only exposure was adjusted to obtain 
similar images in all samples, determined by the brightness in the third ventricle adjacent 
to the PVN. No changes were made to the contrast or brightness of any images obtained 
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on brightfield following capture on the microscope.  
Analysis of Glia and Cytokines Stained via Immunohistochemistry 
For analysis of microglial morphology, randomly sampled images were taken at 
40X from the PVN and blinded. The total number of microglia in a randomly drawn 200 
μm x 200 μm box on that image was then counted for each animal, as well as the number 
of microglia in each box that were determined to be reactive, or activated. Activated 
microglia were determined to be those that were stained more darkly on a subjective 
scoring of 1-3 with 1 being lightest and 3 being most immunoreactive, as well as those that 
possessed processes that were overall shorter than the approximate diameter of the soma 
of that microglia, and which possessed a hypertrophied or amoeboid somal shape. The 
percent of the sampled microglia that were reactive were then calculated as number active 
divided by total number. Group averages were then compared for each of these parameters. 
Additionally, for a less subjective measure of microglial reactivity, 2D Sholl analysis was 
performed. In brief, 10 microglia from each animal tissue section were randomly selected 
in a systematic fashion via a grid placed over the image. Each glia was cropped into its 
own image and then opened in ImageJ/FIJI (ImageJ 1.52p, Java 1.8.0_172; US National 
Institutes of Health). The center of the soma of each glia was then selected, and the whole 
glia was highlighted using the “adjust  threshold” function. The Sholl analysis plugin tool 
was then run, and it placed concentric rings equidistant from another (1 μm) radiating from 
the soma and calculated the number of times processes intersected the rings in all 
directions. These data were then plotted for each glia, averaged for each animal and group, 
and plotted against one another and the mean peak number of intersections was used for 
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statistical comparison of each group to determine if significant differences existed in 
branching complexity, which is considered to increase with increased mean number of ring 
intersections. 
To measure astrocyte activation, images captured at 20X in the PVN were captured 
and blinded. As astrocytic activation can be more subtle than microglia, and involve only 
a slight swelling of the soma and upregulation of GFAP, on ImageJ, the PVN was traced 
out and the percent area stained positively for GFAP was then calculated as pixels stained 
divided by total pixels in that PVN section. This helps to normalize the percent area of 
astrocyte staining in accounting for different sized PVN areas. Data were compared as 
group average percent areas.  
Cytokine immunohistochemistry was then analyzed qualitatively for visual 
differences in cytokine protein expression and taken into context with quantitative PCR 
data to determine if differences were observable. 
Analysis of Cytokines Stained via Immunofluorescence 
Immunofluorescence was performed on brain slices in a subset of studies on 
cytokine expression. Following staining in these studies, images were taken on the GFP 
setting of the microscope at 20X under similar exposures, and without alterations to the 
gamma setting. Images were then blinded and shuffled and then opened in ImageJ/FIJI. 
The PVN was traced out on these images and cytokine percent area was determined by 
utilizing a threshold tool to identify the total number of pixels in the PVN and the number 
of pixels positive for fluorescent staining, and then dividing positively stained pixels by 
total pixels. This normalizes the potential differences in PVN area between samples. Group 
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averages were then determined for comparison.  
Analysis of Neuronal Phenotypic Markers Stained via In-situ Hybridization 
 For in-situ hybridization studies on brain slices, slides were imaged utilizing the 
GFP filter for green stains and Texas Red filter for red stains at 10X and 20X. To determine 
positive RNA puncta staining compared to background, the brightness setting was 
enhanced linearly to an equal degree with respect to the background in all images to allow 
small puncta to become visible, while contrast was also enhanced equally and linearly in 
all images to enable signal detection and discrimination from background. To ensure 
background was identifiable, negative control probes and positive control probes 
commercially available from Advanced Cell Technology/BioTechne were employed for 
image comparison. After image capture, colocalization of Gad1 and Gnai2 or vGlut2 and 
Gnai2 was determined using ImageJ/FIJI. On blinded images, a 300 μm x 300 μm box was 
drawn over the PVN. Cells were then counted using the cell counter plugin available on 
ImageJ. A cell was determined to be positive for the respective mRNA if it contained >5 
punctate dots in that foci. Quantifications of each slice were then used to determine percent 
of Gnai2-expressing neurons that were GABAergic or Glutamatergic, as well as percent of 
GABAergic neurons containing Gnai2 and percent of glutamatergic neurons containing 
Gnai2. Data were averaged and these figures used for comparison across groups.  
Statistical Analyses 
 All data in Chapters 3-5 are expressed as mean ± SD. The magnitude of change in 
cardiovascular (radiotelemetry MAP) and renal excretory studies (urinary sodium balance) 
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at different time points of chronic dietary sodium intake studies, as well as temporal 
changes in MAP to microinjections, was compared with the mean group control value by 
a one-way repeated-measures analysis of variance (ANOVA) with subsequent Dunnett’s 
test. Differences between different ODN infusion groups, as well as different dietary intake 
groups for a single time point were assessed via a two-way ANOVA, with ODN infusion 
being one fixed effect and dietary sodium intake the other, with the interaction included. 
Time (day), if used, was the repeated factor. Post-hoc analyses were performed using 
Bonferroni’s test in comparing differences in variations between groups. Additional 
statistical analyses between control and experimental animals receiving the same ODN and 
on same diet were validated using Student's unpaired t tests. Statistical analysis was carried 
out using GraphPad Prism software (v.8, GraphPad Software, CA). Statistical significance 
was defined as Probability P<0.05.   
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CHAPTER THREE: Inhibition of Microglial Activation in Rats Attenuates 
Paraventricular Nucleus Inflammation in Gαi2 Protein-Dependent, Salt-Sensitive 
Hypertension 
This section was previously published as: Moreira, J.D., Chaudhary, P., Frame, A.A., 
Puleo, F., Nist, K.M., Abkin, E.A., Moore, T.L., George, J.C., and Wainford, R.D. 
“Inhibition of microglial activation in rats attenuates paraventricular nucleus inflammation 
in Gαi2 protein-dependent, salt-sensitive hypertension.” Experimental Physiology 
104(12):1892-1910. PMCID: PMC6884700 © 2019 The Authors. Experimental 
Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society. 
 
Introduction 
 Hypertension (HTN) is one of the most significant public health issues in the USA; 
according to 2017 American Heart Association (AHA) guidelines, it is estimated that one 
in two people are hypertensive (Reboussin et al., 2018). Furthermore, HTN is the leading 
cause of chronic kidney disease, stroke and ischaemic heart disease (Lloyd-Jones et al., 
2010; Dariush Mozaffarian et al., 2016) and is estimated to contribute to 10.4 million 
deaths worldwide per year (Unger et al., 2020). Excess dietary sodium intake, which can 
drive the salt-sensitivity of blood pressure and increase the risk of developing salt-sensitive 
HTN (ssHTN), is of great public health significance, because the average American is 
consuming almost three times the daily sodium intake recommended by the American 
Heart Association (Lloyd-Jones et al., 2010). 
Our laboratory has previously shown that in salt‐resistant animals, upregulation of 
the G‐protein‐coupled receptor αi2 subunit (Gαi2) protein in the paraventricular nucleus 
(PVN) of the hypothalamus of salt‐resistant rats mediates high dietary sodium‐evoked 
sympathoinhibitory responses to facilitate normotension and the maintenance of salt 
resistance (Kapusta et al., 2013; Wainford et al., 2015). In contrast, hypertensive Dahl salt‐
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sensitive (DSS) rats fail to upregulate PVN Gαi2 proteins in response to high dietary 
sodium intake (Wainford et al., 2015). Restoration of the upregulation of Gαi2 proteins in 
the DSS rat via the use of the 8‐congenic rat line attenuated the magnitude of DSS HTN 
(Wainford et al., 2015). Thus, PVN Gαi2 upregulation in response to high dietary sodium 
intake is crucial for the maintenance of salt resistance. 
Several recent studies have suggested that central inflammatory processes 
contribute to the development of HTN, and include the upregulation of pro‐inflammatory 
cytokines (PICs) such as tumor necrosis factor‐α (TNFα), interleukin (IL)‐6 and IL‐1β 
(Jiang et al., 2018; P. Shi et al., 2010; Z. Shi et al., 2011). Furthermore, these processes 
have been shown to feature downregulation of the anti‐inflammatory cytokine IL‐10 
(Segiet et al., 2019). Inflammatory processes have also been demonstrated to mediate 
neuronal excitability and even influence the firing rates of neurons, potentially disrupting 
neural homeostasis (Galic et al., 2012; Z. Shi et al., 2011). Glial cells, including microglia 
and astrocytes, can become activated in response to a pathological stimulus and have been 
demonstrated to produce inflammatory cytokines and reactive oxygen species and to 
disrupt neural homeostasis (Biancardi et al., 2016; Wolf, Boddeke, & Kettenmann, 2017). 
Therefore, we hypothesized that central inflammatory processes, involving activation of 
microglia and astrocytes, contribute to the development of Gαi2 protein‐dependent, ssHTN. 
To test this hypothesis, we used a male Sprague–Dawley rat model infused centrally with 
either a scrambled (SCR) control oligodeoxynucleotide (ODN) or targeted Gαi2 ODN 
alone or in combination with centrally administered minocycline, during a challenge with 
either a normal‐ or high‐salt diet. In these animals, we assessed several markers of central 
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All animal protocols were approved by the Institutional Animal Care and Use 
Committee under protocol number AN15241, in accordance with the guidelines of the 
Boston University School of Medicine and the US National Institutes of Health Guide for 
the Care and Use of Laboratory Animals, 8th edition (2011). Please note that all possible 
steps were taken to minimize pain and suffering, and euthanasia was conducted in 
accordance with approved protocols. We used decapitation in a small, clearly defined 
subset of animals, in which we were measuring basal concentrations of plasma 
norepinephrine, which are suppressed by the administration of sedatives and anaesthetics.  
Animals 
Male Sprague–Dawley rats weighing 275–300 g were purchased from Envigo 
(Indianapolis, IN, USA). Rats were pair‐housed before surgical intervention and housed 
separately after survival surgery. Animals were housed in a facility with controlled 
temperature (range 20–26°C) and humidity (range 30–70%) under a 12 h–12 h light–dark 
cycle and were allowed tap water and standard irradiated rodent diet as described in Table 
2.1 in Chapter 2 or experimental high‐sodium as described in Chapter 2 ad libitum. Rats 
were randomly assigned to experimental groups. 
Surgical procedures 
Chronic blood pressure measurement: A radiotelemetry device (PA‐C40; Data 
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Sciences International, New Brighton, MN, USA) was implanted into the abdominal aorta 
via the left femoral artery under general anaesthesia (ketamine, Zoetis, Inc., Kalamazoo, 
MI, USA, 30 mg/kg IP; xylazine, Akorn, Inc., Lake Forest, IL, USA, 3 mg/kg IP). In these 
studies, animals received buprenorphine (Reckitt Benckiser Pharmaceuticals, Richmond, 
VA, USA) for 48 h after radiotelemetry probe implantation (0.05 mg/kg SC). In all cases, 
radiotelemetry probes were implanted 5 days before intracerebroventricular (ICV) osmotic 
mini pump implantation. Radiotelemetry data were collected, stored and analyzed using 
Dataquest A.R.T. v.4.2 software (Data Sciences International, St. Paul, MN, USA) 
(Brouwers, Smolders, Wainford, & Dupont, 2015; Frame, Carmichael, et al., 2019; 
Wainford et al., 2015). 
Intracerebroventricular oligodeoxynucleotide infusion: Chronic downregulation of 
brain Gαi2 proteins was achieved by continuous ICV infusion of a phosphodiesterase ODN 
probe that selectively and specifically targets Gαi2 proteins (5′‐
CTTGTCGATCATCTTAGA‐3′). Control animals received an ICV infusion of a SCR 
ODN (5′‐GGGCGAAGTAGGTCTTGG‐3′). In these studies, SCR and Gαi2 ODNs were 
dissolved in isotonic saline and infused ICV at 25 µg/ 6 µl/ day, a technique previously 
reported by our laboratory selectively to downregulate Gαi2 subunit proteins throughout 
the brain of conscious Sprague–Dawley rats (Carmichael et al., 2020; Kapusta et al., 2013; 
Wainford et al., 2015). Several publications from our laboratory have confirmed effective 
(∼85%) ODN‐mediated downregulation of Gαi2 protein expression after 
chronic ICV ODN infusion as assessed by western blotting(Kapusta et al., 2013; Wainford 
et al., 2015). 
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To achieve ICV ODN infusion, animals were anaesthetized (ketamine, 
30 mg/kg IP in combination with xylazine, 3 mg/kg IP) and implanted stereotaxically with 
a stainless‐steel cannula into the right lateral cerebral ventricle (Plastics One Inc., Roanoke, 
VA, USA), which was connected via Silastic tubing to an osmotic minipump (Model 2004; 
Durect Corporation, Cupertino, CA, USA). A National Center for Biotechnology 
Information (NCBI) Basic Local Alignment Search Tool (BLAST) search of the Rattus 
norvegicus Reference Sequence (RefSeq) protein database was conducted to confirm: (i) 
the specificity of the Gαi2 ODN for the Gαi2 rat protein sequence; and (ii) that the SCR 
ODN does not match any known rat protein sequence. In addition, our prior studies 
(Carmichael et al., 2020; Kapusta et al., 2012; Wainford et al., 2015; Wainford, Pascale, & 
Kuwabara, 2013) and the studies from other laboratories examining the effects of opioid 
analgesia and opioid‐induced feeding (Hadjimarkou et al., 2002; Rossi et al., 1995; Silva 
et al., 2000; Standifer et al., 1996) have demonstrated the selectivity and specificity of this 
Gαi2 ODN sequence in the downregulation of brain Gαi2 proteins in rats. 
Intracerebroventricular minocycline and oligodeoxynucleotide co‐infusion: 
Chronic downregulation of brain Gαi2 proteins during microglial inhibition was achieved 
by continuous ICV infusion of an ODN probe that targets Gαi2 proteins, as described 
above, in combination with ICV minocycline infusion. In these studies, SCR and 
Gαi2 ODNs were dissolved in isotonic saline and infused ICV at 25 µg/ 6 µl/ day in 





Dietary sodium intake: After ICV osmotic minipump implantation, animals were 
randomly assigned to a normal‐salt (0.6% NaCl) or high‐salt (4% NaCl) diet for a period 
of 7 days. At the end of the 7-day experimental period, animals were either killed by 
conscious decapitation or received ketamine anaesthesia (ketamine, 30 mg kg−1 i.p.) before 
undergoing cardiac perfusion. 
Chronic blood pressure measurement: In certain studies, radiotelemetry was used 
for the chronic measurement of blood pressure. Data were collected via scheduled sampling 
for 10 s every 10 min in all groups of rats. Rats were maintained on a normal‐salt diet 
(0.6% NaCl) for a 5-day baseline period and were then randomly assigned (n = 6 per group) 
to either a normal‐salt (0.6% total NaCl) or high‐salt (4% total NaCl) diet, and blood 
pressure was recorded for a further 7 days. 
Plasma renin activity, urinary angiotensinogen and norepinephrine assays: Plasma 
renin activity (PRA), urinary angiotensinogen and plasma norepinephrine (NE) 
concentrations were determined as previously described (Kapusta et al., 2012; Wainford et 
al., 2015). In brief, after plasma extraction, from blood samples obtained after conscious 
decapitation, samples were frozen at −80°C until later analysis. For the PRA assay, samples 
were analyzed using a plasma renin activity enzyme‐linked immunosorbent assay (ELISA) 
kit (DB52011; Tecan, Mannerdorf, Switzerland) for the quantitative determination of PRA 
by the immunoassay of generated angiotensin I, according to the manufacturer's 
instructions. Plasma NE concentrations were quantified using an ELISA kit (IB89552; 
Immuno‐Biological Laboratories, Inc., Minneapolis, MN, USA) according to the 
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manufacturer's instructions. For the urinary angiotensinogen assay, urine samples were 
obtained from a 4 h urine collection period (09.00–13.00 h) in individual metabolic cages, 
during which time the animals had free access to food and water. These samples were 
analyzed by ELISA (IB27412, Immuno‐Biological Laboratories, Inc.) according to the 
manufacturer's instructions. 
Cytokine mRNA studies: On day 7, a subset of animals (n = 6 per group) was 
sacrificed via conscious decapitation and whole blood was collected for analysis. Fresh 
frozen brains were harvested, and a tissue punching tool was used to take bilateral PVN 
punches (Kapusta et al., 2013; Kapusta et al., 2012). Total RNA was isolated using RNeasy 
kits (Qiagen) according to the manufacturer's instructions, and 200 ng of purified RNA was 
reverse transcribed with a high‐capacity complementary DNA reverse transcription kit 
(Qiagen, Hilden, Germany). The IL‐1β, IL‐6, TNFα and IL‐10 mRNA levels were analyzed 
by quantitative real‐time PCR using specific primers and probes in a PRISM 7000 sequence 
detection system (Applied Biosystems, Bedford, MA, USA) (P. Shi et al., 2010). Data were 
normalized to 18S ribosomal RNA, and the 2−ΔΔ CT method was used to calculate relative 
changes in gene expression (Zuriaga et al., 2017). 
Measurement of brain Gαi2 protein levels: After completion of experimental 
protocols, the rats were killed via conscious decapitation, and whole brains were removed 
from subsets of animals co‐infused with both SCR and Gαi2 ODN–minocycline, and frozen 
at −80°C. Paraventricular nucleus samples were extracted from frozen brains cut on a 
cryostat using a brain punch tool (Stoelting Co., Wood Dale, IL, USA) as previously 
described (Carmichael et al., 2020; Kapusta et al., 2012; Wainford et al., 2015; Wainford 
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et al., 2013). Tissue lysates were prepared and protein levels quantified using the BCA 
assay according to the manufacturer's instructions (Thermo Scientific, Waltham, MA, 
USA). Lysates were resolved on a 10% SDS–PAGE gel and transferred to nitrocellulose 
membrane (catalogue no. 456‐1033; Bio‐Rad, Hercules, CA, USA). Gαi2 levels were 
determined as previously published by our laboratory (Kapusta et al., 2012; Wainford et 
al., 2015) using commercially available antibodies purchased from Santa Cruz 
Biotechnologies (Santa Cruz, CA, USA), directed against Gαi2 (Santa Cruz Biotechnology 
catalogue no. sc‐13534, 1:200, RRID:AB_627644); protein levels were normalized to total 
protein via Coomassie Blue‐stained gels. Chemiluminescent immunoreactive bands were 
detected by a horseradish peroxidase‐conjugated secondary antibody; data were imaged 
and semi‐quantified using Bio‐Rad Quantity One image analysis software. 
Immunohistochemistry: Brain tissue from transcardially perfused animals was post‐
fixed for 24 h in 4% paraformaldehyde and then for 72 h in 30% sucrose before being 
sliced on a cryostat. Slices 40 µm thick were obtained, and immunohistochemistry was 
performed in six‐well plates as described in Chapter 2. Slices of the PVN were selected 
based on coordinates from Paxinos & Watson The Rat Brain atlas (Paxinos & Watson, 
2007), being between bregma −1.6 and −2.16 mm. Slices were taken caudal to the 
interventricular foramen and rostral to the CA1 region of the hippocampus. Slices were 
washed in 0.1 m PBS, incubated in 1% hydrogen peroxide to block endogenous 
peroxidase, blocked with 3% horse serum and primary antibodies against rat OX‐42 (BD 
Biosciences catalogue no. 550299, RRID:AB_393594, 1:60, East Rutherford, NJ, USA) 
were used to stain for microglia and against rat GFAP (Abcam catalogue no. ab53554, 
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RRID:AB_880202, 1:60, Cambridge, MA, USA) to stain for astrocytes. Secondary 
antibodies used were biotinylated IgG (Vector Laboratories catalogue no. BA‐9200, 
RRID:AB_2336171, 1:100, Burlingame, CA, USA). Slices were blocked with avidin 
(VectaStain Kit; Vector Laboratories), and stained with 3′,3′‐diaminobenzidine. After 
immunohistochemistry, slices were mounted on gelatin‐subbed slides (Southern 
Biotechnology, Birmingham, AL, USA) and dehydrated using deionized water to xylenes, 
coverslipped with Permount (UN1294 toluene solution; Fisher Chemical, Waltham, MA, 
USA) and visualized. Furthermore, the same procedure was used, and primary antibodies 
against rat IL‐1β (Santa Cruz Biotechnology catalogue no. sc‐32294, RRID:AB_627790, 
1:100, Santa Cruz, CA, USA; (Somsanith et al., 2018), rat IL‐6 (Santa Cruz Biotechnology 
catalogue no. sc‐28343, RRID:AB_627805, 1:100, Santa Cruz, CA, USA; (Jiang et al., 
2018), rat TNFα (Santa Cruz Biotechnology catalogue no. sc‐133192, RRID:AB_1567355, 
1:100, Santa Cruz, CA, USA; (Jiang et al., 2018) and IL‐10 (Abbiotec catalogue no. 
250713, RRID:AB_2125107, 1:100, San Diego, CA, USA) were used to identify cytokine 
protein distribution in the brain tissue. Secondary antibodies used were biotinylated IgG 
(Vector Laboratories catalogue no. BA‐9200, RRID:AB_2336171, 1:100). After 
immunohistochemistry, slices were mounted on gelatin‐subbed slides (Southern 
Biotechnology, Birmingham, AL, USA) and dehydrated using deionized water to xylenes, 
coverslipped with Permount and visualized. Control experiments for 
immunohistochemistry performed include those done without primary antibodies and those 




Microscopy and image analysis: Stained tissues were visualized using a Keyence 
BZ‐9000 fluorescence microscope set to bright field. Paraventricular nucleus‐containing 
slices were visualized and images captured at ×20 and ×40 magnifications. 
Morphological analysis of microglia: Level 2 PVN slices were obtained 
(approximately bregma −1.8 to −2.0 mm) and SFO slices were obtained (approximately 
bregma −1.8 to −2.0 mm) and microglia in the sections were graded according to 
immunoreactivity on a scale from one to three, with one representing low reactivity and 
faint staining, two representing moderate reactivity with moderate staining, and three 
representing high reactivity with dark staining. In blinded, randomly sampled 200 
µm × 200 µm squares at ×40 magnification, PVN and SFO microglia were determined to 
be ‘activated’ if they demonstrated characteristic morphological changes that including 
becoming amoeboid, where their projections were reduced to a size less than the diameter 
of the microglial soma (4–5 µm) and if the immunoreactivity was a grade 2 or 3 on staining 
(Bardgett, Holbein, Herrera-Rosales, & Toney, 2014; P. Shi et al., 2010). 
Sholl analysis of microglia: Images of level 2 of the PVN at ×40 magnification 
were obtained as previously described. Images were blinded and shuffled, and each image 
was opened in Adobe CC Photoshop (Adobe, 20.0.4 20190227.r.76), and images were 
overlaid with a 5 × 2 grid. Ten microglia were sampled randomly and systematically from 
individual grid squares and cropped so that the new image contained only the single 
microglial cell and its processes. In each group, 10 microglia from each of six animals were 
run, for a total of 60 microglia per group. Each new cropped image was opened in 
ImageJ/FIJI (ImageJ 1.52p, Java 1.8.0_172; US National Institutes of Health). Each image 
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was then converted to 8‐bit, and the ‘measure → threshold’ function was used to identify 
the microglia from the background. The selected microglial cell was then subjected to Sholl 
analysis via the ‘Analysis’ function of FIJI, where concentric rings were placed equally 
distant (1 µm) from one another, radiating outwards from the center of the soma. The 
number of ring intersections at each ring, for a distance of 25 rings, was saved and analyzed 
using GraphPad Prism software (v.7; GraphPad Software, La Jolla, CA, USA) and plotted 
as group means at each given ring with standard deviations. One‐way ANOVA was used 
to compare the overall differences between trend lines within ODN infusion groups. 
Analysis of astrocytes: Astrocytes were analyzed using ImageJ software, in which 
the images were converted to a greyscale and set to ‘Image → Type → RGB’ and then 
analysis was performed to quantify the total percentage area of the PVN that the astrocytes 
composed, i.e. their density in the PVN. Astrocytes stained for GFAP, which is purportedly 
upregulated in astrogliosis (Pekny et al., 2014), were quantified (in pixels) and divided by 
the total number of pixels composing the PVN to obtain a percentage of composition, or 
tissue density. 
Cytokine immunohistochemistry: Cytokine immunohistochemistry was analyzed 
qualitatively for visible differences in stain immunoreactivity in both the PVN and the 
SFO. 
Statistical analysis 
Data are expressed as means ± SD. Differences occurring between treatment groups 
(e.g. SCR versus Gαi2 ODN) were assessed by a two‐way ANOVA, with treatment group 
being one fixed effect and dietary intake the other, with the interaction included. Post 
55 
 
hoc analysis was performed using Bonferroni's test and individual Student's 
unpaired t tests. Statistical analysis was carried out using a software program (GraphPad 




Impact of brain Gαi2 protein downregulation during 7 days of high salt intake on 
plasma NE: In control SCR ODN‐infused male Sprague–Dawley rats, HS diet for 7 days 
had no impact on MAP and evoked global sympathoinhibition (SCR ODN; plasma NE: 
NS 65 ± 5 versus HS 37 ± 6 nmol l−1, P < 0.05; Figure 3.1). In contrast, male Sprague–
Dawley rats receiving a targeted Gαi2 ODN infusion, which selectively downregulates 
brain Gαi2 proteins, developed ssHTN (Gαi2 ODN; MAP day 7 of HS diet: NS 
103 ± 1.1 versus HS 128 ± 2 mmHg, P < 0.05) and dietary sodium‐evoked 
sympathoexcitation, measured as plasma NE (Gαi2 ODN; plasma NE: NS 
67 ± 6 versus HS 91 ± 8 nmol l−1, P < 0.05). Additionally, in these hypertensive rats we 
observed suppression of plasma renin activity and urinary angiotensinogen to the same 
levels as those seen in SCR ODN‐infused rats (Figure 3.1). In control SCR ODN‐infused 
rats maintained on HS intake for 7 days, minocycline infusion had no impact on MAP, 
suppression of plasma NE, plasma renin activity or urinary angiotensinogen (Figure 3.1). 
Significantly, central minocycline co‐infusion attenuated the magnitude of HTN in rats on 
HS diets receiving a Gαi2 ODN infusion (Gαi2 ODN; MAP on day 7 of HS diet: HS 
128 ± 2 versus HS + MINO 114 ± 1.1 mmHg, P < 0.05; Figure 3.1b) and abolished dietary 
salt‐evoked elevations in plasma NE (Gαi2 ODN; plasma NE: HS 91 ± 8 versus HS + 
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MINO 72 ± 6 nmol l−1, P < 0.05; Figure 3.1c). 
 
Figure 3.1.  Impact of ODN Infusion and MINO co-infusion on MAP, Plasma NE, Plasma 
Renin Activity, and Plasma UAGT in SD Rats on NS and HS diet.  
Impact of control scrambled (SCR) and targeted Gαi2 intracerebroventricular 
oligodeoxynucleotide (ODN) infusion [25 µg/ 6 µl/ day for 7 days] and minocycline (MINO)–
ODN co‐infusion [ODN, 25 µg/ 6 µl/ day; MINO: 120 µg/ day for 7 days in high‐salt (HS) group 
only] in male Sprague–Dawley rats receiving 7 days of normal‐salt (NS; 0.6% NaCl) or HS (4% 
NaCl) diets on: (a,b) mean arterial pressure (MAP) as assessed via radiotelemetry over 5 days 
preceding the experimental diet and the 7 days of the experimental diet; (c) plasma norepinephrine 
(NE) concentrations; (d) urinary angiotensinogen (UAGT) concentrations; and (e) plasma renin 
activity. (n = 6 per group, * P < 0.05 versus pre‐experimental diet NS in respective ODN treatment 
group; τ P < 0.05 versus 7 days of experimental HS in respective ODN treatment 
group; ϕ P < 0.05 versus 7 days of experimental NS diet in the respective ODN treatment group, 




Impact of minocycline on Gαi2 ODN‐mediated downregulation of PVN 
Gαi2 proteins: In subsets of animals co‐infused with ODN and minocycline, 
immunoblotting was performed to assess the impact of co‐infusion of minocycline and 
ODNs on targeted Gαi2 protein downregulation. The Gαi2 ODN–MINO co‐infusion 
resulted in an average 79% reduction in PVN‐specific Gαi2 protein expression as assessed 
by immunoblotting, normalized to total protein in Coomassie Blue‐stained gels 
(Figure 3.2; SCR ODN fold change HS + MINO 1.04 ± 0.24 versus Gαi2 HS + MINO 
0.209 ± 0.12, P < 0.0001). Therefore, minocycline did not appear to have an impact on the 
ability of the ODN to induce protein knockdown successfully. 
 
Figure 3.2.  Impact of MINO on ODN Infusion in SD Rats.  
(a) Representative immunoblot demonstrating impact of Gαi2 oligodeoxynucleotide (ODN)–
minocycline co‐infusion [25 µg/ 6 µl/ day + MINO: 120 µg/ day for 7 days] on paraventricular 
nucleus (PVN) Gαi2 protein expression. L1 and L2 are ladder, S1–S6 are protein extracts from the 
PVN of scrambled control (SCR) ODN–minocycline co‐infused animals, and G1–G6 are protein 
extracts from the PVN of Gαi2 ODN–minocycline co‐infused animals. (b) Representative 
Coomassie Blue‐stained gel demonstrating total protein loaded, and bands outlined in yellow for 
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normalization of bands in (a). (c) Quantification of the fold change in PVN Gαi2 protein expression 
between SCR ODN–minocycline co‐infused animals on high salt (HS) diet (4% NaCl) and 
Gαi2 ODN–minocycline co‐infused animals on HS diet. (n = 6 per group, 
* P < 0.05 versus SCR 
ODN treatment group, mean ± SD.) 
 
 
Impact of brain Gαi2 protein downregulation during 7 days of high salt intake on 
PVN inflammatory cytokine levels: In control SCR ODN‐infused male Sprague–Dawley 
rats, 7 days of HS diet had no impact on the PVN mRNA expression of the pro‐
inflammatory cytokines IL‐1β, IL‐6 and TNFα or the anti‐inflammatory cytokine IL‐10 
(Figure 3.3). In contrast, in male Sprague–Dawley rats receiving a targeted Gαi2 ODN 
infusion, which develop ssHTN (Figure 3.1a), dietary sodium evoked a ∼2‐ to 2.5‐fold 
increase (P < 0.05) in the PVN mRNA levels of the pro‐inflammatory cytokines IL‐1β, IL‐
6 and TNFα (Figure 3.3a–c). Additionally, in these same rats, we observed suppression of 
PVN mRNA expression of the anti‐inflammatory cytokine IL‐10 (Figure 3.3d). In control 
SCR ODN‐infused rats maintained on 7 days of HS intake, minocycline infusion had no 
impact on the expression of cytokine mRNA levels (Figure 3.3). Significantly, central 
minocycline co‐infusion abolished dietary sodium‐evoked increases in pro‐inflammatory 
cytokines and the decrease in anti‐inflammatory IL‐10 (Figure 3.3a–d) in targeted 




Figure 3.3: Impact of targeted Gαi2 or control scrambled ICV oligodeoxynucleotide infusion 
and minocycline co‐infusion on PVN cytokines.  
Impact of targeted Gαi2 or control scrambled (SCR) intracerebroventricular oligodeoxynucleotide 
(ODN) infusion [25 µg/ 6 µl/ day for 7 days] and minocycline (MINO)–ODN co‐infusion [ODN, 
25 µg/ 6 µl/ day; MINO, 120 µg/ day for 7 days in HS group only] in male Sprague–Dawley rats 
receiving 7 days of normal‐salt (NS; 0.6% NaCl) or high‐salt (HS; 4% NaCl) diets on 
paraventricular nucleus (PVN) mRNA levels of IL‐1β (a), IL‐6 (b), TNFα (c) and IL‐10 (d) (n = 6 
per group, * P < 0.05 versus control in respective ODN treatment group, τ P < 0.05 versus HS in 
respective ODN treatment group, mean ± SD.) 
 
In control SCR ODN‐infused male Sprague–Dawley rats, 7 days of HS diet had no 
impact on the PVN protein expression of the pro‐inflammatory cytokines IL‐1β, IL‐6 or 
TNFα as determined via immunohistochemistry (Figures 3.4, 3.5, 3.6). In these same 
normotensive SCR ODN‐infused animals, 7 days of HS intake increased the 
immunoreactivity of the anti‐inflammatory cytokine IL‐10 (Figure 3.7). In contrast, in 
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male Sprague–Dawley rats receiving a targeted Gαi2 ODN infusion, which develop ssHTN 
(Figure 3.1a), high salt intake evoked increased protein expression of the pro‐inflammatory 
cytokines IL‐1β and IL‐6 but no change in the expression of TNFα (Figures 3.4, 3.5, 3.6). 
Furthermore, in contrast to the response seen in controlled SCR ODN‐infused rats, the HS 
diet did not increase IL‐10 immunoreactivity in Gαi2 ODN‐infused rats (Figure 3.7). 
 
Figure 3.4: Representative photomicrographs of IL‐6 immunoreactivity in the PVN of 
targeted Gαi2 or control scrambled ICV oligodeoxynucleotide‐infused SD rats.  
Representative photomicrographs of IL‐6 immunoreactivity in the paraventricular nucleus (PVN) 
of targeted Gαi2 or control scrambled (SCR) intracerebroventricular oligodeoxynucleotide (ODN)‐
infused [25 µg/ 6 µl/ day for 7 days] male Sprague–Dawley rats on 7 days of normal‐salt (NS; 0.6% 
NaCl) or high‐salt (HS; 4% NaCl) diet. (a) SCR ODN‐infused rat on NS diet. (b) SCR ODN‐infused 
rat on HS diet. (c) Gαi2 ODN‐infused rat on NS diet. (d) Gαi2 ODN‐infused rat on HS diet. 
Abbreviation: 3V, third ventricle. (n = 6 per group, scale bars: 200 µm; large images ×20 




Figure 3.5: Representative photomicrographs of IL‐1β immunoreactivity in the PVN of 
targeted Gαi2 or control scrambled ICV oligodeoxynucleotide‐infused SD rats.   
Representative photomicrographs of IL‐1β immunoreactivity in the paraventricular nucleus (PVN) 
of targeted Gαi2 or control scrambled (SCR) intracerebroventricular oligodeoxynucleotide (ODN)‐
infused [25 µg/ 6 µl/ day for 7 days] male Sprague–Dawley rats on 7 days of normal‐salt (NS; 0.6% 
NaCl) or high‐salt (HS; 4% NaCl) diet. (a) SCR ODN‐infused rat on NS diet. (b) SCR ODN‐infused 
rat on HS diet. (c) Gαi2 ODN‐infused rat on NS diet. (d) Gαi2 ODN‐infused rat on HS diet. 
Abbreviation: 3V, third ventricle. (n = 6 per group, scale bars: 200 µm; large images ×20 






Figure 3.6: Representative photomicrographs of TNFα immunoreactivity in the PVN of 
targeted Gαi2 or control scrambled ICV oligodeoxynucleotide‐infused SD rats. 
Representative photomicrographs of TNFα immunoreactivity in the paraventricular nucleus (PVN) 
of targeted Gαi2 or control scrambled (SCR) intracerebroventricular oligodeoxynucleotide (ODN)‐
infused [25 µg/ 6 µl/ day for 7 days] male Sprague–Dawley rats on 7 days of normal‐salt (NS; 0.6% 
NaCl) or high‐salt (HS; 4% NaCl) diet. (a) SCR ODN‐infused rat on NS diet. (b) SCR ODN‐infused 
rat on HS diet. (c) Gαi2 ODN‐infused rat on NS diet. (d) Gαi2 ODN‐infused rat on HS diet. 







Figure 3.7: Representative photomicrographs of TNFα immunoreactivity in the PVN of 
targeted Gαi2 or control scrambled ICV oligodeoxynucleotide‐infused SD rats. 
Representative photomicrographs IL‐10 immunoreactivity in the paraventricular nucleus (PVN) of 
targeted Gαi2 or control scrambled (SCR) intracerebroventricular oligodeoxynucleotide (ODN)‐
infused [25 µg/ 6 µl/ day for 7 days] male Sprague–Dawley rats on 7 days of normal‐salt (NS; 0.6% 
NaCl) or high‐salt (HS; 4% NaCl) diet. (a) SCR ODN‐infused rat on NS diet. (b) SCR ODN‐infused 
rat on HS diet. (c) Gαi2 ODN‐infused rat on NS diet. (d) Gαi2 ODN‐infused rat on HS diet. 
Abbreviation: 3V, third ventricle. (n = 6 per group, scale bars: 200 µm; ×20 magnification, insets 
×40 magnification; arrows point to IL‐10 stain.) 
 
Impact of brain Gαi2 protein downregulation during 7 days of high salt intake on 
PVN microglia and astrocytes: Immunohistochemistry for OX‐42 (CD11b/c; microglial 
antigen) in control SCR ODN‐infused male Sprague–Dawley rats demonstrated that 7 days 
of HS diet had no impact on PVN microglial density, assessed as the average number of 
microglia (Figure 3.8) or as microglial activation (Figure 3.9). In contrast, in hypertensive 
male Sprague–Dawley rats receiving a targeted Gαi2 ODN infusion, the HS diet increased 
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PVN microglial recruitment (Gαi2 ODN; number of microglia: NS 22 ± 8 versus HS 35 ± 
7, P < 0.05; Figure 3.8) and activation (Gαi2 ODN; activation of microglia: NS 17 ± 6 
versus HS 29 ± 2%, P < 0.05; Figure 3.9). Central minocycline co‐infusion in control SCR 
ODN‐infused rats maintained on 7 days of HS intake reduced average microglial density 
without impacting levels of microglial activation (Figures 3.8 and 3.9). Significantly, 
central minocycline co‐infusion abolished the HS diet‐evoked increase in microglial 
infiltration and activation in rats receiving a Gαi2 ODN infusion (Gαi2 ODN; number of 
microglia: HS 36 ± 7 versus HS + MINO 16 ± 6, P < 0.05; Figure 3.8; activation of 
microglia: HS 29 ± 2 versus HS + MINO 13 ± 6%, P < 0.05; Figure 3.9). 
 
Figure 3.8: Representative photomicrographs (20X) of microglia in the PVN of targeted 
Gαi2 or control scrambled ICV oligodeoxynucleotide‐infused SD rats.  
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(a–f) Representative photomicrographs of microglia (primary antibody against OX‐42) in the 
paraventricular nucleus (PVN) of targeted Gαi2 or control scrambled (SCR) intracerebroventricular 
oligodeoxynucleotide (ODN)‐infused [25 µg/ 6 µl/ day for 7 days] and minocycline (MINO)–ODN 
co‐infused [ODN, 25 µg/ 6 µl/ day; MINO, 120 µg/ day for 7 days in HS only] male Sprague–
Dawley rats on 7 days of normal‐salt (NS; 0.6% NaCl) or high‐salt (HS; 4% NaCl) diet. (a) SCR 
ODN‐infused rat on NS diet. (b) SCR ODN‐infused rat on HS diet. (c) SCR ODN‐infused rat on 
HS diet co‐infused with minocycline. (d) Gαi2 ODN‐infused rat on NS diet. (e) Gαi2 ODN‐infused 
rat on HS diet. (f) Gαi2 ODN‐infused rat on HS diet co‐infused with MINO (scale bars: 200 µm, 
×20 magnification). (g) Average number of PVN microglia in randomly selected 200 µm × 200 µm 
box in Sprague–Dawley rats during SCR or Gαi2 ODN infusion maintained on NS or HS diet and 
minocycline–ODN co‐infusion on HS diet. Abbreviation: 3V, third ventricle. (n = 6 per 
group, * P < 0.05 versus NS in respective ODN treatment group; τ P < 0.05 versus HS in respective 





Figure 3.9: Representative photomicrographs (40X) of microglia in the PVN of targeted 
Gαi2 or control scrambled ICV oligodeoxynucleotide‐infused SD rats.  
Representative photomicrographs of microglia in the paraventricular nucleus (PVN) of targeted 
Gαi2 or control scrambled (SCR) intracerebroventricular oligodeoxynucleotide (ODN)‐infused 
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[25 µg/ 6 µl/ day for 7 days] and minocycline (MINO)–ODN co‐infused [ODN, 25 µg/ 6 µl/ day; 
MINO, 120 µg/ day for 7 days in HS only] male Sprague–Dawley rats on 7 days of normal‐salt 
(NS; 0.6% NaCl) or high‐salt (HS; 4% NaCl) diet. (a) SCR ODN‐infused rat on NS diet. (b) SCR 
ODN‐infused rat on HS diet. (c) SCR ODN‐infused rat on HS diet co‐infused with minocycline. 
(d) Gαi2 ODN‐infused rat on NS diet. (e) Gαi2 ODN‐infused rat on HS diet. (f) Gαi2 ODN‐infused 
rat on HS diet co‐infused with minocycline. (g) Impact of minocycline co‐infusion 
(120 µg day−1 for 7 days) on percentage activation of PVN microglia in Sprague–Dawley rats 
during SCR or Gαi2 ODN infusion maintained on HS diet. (h) Impact of minocycline on number 
of PVN active microglia in Sprague–Dawley rats during SCR or Gαi2 ODN infusion maintained 
on HS diet. (n = 6 per group, scale bars: 20 µm; green arrowheads indicate representative activated 
microglia; red arrowheads indicates representative inactivated microglia; ×40 
magnification; * P < 0.05 versus NS in respective ODN treatment group; τ P < 0.05 versus HS in 
respective ODN treatment group, mean ± SD.) 
 
Sholl analysis of microglia in control SCR ODN‐infused male Sprague–Dawley 
rats demonstrated that 7 days of HS diet had no impact on PVN microglial branching 
complexity, because there were no statistically significant differences in the trend lines 
(Figure 3.10a). In contrast, in hypertensive male Sprague–Dawley rats receiving a targeted 
Gαi2 ODN infusion, the HS diet significantly decreased the branching complexity of 
microglia, as shown by the decreased number of ring intersections along the entire trend 
line compared with animals on the NS diet (P < 0.05; Figure 3.10b). Central minocycline 
co‐infusion in control SCR ODN‐infused rats maintained on 7 days of HS diet significantly 
increased microglial branching complexity, as shown by a significant elevation in ring 
intersections distant from the soma (P < 0.05; Figure 3.10a). Significantly, central 
minocycline co‐infusion abolished the HS diet‐evoked reduction in microglial branching 




Figure 3.10: Sholl analyses of microglia in the PVN of targeted Gαi2 or control scrambled 
ICV oligodeoxynucleotide‐infused and minocycline co‐infused SD rats. 
Sholl analyses of microglia in the paraventricular nucleus (PVN) of the hypothalamus of targeted 
Gαi2 or control scrambled (SCR) intracerebroventricular oligodeoxynucleotide (ODN)‐infused 
[25 µg/ 6 µl/ day for 7 days] and minocycline (MINO)–ODN co‐infused [ODN, 25 µg/ 6 µl/ day; 
MINO, 120 µg/ day for 7 days in HS only] male Sprague–Dawley rats on 7 days of normal‐salt 
(NS; 0.6% NaCl) or high‐salt (HS; 4% NaCl) diet. Sholl analysis of microglia, depicting branching 
intersections as a function of radius from the soma, in: (a) control SCR ODN‐infused animals on 
NS and HS diets and SCR ODN–minocycline co‐infused animals on HS diet; and (b) targeted 
Gαi2 ODN‐infused animals on NS and HS diets and Gαi2 ODN–minocycline co‐infused animals 
on HS diet. (* P < 0.05 versus HS in respective ODN treatment group, mean ± SD.) 
 
Immunohistochemistry for the astrocytic marker GFAP demonstrated that, in both 
control SCR and targeted Gαi2 ODN‐infused rats, the dietary salt intake had no impact on 




Figure 3.11: Representative photomicrographs of astrocytes in the third level of the PVN of 
targeted Gαi2 or control scrambled ICV oligodeoxynucleotide‐infused SD rats. 
(a–d) Representative photomicrographs of astrocytes in the third level of the paraventricular 
nucleus (PVN) of targeted Gαi2 or control scrambled (SCR) intracerebroventricular 
oligodeoxynucleotide (ODN)‐infused [25 µg/ 6 µl/ day for 7 days] male Sprague–Dawley rats on 
7 days of normal‐salt (NS; 0.6% NaCl) or high‐salt (HS; 4% NaCl) diet. (a) SCR ODN‐infused rat 
on NS diet. (b) SCR ODN‐infused rat on HS diet. (c) Gαi2 ODN‐infused rat on NS diet. (d) 
Gαi2 ODN‐infused rat on HS diet. (e) Percentage tissue composition of astrocytes in the PVN of 
Sprague–Dawley rats during SCR or Gαi2 ODN infusion maintained on NS or HS diet. 




Impact of brain Gαi2 protein downregulation during 7 days of high salt intake on 
SFO microglia and cytokines: Immunohistochemistry for OX‐42 (CD11b/c; microglial 
antigen) demonstrated that 7 days of HS diet had no impact on SFO microglial density, 
number of active microglia or percentage of active microglia, regardless of ODN infusion 
(Figure 3.12). Furthermore, minocycline co‐infusion had no statistically significant impact 
on the aforementioned parameters, regardless of ODN infusion. 
 
Figure 3.12: Representative photomicrographs (20X) of microglia in the SFO of targeted 
Gαi2 or control scrambled ICV oligodeoxynucleotide‐infused SD rats 
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(a–f) Representative photomicrographs of microglia (primary antibody against OX‐42) in the 
subfornical organ (SFO) of targeted Gαi2 or control scrambled (SCR) intracerebroventricular 
oligodeoxynucleotide (ODN)‐infused [25 µg/ 6 µl/ day for 7 days] and minocycline (MINO)–ODN 
co‐infused [ODN, 25 µg/ 6 µl/ day; MINO, 120 µg/ day for 7 days in HS only] male Sprague–
Dawley rats on 7 days of normal‐salt (NS; 0.6% NaCl) or high‐salt (HS; 4% NaCl) diet. (a) SCR 
ODN‐infused rat on NS diet. (b) SCR ODN‐infused rat on HS diet. (c) SCR ODN‐infused rat on 
HS diet co‐infused with minocycline. (d) Gαi2 ODN‐infused rat on NS diet. (e) Gαi2 ODN‐infused 
rat on HS diet. (f) Gαi2 ODN‐infused rat on HS diet co‐infused with MINO. (g) Impact of 
minocycline co‐infusion (120 µg day−1 for 7 days) on percentage activation of PVN microglia in 
Sprague–Dawley rats during SCR or Gαi2 ODN infusion maintained on HS diet. (h) Impact of 
minocycline co‐infusion (120 µg day−1 for 7 days) on number of active PVN microglia in Sprague–
Dawley rats during SCR or Gαi2 ODN infusion maintained on HS diet. (I) Impact of minocycline 
co‐infusion (120 µg day−1 for 7 days) on total number of PVN microglia in Sprague–Dawley rats 
during SCR or Gαi2 ODN infusion maintained on HS diet. (n = 6 per group, scale bar: 200 µm, ×20 
magnification, mean ± SD.) 
 
Immunohistochemistry in the subfornical organ suggested that 7 days of HS diet 
elicited no change in SFO PIC protein levels of IL‐6, IL‐1β or TNFα, or anti‐inflammatory 





Figure 3.13: Representative photomicrographs of cytokine immunoreactivity in the SFO of 
targeted Gαi2 or control scrambled ICV oligodeoxynucleotide‐infused SD rats. 
Representative photomicrographs of cytokine immunoreactivity in the subfornical organ (SFO) of 
control scrambled (SCR; a,c,e,g) or targeted Gαi2 (b,d,f,h) intracerebroventricular 
oligodeoxynucleotide (ODN)‐infused [25 µg/ 6 µl/ day for 7 days] male Sprague–Dawley rats on 
7 days of high‐salt (HS; 4% NaCl) diet. (a,b) IL‐6 stain. (c,d) IL‐1β stain. (e,f) TNFα stain. (g,h) 








Figure 3.14: Validation of antibodies used in microglial, astrocyte, and cytokine 
immunohistochemistry. 
(A-M) Photomicrographs of immunoreactivity in the paraventricular nucleus (PVN) of the 
hypothalamus in male Sprague Dawley rats infused with targeted Gαi2 intracerebroventricular 
(ICV) oligodeoxynucleotide (ODN) on high salt (4% NaCl, HS) diet. (A) Gαi2 ODN infused rat 
on HS diet with primary antibody (1° Ab) against rat IL-1β and secondary antibody (2° Ab) 
against mouse IgG, (B) Gαi2 ODN infused rat on HS diet with 1° Ab against IL-1β and no 2° Ab, 
(C) Gαi2 ODN infused rat on HS diet with 1° Ab against rat IL6 and 2° Ab against mouse IgG, 
(D) Gαi2 ODN infused rat on HS diet with 1° Ab against rat IL-6 and no 2° Ab, (E) Gαi2 ODN 
infused rat on HS diet with 1° Ab against rat IL-10 and 2° Ab against mouse IgG, (F) Gαi2 ODN 
infused rat on HS diet with 1° Ab against rat IL-10 and no 2° Ab, (G) Gαi2 ODN infused rat on 
HS diet with 1° Ab against rat TNFα and 2° Ab against mouse IgG, (H) Gαi2 ODN infused rat on 
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HS diet with 1° Ab against rat TNFα and no 2° Ab, (I) Gαi2 ODN infused rat on HS diet with 1° 
Ab against rat OX-42 and 2° Ab against mouse IgG, (J) Gαi2 ODN infused rat on HS diet with 1° 
Ab against rat OX-42 and no 2° Ab, (K) Gαi2 ODN infused rat on HS diet with 1° Ab against rat 
GFAP and 2° Ab against mouse IgG, (L) Gαi2 ODN infused rat on HS diet with 1° Ab against rat 
GFAP and no 2° Ab, and (M) Gαi2 ODN infused rat on HS diet with no 1° Ab and 2° Ab against 
mouse IgG. (Images at 20X, scale bar = 200 µm). 
 
Discussion 
The present study was designed to investigate the potential involvement of central 
inflammation in Gαi2 protein‐dependent, ssHTN. First, we demonstrated that PVN 
inflammation, but not SFO inflammation, involving increased PVN PIC levels, PVN 
microglial activation and infiltration, occurred in Gαi2 protein‐dependent, ssHTN. 
Additionally, central administration of minocycline, a known inhibitor of microglia, 
attenuated PVN microglial activation and infiltration, abolished PVN inflammation, 
attenuated the elevation in plasma norepinephrine and attenuated the magnitude of HTN in 
Gαi2 ODN‐infused rats fed a HS diet. These data together suggest a new mechanism 
whereby microglial activation and PVN inflammation contribute to the development of 
Gαi2 protein‐dependent, ssHTN and suggest a potential role of Gαi2 protein signaling in 
countering PVN inflammatory processes during HS intake in the salt‐resistant Sprague–
Dawley rat. 
In agreement with our previous data generated in male Sprague–Dawley rats 
(Kapusta et al., 2013), we observed the development of sympathetically mediated ssHTN 
after the central ODN‐mediated downregulation of Gαi2 proteins. These data extend our 
earlier report that Gαi2 protein downregulation evokes ssHTN after 21 days of 8% NaCl 
intake (Kapusta et al., 2013), confirm our data generated in Dahl salt‐resistant rats that 
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Gαi2 protein downregulation evokes HTN by day 7 (Wainford et al., 2015) and establish 
that the salt sensitivity of blood pressure after central downregulation of Gαi2 protein 
develops at a lower, more physiologically relevant dietary intake level (4% NaCl). Owing 
to the incompatible methods of tissue preparation for immunohistochemistry 
(paraformaldehyde fixation) and western blotting (snap‐freezing) of PVN tissue, it was not 
possible to validate Gαi2 protein knockdown in animals in which microglia and cytokine 
expression were assessed by immunohistochemistry. However, to determine whether 
minocycline co‐infusion was impacting ODN‐mediated Gαi2 protein downregulation, in 
separate groups of animals co‐infused with Gαi2 or SCR ODN and minocycline, we 
performed immunoblotting of PVN punches. In these animals, minocycline did not impact 
ODN infusion, and Gαi2 ODN infusion successfully reduced PVN Gαi2 protein expression 
by 79%. In certain groups of animals in which we were unable to validate knockdown via 
western blot, blood pressure and plasma NE concentrations were used as a physiological 
measure of the development of ssHTN (Carmichael et al., 2016; Kapusta et al., 2013; 
Wainford et al., 2015). Despite experimental limitations preventing the confirmation of 
Gαi2 protein knockdown, based on our many earlier publications demonstrating the 
efficacy of our ODN approach to downregulate central Gαi2 proteins acutely and 
chronically, our confirmatory studies presented in minocycline‐infused animals, and the 
clear differences observed in Gαi2 versus SCR ODN‐infused animals in several 
inflammatory markers, we are confident that Gαi2 knockdown was achieved. 
Several studies, conducted in different models of HTN, including the spontaneously 
hypertensive rat and the angiotensin II infusion model in Sprague–Dawley rats, have 
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reported the presence of neuroinflammation, including increased production of pro‐
inflammatory cytokines (Bardgett et al., 2014; Biancardi et al., 2016; P. Shi et al., 2010). 
A recent study conducted in the DSS rat model also reported an upregulation of PVN pro‐
inflammatory cytokines in response to high dietary sodium intake (Jiang et al., 2018). As 
such, we elected to investigate the potential role of PVN inflammation in our salt‐sensitive 
Gαi2 protein‐dependent ssHTN model. On day 7 of high salt intake, we observed increased 
PVN PIC production of IL‐6, IL‐1β and TNFα mRNA. Interestingly, 
immunohistochemistry for these cytokines in the PVN suggested the increased protein 
expression of IL‐6 and IL‐1β only. It is possible that TNFα protein levels may be increased 
only transiently during the development of ssHTN and are not required to maintain 
established HTN. Alternatively, it is possible that although TNFα mRNA is upregulated, 
the neuroinflammatory response observed after Gαi2 protein downregulation is TNFα 
independent, as reported in angiotensin II‐dependent HTN (Bardgett et al., 2014). At 
present, we are unable to determine the cell types to which pro‐inflammatory cytokines are 
localized. Given the high expression of multiple G‐Protein Coupled Receptors, 
metabotropic receptors containing alpha, beta and gamma subunits which activate upon 
ligand binding (GPCRs) in neurons and the impact of Gαi2 protein downregulation on 
sympathetic outflow, we speculate that the observed inflammatory processes might be 
occurring in neurons. To address this issue experimentally, future studies might use the 
double labelling of cells types in combination with cytokine expression to determine the 
cell type to which inflammatory cytokines in the PVN are localized. Interleukin‐10, an 
anti‐inflammatory cytokine, has previously been shown to be neuroprotective (P. Shi et al., 
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2010; Song et al., 2014). Levels of IL‐10 were downregulated at both the mRNA and 
protein levels during Gαi2 ODN infusion on the HS diet, suggesting a decrease in 
neuroprotective signaling in the PVN, consistent with literature suggesting that IL‐10 is 
protective against other forms of HTN (Drews et al., 2019; Segiet et al., 2019). Lastly, 
minocycline administration, which lowered blood pressure and plasma NE levels in 
Gαi2 ODN‐infused rats on a HS diet, restored mRNA levels of PIC and anti‐inflammatory 
cytokines to baseline, suggesting a direct role of neuroinflammation in Gαi2 protein‐
dependent ssHTN. We speculate that there is an imbalance between anti‐inflammatory and 
pro‐inflammatory mechanisms occurring within the PVN that contributes to the 
development of ssHTN, potentially via modulation of sympathetic outflow, a hypothesis 
supported by the recent data generated in DSS rats (Jiang et al., 2018). Given that in our 
previous study, we reported that an absence of PVN Gαi2 protein upregulation during high 
salt intake in the DSS rat contributes to sympathoexcitation and HTN (Wainford et al., 
2015), we speculate that impaired PVN Gαi2 protein signaling might contribute to PVN 
inflammation in the Dahl rat phenotype. 
To attempt to identify the source of the PICs being produced in the PVN in the 
setting of Gαi2 protein‐dependent ssHTN, we investigated the involvement of microglia 
and astrocytes. We elected to examine these as potential mediators of the observed increase 
in PICs because both microglia (innate immune cells in brain that are tightly linked to the 
production of PICs; (Galic et al., 2012; P. Shi et al., 2010)) and astrocytes (regulators of 
CNS inflammation;(Colombo & Farina, 2016; Pekny et al., 2014)) become activated in 
response to pathological stimuli (e.g. HTN). Our immunohistochemical analysis revealed 
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no impact of central Gαi2 protein downregulation on PVN astrocytic density or 
immunoreactivity irrespective of dietary salt intake or HTN. These data suggest that 
Gαi2 protein‐dependent ssHTN occurs independently of astrocyte activation. This finding 
supports earlier studies conducted in the angiotensin II‐dependent model of HTN that 
reported an absence of astrocyte recruitment despite the presence of HTN and PVN 
inflammation (Pekny et al., 2014; X. Z. Shen et al., 2015; Verkhratsky & Nedergaard, 
2018; Zubcevic et al., 2017). When examining PVN microglia, we saw increased 
microglial infiltration (assessed as the number of microglia present within the PVN) and 
activation of microglia, as indicated by reduction in cell size and decreased branching 
complexity on Sholl analysis, suggesting that microglia play a role in the inflammation 
observed in Gαi2 protein‐dependent ssHTN. Additionally, microglial infiltration, 
activation and PIC production were not observed in the SFO, a chemosensitive region 
important in blood pressure regulation. Given that activated microglia are primary 
producers of CNS PICs, this observation might suggest that the inflammatory mechanism 
in our model of HTN is PVN specific. Further studies, beyond the scope of the present 
study, might be undertaken to investigate the potential role of inflammation in other neural 
control regions, such as the rostral ventrolateral medulla. To test the role of microglia in 
the observed PVN inflammatory response, we infused minocycline (inactivator of 
microglia; (Yoon, Patel, & Dougherty, 2012)). In rats in which central Gαi2 proteins were 
downregulated, minocycline co‐infusion abolished PVN microglial infiltration and 
activation, abolished PIC upregulation at the mRNA level, prevented elevations in plasma 
NE and significantly attenuated the magnitude of dietary sodium‐evoked HTN. Therefore, 
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we hypothesize that PVN microglia evoke central inflammation that contributes 
significantly, possibly via modulation of sympathetic outflow, to the pathophysiology of 
Gαi2 protein‐dependent ssHTN. To elucidate the potential causal relationship between 
microglial activation, PIC production and Gαi2 protein‐dependent ssHTN, future studies, 
beyond the scope of the present investigations, will assess the time course of microglial 
activation, PIC production and development of HTN. Additionally, we have not 
characterized the impact of minocycline on PVN neuron excitability 
electrophysiologically. It is possible that minocycline, which has been demonstrated in 
subpopulations of neurons to modulate excitability (Liu, Zhang, Zhu, Luo, & Liu, 2015)), 
operates independently of microglia to decrease the intrinsic excitability of PVN 
presympathetic neurons. 
Collectively, these data indicate that Gαi2 protein signal transduction is a novel 
CNS mechanism that influences PVN inflammation in response to a chronic HS challenge 
to counter the development and magnitude of sympathetically mediated ssHTN. Our 
present findings also suggest a potential role of Gαi2 protein signaling in countering PVN 
inflammatory processes during HS intake to prevent the development of ssHTN. Given 
that we observed attenuated plasma NE and reductions in PIC and MAP after minocycline 
infusion, we speculate that microgliosis contributes significantly to Gαi2 protein‐dependent 
ssHTN. Our data add to our understanding of the CNS inflammatory pathways influencing 
blood pressure regulation and contribute to the growing body of evidence that PVN PIC 
pathways have a direct influence on sympathetic outflow (Z. Shi et al., 2011). Increased 
understanding of the PVN inflammatory responses to elevations in dietary salt intake has 
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implications for the development of ssHTN. We speculate that PVN neuro‐inflammation, 
mediated by microglial activation, plays a significant role in the pathophysiology of disease 
states in which sympathoexcitation is evident (e.g., several forms of HTN, heart failure) 
and represents a potential therapeutic target. After our report of a positive association 
between the single nucleotide polymorphism rs10510755 in the human GNAI2 gene and 
the salt sensitivity of blood pressure, independently of sex or age, in the Genetic 
Epidemiology of Salt Sensitivity data set (X. Zhang, Frame, Williams, & Wainford, 2018), 
our data have translational implications for the development of personalized anti‐




CHAPTER FOUR: High Salt Diet-Induced PVN Inflammation and 
Sympathoexcitation Occurs in Male but not Female Rats Lacking Central Gαi2 
Proteins 
Introduction 
Hypertension (HTN) is a critical public health issue that is estimated to impact one 
in two adults in the United States (Reboussin et al., 2018). Additionally, HTN is the leading 
risk factor for chronic kidney disease, myocardial infarction, and stroke (Lloyd-Jones et 
al., 2010; D. Mozaffarian et al., 2014). The salt sensitivity of blood pressure, an 
exaggerated pressor reflex to elevated dietary sodium intake, is a significant contributor to 
HTN. The impact of the salt sensitivity of blood pressure on HTN risk is compounded by 
the fact that the average American consumes an excess of three times the American Heart 
Association’s recommended daily intake of sodium (Lloyd-Jones et al., 2010).  
 
Our laboratory has previously demonstrated that site-specific upregulation of 
Guanine Nucleotide–Binding Protein Alpha Inhibiting Activity Polypeptide 2 subunit 
(Gαi2) proteins in the paraventricular nucleus (PVN) of the hypothalamus is critical to the 
maintenance of salt resistance in male Sprague-Dawley (SD) and Dahl Salt-Resistant rats 
(Kapusta et al., 2013; Wainford et al., 2015). Additionally, a failure to upregulate these 
proteins in response to elevated sodium intake results in salt-sensitive HTN (ssHTN) in 
male rats (Kapusta et al., 2013; Moreira et al., 2019). Research in multiple models of HTN, 
including angiotensin-II dependent HTN, has demonstrated a role for PVN inflammation 
in the development of HTN. We recently demonstrated that in the absence of central Gαi2 
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proteins elevated dietary sodium intake evokes significant microglial-mediated PVN 
inflammation and sympathoexcitation, as well as ssHTN in male SD rats (Moreira et al., 
2019). Moreover, our work demonstrated that inhibition of microglial activation abolished 
dietary sodium-evoked pro-inflammatory cytokine (PIC) production and increased 
sympathetic outflow and attenuated the magnitude of HTN. These data suggest a 
correlation between PVN inflammation and the development of ssHTN. 
 
It remains unknown if PVN inflammation is a result of HTN and elevated 
sympathetic outflow or if inflammation precedes and possibly drives these phenomena. 
Additionally, the role of central Gαi2 proteins in mediating salt resistance in female rats is 
unknown. We hypothesized that PVN inflammation precedes sympathoexcitation, and 
likely drives the development of sympathetically-mediated ssHTN in the absence of central 
Gαi2 proteins in both male and female SD rats. To test this hypothesis, we infused male 
and female SD rats with either scrambled control (SCR) or targeted Gαi2 
oligodeoxynucleotides (ODN) and challenged them with a normal or high salt diet over a 
7-day time course. We assessed PVN inflammation, plasma and renal norepinephrine (NE) 




Three-month old male and female SD rats weighing 275–300g and 200–225g, 
respectively, were purchased from Envigo (Indianapolis, IN). Animals were pair-housed 
before surgical intervention and individually-housed post-operatively. All animals were 
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housed in the Boston University School of Medicine Laboratory Animal Science Center, a 
temperature (range 20–26°C) and humidity (range 30–70%) controlled facility, on a 12:12 
hour light:dark cycle, and were allowed tap water and standard irradiated rodent diet, which 
we will refer to as normal salt diet, (NS, 0.6% NaCl, Envigo Teklad, Teklad Global Diet 
No. 2918, 18% protein, 5% crude fat, 5% fiber, total potassium (K+) content 0.6%, total 
NaCl content 0.6% [174 mEq Na+/kg]) ad libitum. Rats were randomly assigned to 
experimental groups.  All animal protocols were approved by the Boston University 
Institutional Animal Care and Use Committee (IACUC) under protocol number AN15241 
and in accordance with the National Institutes of Health Guide for the Care and Use of 
Laboratory Animals (8th edition). Euthanasia was conducted in accordance with approved 




Intracerebroventricular Oligodeoxynucleotide Infusions: 
Intracerebroventricular (ICV) oligodeoxynucleotide (ODN) infusions were 
performed as previously described (Moreira et al., 2019; Wainford et al., 2015). In brief, 
animals were anesthetized [ketamine 30 mg/kg IP + xylazine 3 mg/kg IP] and 
stereotaxically implanted with a stainless-steel cannula (PlasticsOne) in the right lateral 
cerebral ventricle. The cannula was connected via silastic tubing (PlasticsOne) to a 
subcutaneous Alzet Osmotic Minipump (Durect Corporation, Model 2004) filled with 
either scrambled (SCR) control (sequence: 5′‐GGGCGAAGTAGGTCTTGG‐3′) or Gαi2 
targeted (sequence: 5′‐CTTGTCGATCATCTTAGA‐3′)(Carmichael et al., 2020; Moreira 
et al., 2019; Wainford & Kapusta, 2012) ODN (Midland Certified Reagents, Midland, TX). 
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ODNs were infused at a rate of 25μg/ 6µl/ day. In our prior work, we utilized the National 
Center for Biotechnology Information Basic Local Alignment Search Tool (BLAST) to 
validate a lack of similarity between our SCR ODN sequence and known Rattus norvegicus 
gene sequences, and the specificity of our targeted Gαi2 ODN for the Gαi2 subunit protein 
sequence (Wainford & Kapusta, 2012). Due to the nature of fixation for 
immunohistochemical staining, it was not possible to immunoblot for Gαi2 proteins in 
animals in which microglial reactivity was assessed, and so day 7 mean arterial pressure 
(MAP), sodium balance, and levels of circulating and renal norepinephrine (NE), as known 
components of Gαi2 protein dependent ssHTN (Moreira et al., 2019; Wainford et al., 2013) 
were used to validate the phenotype in male animals. As we have not previously reported 
the efficacy of our targeted Gαi2 ODN in female rats, brains from female rats in which 
sodium balance studies and plasma and renal NE content analysis were conducted were 
used for immunoblotting, and alternative groups were run to assess immunohistochemical 
markers of neuroinflammation. 
Acute Femoral Artery and Femoral Vein Cannulation: 
On day 7 of high salt (4% NaCl, HS) diet, subsets of male and female animals 
infused with either a Gαi2 or SCR ODN on a NS or HS diet were anesthetized [sodium 
brevital 20 mg/kg IP supplemented 10 mg/kg IV as necessary] and the left femoral triangle 
was dissected out. The left femoral vein was cannulated using a PE50 catheter for the 
infusion of IV anesthetics and IV isotonic saline, and the left femoral artery cannulated in 
the same manner for the measurement of MAP. Rats were placed in a plexiglass rat holder 
and an isotonic infusion of saline (20 μL/ min IV) was given over a 2-hour recovery period 
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allowing rats to return to full consciousness and stable renal and cardiovascular function. 
MAP and heart rate (HR) were recorded continuously via the femoral artery cannula using 
computer driven BIOPAC data acquisition software (MP150 and AcqKnowledge 3.8.2; 
BIOPAC Systems In., Goleta, CA, USA) connected to an external pressure transducer 
(P23XL; Viggo Spectramed Inc., Oxnard, CA, USA) (Carmichael et al., 2020). 
Transcardial Perfusion: 
Subsets of male and female animals used for immunohistochemical analysis of the 
paraventricular nucleus (PVN) were sacrificed via transcardial perfusion as previously 
described . In brief, animals were deeply anesthetized [ketamine 30 mg/kg IP + xylazine 3 
mg/kg IP] and perfused with ice-cold 0.1M phosphate buffered saline until the liver and 
kidneys cleared, and then with 4% paraformaldehyde in 0.1M PBS. Brains were extracted 
and post-fixed in 4% paraformaldehyde for 24 hours, and switched to 30% sucrose in 0.1M 
PBS for 72 hours, and stored at 4°C until processing.  
Experimental Approaches: 
Experimental Diet: 
After a 5-day recovery following ICV implantation, to allow potential 
inflammation from surgery to subside, animals were placed on a NS or experimental HS 
(Envigo Teklad Diets, TD.03095, 19% protein, 5% crude fat, 3% fiber, total K+ content 
0.8%, total NaCl content 4% [678 mEq Na+ /kg]) diet for a 1–7-day period and were then 




Metabolic balance studies: 
Metabolic balance studies were conducted in male and female SD rats. In brief, rats 
were continuously housed individually in metabolic cages with ad libitum access to food 
and water. Following 48 h acclimatization, all rats underwent a 2-day baseline period on a 
NS diet prior to assignment to a 7-day experimental dietary period of HS intake. Food and 
water consumption and urine output were measured every 24 hours. Twenty four hour 
sodium balance was calculated as the difference between dietary sodium intake and urinary 
sodium excretion, as previously described (Kapusta et al., 2013; Kapusta et al., 2012; 
Moreira et al., 2019; Wainford et al., 2015). 
Plasma and Renal Norepinephrine and Plasma Estrogen Analysis: 
On days 1, 3 and 7 of the dietary sodium challenge subgroups of male rats 
(n=5/group/day) and on day 7 of the dietary sodium challenge subgroups of female rats 
were sacrificed via conscious decapitation and blood and kidneys were collected. Plasma 
was isolated from whole blood and was stored with kidneys at -80°C until use. Plasma and 
Renal NE content was analyzed via ELISA (IB89552, IB89537 respectively; Immuno‐
Biological Laboratories, Inc., Minneapolis, MN, USA) according to manufacturer’s 
instructions and as previously described (Carmichael et al., 2016; Frame, Carmichael, et 
al., 2019; Moreira et al., 2019; Wainford et al., 2015). From the same blood samples 
analyzed for plasma NE in female rats, plasma estrogen levels were determined to identify 
any potential differences across groups that may impact other study parameters. In brief, 
plasma extracted from rats was analyzed via ELISA (IB79329 Immuno‐Biological 




Brains were sectioned on a cryostat and 40 micrometer thick sections were placed 
into a storage cryoprotectant solution containing 1M saline, 30% sucrose, 0.1% 
polyvinylpyrrolidone, and 30% ethylene glycol and stored at 4°C until staining.  
Immunohistochemistry for microglial reactivity and astrocyte reactivity were 
performed in 6-well plates as previously described. Briefly, sections were washed in 0.1M 
PBS, blocked in 1% hydrogen peroxide and in 3% horse serum, and permeabilized in 
0.25% Triton-X, and primary antibodies directed against rat CD 11 b/c (clone OX-42, BD 
Biosciences Cat# 550299, RRID:AB_393594, 1:100)(Moreira et al., 2019) or rat GFAP 
(Abcam catalogue no. ab53554, RRID:AB_880202, 1:500, Cambridge, MA, USA) were 
used in conjunction with secondary biotinylated antibodies (Vector Laboratories Cat# BA-
9200 RRID:AB_2336171, 1:100 and BA-9500 RRID: AB_2336123, 1:1000)(Moreira et 
al., 2019). Vector Laboratories VECTASTAIN Elite ABC HRP kits (Vector Laboratories, 
Fisher Sci, Cat# NC9313719) and Nickel-DAB substrate was used for staining of 
biotinylated secondary antibodies (Moreira et al., 2019). Sections were wet mounted on 
gelatin-subbed slides (Southern Biotechnology), dehydrated in a sequential series of water, 
ethanol, and xylenes and cover slipped using Toluene permount solution UN1294 (Toluene 
Solution, Fisher Chemical) (Moreira et al., 2019).  
Immunofluorescence: 
Brains were sectioned on a cryostat at 40 micrometer thick sections throughout the 
brain and slices were placed into a storage cryoprotectant solution until staining. 
Immunofluorescence for cytokine production was performed in 6-well plates. Sections 
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were washed in 0.1M PBS, blocked in 3% horse serum, permeabilized in 0.25% Triton-X, 
and primary antibodies directed against pro-inflammatory cytokines (PICs) rat interleukin 
(IL)-6 (Santa Cruz Biotechnology catalogue no. sc‐28343, RRID:AB_627805, 1:100, 
Santa Cruz, CA, USA; (Moreira et al., 2019)), IL-1β (Santa Cruz Biotechnology catalogue 
no. sc‐32294, RRID:AB_627790, 1:100, Santa Cruz, CA, USA; (Moreira et al., 2019)), 
tumor necrosis factor (TNF)α (Santa Cruz Biotechnology catalogue no. sc‐133192, 
RRID:AB_1567355, 1:100, Santa Cruz, CA, USA; (Moreira et al., 2019)), were used. 
Secondary antibodies conjugated to Alexa Fluor 488 and directed against mouse IgG were 
used (Invitrogen catalogue no. A11001, RRID: AB_2534069, 1:200, Waltham, MA, USA) 
to detect IL-6, IL-1β, and TNFα.  
Microscopy and Image Analysis: 
Microscopy was performed on a Keyence BZ-9000 Fluorescence Microscope set 
to bright field for IHC or fluorescence for IF. Images were captured at 20X and 40X 
magnification. Brain structures were identified using Paxinos & Watson The Rat Brain 
Atlas as previously described (Moreira et al., 2019). The PVN was identified between ~ 
Bregma -1.8 and Bregma -2.0, representing the caudal segment of level 1, all of level 2, 
and the rostral segment of level 3 of the PVN. A majority of slices contained level 2 as 
previously reported (Moreira et al., 2019), as the major pre-sympathetic subnuclei (the 
dorsal parvocellular or dorsal cap and ventrolateral parvocellular) are all present in the 
same slice at this level and thus local inflammation to these neurons may be the most 
relevant, if present.   
To analyze microglial morphology, on blinded images in each animal, a 200 micron 
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by 200 micron box was drawn and the microglia within the box were counted for total 
number. Then, a reactivity assessment was performed as previously described (Moreira et 
al., 2019). Briefly, each cell was assessed and scored as either ramified or reactive, with 
the criteria being that a cell must be darkly immunoreactive as well as possess cellular 
projections that are of no greater length than the approximate soma size (~5 microns). 
Microglial reactivity was then compared to SCR ODN infused controls as total number, 
number reactive, and percent of microglia within the scored area that were reactive.  
Astrocytes were analyzed as previously described (Moreira et al., 2019). In brief, 
on ImageJ software, images were converted to 16-bit and set to ‘Image → Type → RGB’ 
and then analysis was performed to quantify the percent area of the PVN that the astrocytes 
composed. Astrocytes were quantified (in pixels) and divided by the total number of pixels 
in the PVN to obtain a percentage tissue density. 
Cytokine analysis was performed using Image J/FIJI (ImageJ 1.52p, Java 
1.8.0_172; US National Institutes of Health). Blinded images of fluorescent cytokine stains 
in the PVN were opened, and the threshold of brightness was adjusted to remove 
background signal for the analysis. Only brightly stained puncta were counted. Once 
background was reduced, the image was converted to 16 bit and a threshold selection 
function was used to select just the fluorescent punctae, and then a percent area of the PVN 
area was calculated and compared across groups and timepoints.  
Sholl analysis of microglia: 
Sholl analysis was conducted as previously described (Moreira et al., 2019). In brief, 
images were blinded and shuffled, and each image was opened in Adobe CC Photoshop 
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(Adobe, 20.0.4 20190227.r.76), and images were overlaid with a 5 × 2 grid. Ten microglia 
were randomly sampled from individual grid squares and cropped so that the new image 
contained only the single microglial cell and its processes. Each new cropped image was 
opened in ImageJ/FIJI (ImageJ 1.52p, Java 1.8.0_172; US National Institutes of Health), 
converted to 8‐bit, and the ‘measure → threshold’ function was used to identify the 
microglia from the background. The selected microglial cell was then subjected to Sholl 
analysis via the ‘Analysis’ function of FIJI, where concentric rings were placed equally 
distant (1 µm) from one another, radiating outwards from the center of the soma. The 
number of ring intersections at each ring, for a distance of 25 rings, was saved and analyzed 
using GraphPad Prism software (v.8; GraphPad Software, La Jolla, CA, USA) and plotted 
as group means at each given ring with standard deviations. Student t-test was used to 
compare groups with one another at given radii form the soma to determine significant 
differences at those intersections in branch complexity(Moreira et al., 2019). 
Immunoblotting for PVN Gαi2 Protein in Female Rats 
Following a SCR or Gαi2 ODN infusion, a 5-day recovery period, and a 7-day NS or HS 
diet, fresh brains were extracted from female rats sacrificed via conscious decapitation and 
immediately frozen at -80°C. These brains were then mounted on a cryostat and PVN 
punches were taken using a brain punching tool (Stoelting Co., Wood Dale, IL, USA) as 
previously described (Kapusta et al., 2012; Wainford et al., 2015). Tissue lysates were 
prepared and measured via BCA as per manufacturer’s instructions (Thermo Scientific, 
Waltham, MA, USA). Lysates were resolved on a 7.5% SDS–PAGE gel and transferred to 
a nitrocellulose membrane (catalogue no. 456‐1033; BioRad, Hercules, CA, USA). Gαi2 
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protein levels were determined as previously published by our laboratory (Kapusta et al., 
2012; Moreira et al., 2019; Wainford et al., 2015) using primary antibodies purchased from 
Santa Cruz Biotechnologies (Santa Cruz, CA, USA), directed against Gαi2 (Santa Cruz 
Biotechnology catalogue no. sc‐13534, 1:200, RRID:AB_627644) and horseradish 
peroxidase-conjugated secondary antibodies from Abcam (Cambridge, MA, USA) against 
mouse IgG (Abcam catalogue no. Ab6789, 1:2000, RRID: AB_955439); protein levels 
were normalized to total protein via Coomassie Blue‐stained gels. Immunoreactive bands 
were detected via a horseradish peroxidase‐conjugated secondary antibody and data were 
imaged and semi‐quantified using Bio‐Rad Quantity One image analysis software. 
Statistical Analysis: 
Data are expressed as mean ± SD. Differences occurring between treatment groups 
(e.g., SCR vs. Gαi2 ODN in conjunction with dietary intake) were assessed by a two-way 
ANOVA with treatment group being one fixed effect and dietary intake the other, with the 
interaction included. Post hoc analysis was performed using Bonferroni’s test. Differences 
occurring between subgroups within ODN treatment group were assessed by an unpaired 
student t-test. Statistical analysis was carried out using a software program (GraphPad 
Prism v.8; GraphPad Software, CA). Statistical significance was defined as probability 
P<0.05. 
Results 
Targeted Gαi2 ODN infusion and a 7-day HS diet evokes sodium retention, 
sympathoexcitation and ssHTN in male rats: In 3-month-old male SD rats, a control central 
SCR ODN infusion, in conjunction with a 7-day HS diet evoked rapid and robust global 
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sympathoinhibition by day 1 (SCR ODN NS plasma NE [nmol/L] 6611 vs. HS Day 1 
4210; p<0.05) and reduced sympathetic outflow to the kidney by day 3 (SCR ODN NS 
renal NE [pg/mg] 51617 vs. SCR ODN HS D3 44863; p<0.05). Both global and renal 
specific sympathoinhibition were maintained for the full duration of the 7-day HS intake 
time course. In these same animals there was a transient increase in 24-h sodium balance 
on day 1 of HS intake and the maintenance of normotension (Figure 4.1). In contrast, an 
experimental Gαi2 ODN infusion in conjunction with a 7-day HS diet evoked ssHTN by 
day 7 (mean arterial pressure (MAP) [mmHg] D7: Gαi2 ODN NS 1243 vs. Gαi2 ODN HS 
1494; p<0.05). It also prevented the observed rapid sympathoinhibitory response 
observed in SCR ODN treated rats and elicited significant increases in global and renal 
specific sympathetic outflow by day 3 (Gαi2 ODN NS Plasma NE [nmol/L] 726 vs. Gαi2 
ODN HS D3 9511; p<0.05) (Gαi2 ODN NS Renal NE [pg/mg] 52278 vs. Gαi2 ODN HS 
D3 968109; p<0.05). In Gαi2 ODN infused rats, we observed significant increases in 24-
h sodium retention for days 1-5 of HS intake with a peak sodium of 5 mEq on day 2 of HS 




Figure 4.1: Day 7 Mean Arterial Pressure and Temporal Dynamics of Sodium Balance and 
Sympathetic Tone in Male SD Rats With and Without Central Gαi2 Proteins. 
Impact of intracerebroventricular (ICV) control scrambled (SCR) or targeted Gαi2 
oligodeoxynucleotide (ODN) infusion (25 μg/ 6μL/ day) and 7-day (A-B) or 1-7-day (C-
D) normal (NS, 0.6% NaCl) or high (HS, 4% NaCl) salt diet in 3 month old male Sprague-
Dawley rats on A) mean arterial pressure (MAP, mmHg) B) sodium balance (mEq/day), 
C) plasma norepinephrine (NE, nmol/L) and D) renal NE content (pg/mg) (*p<0.05 
compared to NS control within ODN infusion group, τp<0.05 compared to SCR ODN 
infusion at same time point; n=5/group, 2-way analysis of variance (ANOVA)). 
 
Targeted Gαi2 ODN infusion and a 7-day HS diet evokes PVN neuroinflammation in male 
rats: In contrast to control SCR ODN infused 3-month-old male SD rats on a HS diet, 
which display comparable levels of PVN microglial reactivity to SCR ODN infused 
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animals on NS diet, an experimental Gαi2 ODN infusion and HS diet evoked significant 
increases in PVN microglial activation by 24 hours (Gαi2 ODN NS percent microglia active 
per 40,000 μm2 sample area 12±4% vs. Gαi2 ODN HS D1 25±3%; p<0.05) that were 
maintained over the duration of the study (Figure 4.2). In these animals, the total number 
of microglia present in the sample area of the PVN was not significantly upregulated in 
Gαi2 ODN infused male rats until 72 hours post-placement on HS intake (Gαi2 ODN NS 
total number microglia per 40,000 μm2 sample area 17±3 vs Gαi2 ODN HS D3 29±3; 
p<0.05) and was maintained until day 7. Sholl analysis in these same animals revealed that 
the microglial branching complexity, evident as number of intersections in concentric rings 
radiating from the soma, was significantly decreased at proximal ring intersections 






Figure 4.2: Temporal Dynamics of High-Salt-Induced Microglial Activation in Male SD 
Rats With and Without Central Gαi2 Proteins. 
(A-B) Representative photomicrographs of microglia (OX-42 immunohistochemistry) in the 
hypothalamic paraventricular nucleus (PVN) of intracerebroventricular (ICV) control scrambled 
(SCR, A) or targeted Gαi2 (B) oligodeoxynucleotide (ODN) infused (25 μg/ 6μL/ day) male rats 
subjected to a 1-7-day normal (NS, 0.6% NaCl) or high (HS, 4% NaCl) salt diet. (C-D) 
Quantification of photomicrographs of PVN microglial activation expressed as (C) total number of 
all microglia and (D) percent of microglia active per 40,000 μm2 (scale bar = 20 μm, images 
captured at 40X, red arrows indicate examples of ramified microglia, green arrows indicate 
examples of active microglia, *p<0.05 compared to NS within ODN infusion group, n=5/group, 2-





Figure 4.3: Sholl Analysis of Microglial Branching Complexity on Day 1 of HS in Male SD 
Rats With and Without Central Gαi2 Proteins. 
Impact of intracerebroventricular (ICV) infusion of control scrambled (SCR) or targeted Gαi2 
oligodeoxynucleotide (ODN) infusion in conjunction with 7-day high (HS; 4% NaCl) salt diet on 
hypothalamic paraventricular nucleus (PVN) microglial morphology as assessed via Sholl analysis 
in 3-month-old male Sprague Dawley rats (*p<0.05 vs SCR ODN infusion at respective radius 
from soma, n=5/group at sampling rate of 10 microglia per animal for 50 microglia per group, 
unpaired student t-test). 
 
In 3-month-old male SD rats, Gαi2 ODN infusion and HS diet evoked significant 
increases in the immunofluorescence of the PIC IL-1β by day 3 and IL-6 by day 7 with no 
observable change in the expression of TNFα, in the PVN by day 7 of HS diet compared 
to SCR ODN and HS (Figures 4.4 and 4.5). Negative controls demonstrating selectivity of 









Figure 4.4: Immunofluorescent Stains of PVN Pro-Inflammatory Cytokines IL-1β and IL-6 
in Male SD Rats With and Without Central Gαi2 Proteins. 
(A-B) Representative photomicrographs of cytokine immunofluorescent staining (A, interleukin-6 
(IL-6)) and (B, interleukin-1β (IL-1β) in the hypothalamic paraventricular nucleus (PVN) of 
intracerebroventricular (ICV) control scrambled or targeted Gαi2 oligodeoxynucleotide (ODN) 
infused (25 μg/ 6μL/ day) male rats subjected to a 1-7-day high (4% NaCl) salt diet. (C-D) 
Quantification of positive immunofluorescent puncta in (A-B) as a percent pixel composition of 
total PVN area (scale bar = 200 μm, images captured at 20X, red arrows indicate positive puncta, 






Figure 4.5: Immunofluorescent Stain of PVN Pro-Inflammatory Cytokine TNFα in Male 
SD Rats With and Without Central Gαi2 Proteins. 
(A) Representative photomicrographs of cytokine immunofluorescent staining (A, tumor necrosis 
factor α (TNFα)) in the hypothalamic paraventricular nucleus (PVN) of intracerebroventricular 
(ICV) control scrambled or targeted Gαi2 oligodeoxynucleotide (ODN) infused (25 μg/ 6μL/ day) 
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male rats subjected to a 1–7-day high (4% NaCl) salt diet. (B) Quantification of positive 
immunofluorescent puncta in (A) as a percent pixel composition of total PVN area (scale bar = 200 
μm, images captured at 20X, red arrows indicate positive puncta, *p<0.05 compared to SCR ODN 
infusion control, n=5/group, 2-way analysis of variance (ANOVA)). 
 
 
Figure 4.6: Immunofluorescent Control Stain Omitting Primary Antibodies in the PVN of 
Male SD Rat Lacking Central Gαi2 Proteins on High-Salt Diet. 
Representative photomicrograph of negative control immunofluorescent staining performed of 
hypothalamic paraventricular nucleus (PVN) cytokines utilizing Alexa-Fluor 488-conjugated goat 
anti-mouse secondary antibodies but no primary antibodies in 3-month old male Sprague Dawley 
rats receiving an intracerebroventricular (ICV) infusion (25 μg/ 6 μL/ day) of targeted Gαi2 
oligodeoxynucleotides (ODN) in conjunction with 7-day high (HS; 4% NaCl) salt diet (scale bar = 
200 μm, images captured at 20X, n=5/group). 
 
  
Targeted Gαi2 ODN infusion and a 7-day HS diet do not induce sympathoexcitation or 
PVN neuroinflammation in female rats: In 3-month-old female SD rats, as observed in 
male SD rats, a control SCR ODN infusion in conjunction with a 7-day HS diet resulted in 
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global sympathoinhibition (SCR ODN NS Plasma NE [nmol/L] 558 vs. HS 3512; 
p<0.05) and renal sympathoinhibition (SCR ODN NS Renal NE [pg/mg] 51729 vs. HS 
41790; p<0.05) accompanied by sodium homeostasis and normotension (Figure 4.7). In 
contrast to our findings in male SD rats, a Gαi2 ODN infusion in conjunction with a 7-day 
HS diet elicited a significantly lower increase in MAP in female vs. male SD rats compared 
to rats maintained on a NS intake (MAP [mmHg] Male SD Gαi2 ODN NS vs. HS +242 
vs. Female Gαi2 ODN NS vs. HS +71; p<0.05) and an increase in renal sodium retention 
on only day 1 of HS intake (Figure 4.7). In opposition to our results obtained in male rats, 
Gαi2 ODN infusion and HS intake failed to elicit sympathoexcitation or increases in total 
number of PVN microglia or percent of active microglia present (Figures 4.7 and 4.8). In 
female rats we also observed no Gαi2 ODN-induced changes in PVN astrocyte levels. As 
documented (Figure 4.9), we observed no impact of dietary sodium intake or ODN infusion 
on plasma estrogen levels. Replicating our prior findings in male SD and DSR rats, we 
observed a significant approximate 2-fold increase in PVN Gαi2 protein expression (Figure 
4.10). Validating the efficacy of a targeted Gαi2 ODN, but not control SCR ODN, infusion 
to downregulate Gαi2 protein levels we observed significant (greater than 85%) 




Figure 4.7 Day 7 Mean Arterial Pressure, Sodium Balance and Sympathetic Tone in Female 
SD Rats With and Without Central Gαi2 Proteins. 
Impact of intracerebroventricular (ICV) control scrambled (SCR) or targeted Gαi2 
oligodeoxynucleotide (ODN) infusion (25 μg/ 6μL/ day) and 7-day normal (NS, 0.6% NaCl) or 
high (HS, 4% NaCl) salt diet in 3 month old female Sprague-Dawley rats on A) mean arterial 
pressure (MAP, mmHg) B) sodium balance (mEq/day), C) plasma norepinephrine (NE, nmol/L) 
and D) renal NE content (pg/mg) (*p<0.05 compared to NS within ODN infusion group, 







Figure 4.8 Analysis of Microglia and Astrocytes in the PVN of Female SD Rats With and 
Without Central Gαi2 Proteins. 
Representative photomicrographs of (A) microglia (OX-42 immunohistochemistry) and (B) 
astrocytes (GFAP immunohistochemistry) in the hypothalamic paraventricular nucleus (PVN) of 
intracerebroventricular (ICV) control scrambled (SCR, A) or targeted Gαi2 (B) 
oligodeoxynucleotide (ODN) infused (25 μg/ 6μL/ day) female rats subjected to a 7-day normal 
(NS, 0.6% NaCl) or high (HS, 4% NaCl) salt diet. (C-D) Quantification of photomicrographs of 
(A) PVN microglial activation expressed as total number of microglia and percent of microglia 
active per 40,000 μm2 and D) astrocyte percent tissue composition of the PVN (scale bar = 20 μm 
in A, 200 μm in B, images captured at 40X in A and 20X in B, red arrows indicate examples of 
ramified microglia, green arrows indicate examples of active microglia, n=5/group, 2-way analysis 






Figure 4.9 Plasma 17β-Estradiol Levels in Female SD Rats With and Without Central Gαi2 
Proteins. 
Impact of intracerebroventricular (ICV) infusion of control scrambled (SCR) or targeted Gαi2 
oligodeoxynucleotide (ODN) infusion (25 μg/ 6 μL/ day)  in conjunction with either 7-day normal 
(NS; 0.6% NaCl) or high (HS; 4% NaCl) salt diet on plasma estrogen levels in 3-month-old female 







Figure 4.10: Impact of Elevated Dietary Sodium Intake on PVN Gαi2 Protein Levels in 
Control Scrambled ODN-Infused Female SD Rats. 
(A) Immunoblot demonstrating impact of high (HS; 4% NaCl) salt diet on hypothalamic 
paraventricular nucleus (PVN) Gαi2 protein levels in 3-month-old female Sprague-Dawley rats 
receiving intracerebroventricular (ICV) infusion (25 μg/ 6 μL/ day) of control scrambled (SCR) 
oligodeoxynucleotides (ODN), (B-C) representative (B) quantification and (C) Coommassie blue-







Figure 4.11: Impact of Targeted Gαi2 ODN Infusion on PVN Gαi2 Protein Levels in Female 
SD Rats. 
(A) Immunoblot of impact of ICV infusion of control scrambled (SCR) or targeted Gαi2 
oligodeoxynucleotide (ODN) infusion (25 μg/ 6 μL/ day) in 3-month-old female rats in conjunction 
with 7-day normal (NS; 0.6% NaCl) salt diet on hypothalamic paraventricular nucleus (PVN) Gαi2 
protein levels, (B) quantification of PVN Gαi2 protein levels in A and (C) Coommassie blue-stained 
gel for normalization of protein in A. (*p<0.05 vs respective control, n=5/group, unpaired student 
t-test).   
 
Discussion 
These studies were designed to test the hypotheses that 1) microglial-mediated PVN 
inflammation precedes the development of sympathoexcitation in rats in Gαi2 protein-
dependent ssHTN and 2) sex differences would be present in the development of Gαi2 
protein-dependent ssHTN. The major finding of this study is that PVN microglial-mediated 
neuroinflammation following HS administration in Gαi2 ODN infused male rats precedes 
the development of sympathoexcitation, but develops concurrently with ssHTN. This 
suggests that the development of Gαi2 dependent ssHTN occurs in a multiphasic manner. 
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Critically, we identified a sex-difference in the magnitude and contributing components of 
ssHTN elicited by central downregulation of Gαi2 proteins in female SD rats.  
 
Sodium retention and PVN microglial-mediated neuroinflammation precedes 
sympathoexcitation in the development of Gαi2 protein-dependent ssHTN in male SD 
rats. 
We have previously demonstrated, via radiotelemetry, that MAP rises sharply in 
Gαi2 ODN infused male SD and Dahl Salt-resistant rats in the 24-hour period immediately 
following HS administration. MAP then continues to rise gradually over a 72-h period to 
reach a new higher set point that is maintained at this new level for a 21-day period 
(Moreira et al., 2019). In these studies, we verified the development of ssHTN on day 7 of 
dietary HS, which we have previously reported is well established by day 7 of HS intake 
in male SD rats (Carmichael et al., 2020; Moreira et al., 2019) via the acute measurement 
of MAP (Carmichael et al., 2016; Frame, Carmichael, et al., 2019; Kapusta et al., 2013; 
Kapusta et al., 2012; Wainford et al., 2015; Wainford & Kapusta, 2012).  
Recapitulating our prior work in male SD rats, which maintain salt-resistance when 
challenged with a HS intake, (Carmichael et al., 2020; Kapusta et al., 2013; Kapusta et al., 
2012; Moreira et al., 2019; Wainford et al., 2015) we observed that during a control SCR 
ODN infusion and a 7-day HS intake male SD rats maintain normotension that is 
accompanied by sympathoinhibition, sodium homeostasis and the absence of PVN 
inflammation. The current studies provide new insight into the timing of these 
physiological responses to HS intake. In control SCR ODN infused male SD rats on HS 
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diet, we observed the rapid suppression of global sympathetic outflow within 24 hours of 
HS intake that was followed by a significant and persistent reduction in sympathetic 
outflow to the kidney by 72 hours. Additionally, we observed a transient increase in 24-h 
sodium balance, observed only on day 2 of the HS intake period. Extending our prior data, 
in control animals, we observed no PVN microgliosis on day 1 or day 7 of HS intake and 
very low expression of the PICs IL-1β, IL-6, and TNFα on day 1 of HS intake. These data, 
in combination with our prior publication (Moreira et al., 2019) in which we saw no change 
in PVN IL-1β, IL-6, or TNFα levels 7-days post HS intake, strongly suggest in control salt-
resistant SD rats receiving an ICV SCR ODN infusion animals there is no activation of 
PVN inflammatory mechanisms in response to HS intake. 
Validating our prior published findings, male SD rats receiving a central targeted 
Gαi2 ODN infusion and a HS intake developed ssHTN, sodium retention, 
sympathoexcitation and PVN inflammation (Carmichael et al., 2020; Moreira et al., 2019). 
In contrast to the sympathoinhibitory responses observed in control SCR ODN treated rats, 
animals receiving a Gαi2 ODN failed to exhibit global or renal specific sympathoinhibition 
at any time point during HS intake. Further in these animals, we observed significant 
increases in sympathetic outflow systemically and to the kidneys from 72-hours post HS 
intake. As previously reported in Dahl salt-resistant rats in which the influence of central 
Gαi2 proteins is removed, we observed significant and prolonged sodium retention on days 
1-5 of HS intake in male SD rats. Collectively, these data suggest that rapid activation of 
the pressure-natriuresis mechanism coupled with an absence of sympathoinhibition drives 
the initial rapid development of ssHTN in animals in which the influence of central Gαi2 
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are removed.  
We have previously identified a critical role of PVN microglial-mediated 
neuroinflammation in mediating enhanced sympathetic outflow in Gαi2 protein-dependent 
ssHTN (Moreira et al., 2019). The current study extends our previous finding by 
identifying early and robust PVN microgliosis that occurs within 24 hours of HS intake 
and is maintained at a consistent elevated level for the duration of the study in Gαi2 ODN 
infused male rats. This early inflammatory response, which precedes the development of 
both sympathoexcitation and peak sodium retention suggests that PVN microglial 
activation plays a prominent role in the development and maintenance of Gαi2 protein-
dependent ssHTN. Additionally, we performed immunofluorescent staining in the PVN for 
the PICs IL-1β, IL-6, and TNFα. In this study, further strengthening the hypothesis that 
PVN inflammation contributes to the development of Gαi2 protein-dependent ssHTN of 
we detected significant robust increases in PVN PIC levels of IL-1β and IL-6, but not 
TNFα, in Gαi2 ODN infused male rats on HS compared to values obtained in SCR ODN 
pre-treated rats on a HS intake. The absence of an apparent role of PVN TNFα levels in 
our studies is consistent with our prior study and studies conducted in an Angiotensin-II 
Salt HTN model which also exhibited no role of PVN TNFα (Bardgett et al., 2014). Our 
prior work (Moreira et al., 2019) reported that PVN IL-1β, IL-6 and TNFα expression 
levels are not altered by HS intake in SCR ODN pretreated animals and that baseline 
expression of these PICs is not different in SCR vs. Gαi2 ODN infused male rats on a NS 
intake. As such, for the purposes of this study, we compared PIC levels against those 
detected in control SCR ODN animals on a HS diet. While this is a limitation in that there 
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are no NS animals for comparison, we believe that the earlier detected absence of a 
difference between SCR ODN and NS diet and SCR ODN and HS diet facilitates this 
comparison. Additionally, we acknowledge our inability to determine the cellular 
localization of a given cytokine via this technique, and as such cannot conclude the source 
of the cytokines or the definitive target, although we believe they may originate in 
microglia as immune cells displaying pro-inflammatory cytokine production when active.  
Our data suggest that there are temporal changes in PVN PIC expression with IL-
1β levels rising more rapidly than those of IL-6.  These findings, in conjunction with 
existing literature demonstrating a role of IL-1β and IL-6 in modulating neuronal 
excitability (Galic et al., 2012; Vezzani & Viviani, 2015) and neural sympathoexcitatory 
processes in HTN, (P. Shi et al., 2010; H. Yang et al., 2020) provide strong evidence for 
the possibility that early PVN microglial activation and microglial-mediated 
neuroinflammation contribute to the elevations observed in sympathetic outflow in the 
setting of Gαi2 protein-dependent ssHTN. This hypothesis is further supported by the 
growing body of literature, including from our laboratory, that demonstrates that 
inactivation of microglia in hypertensive rats via minocycline normalizes sympathetic 
activity and blood pressure (Du et al., 2017; Moreira et al., 2019; Sharma et al., 2019). 
 
The development of Gαi2 protein-dependent ssHTN in male rats is multi-phasic 
As proposed by Van Vliet, et al. in the Dahl salt-sensitive rat model of HTN, (V. 
McLoone, Ringwood, & Van Vliet, 2011; V. I. McLoone, Ringwood, & Van Vliet, 2009; 
Van Vliet, Chafe, Halfyard, & Leonard, 2006) our studies suggest that the development 
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and maintenance of central Gαi2 protein-dependent ssHTN occurs in a multiphasic manner. 
Initially MAP increases rapidly over the first 24-h period (Moreira et al., 2019) of HS 
intake, during which time, there is a failure to evoke sympathoinhibition to increase the 
renal excretion of sodium, resulting in activation of the pressure-natriuresis mechanism to 
aid in the restoration of sodium homeostasis. Our new data demonstrate that PVN 
microgliosis precedes sympathoexcitation that develops in animals in which central Gαi2 
proteins are down-regulated. In conjunction with our previous finding that inhibition of 
PVN microglial activation abolishes sympathoexcitation, (Moreira et al., 2019) we 
hypothesize that a component of the long term rise in MAP is driven by PVN microglial-
mediated elevations in sympathetic outflow. Our data also suggest that temporal changes 
in PVN neuroinflammation following microglial activation and increased IL-1β production 
likely contribute to the development of sympathoexcitation and that persistent microgliosis 
and elevations in IL-1β and IL-6 are implicated in maintaining prolonged elevations in 
sympathetic outflow. Collectively, our data support a multiphasic model of Gαi2 protein-
dependent ssHTN featuring temporally independent yet additive mechanisms in which 
pressure-natriuresis rapidly elevates MAP to a new higher set point that is maintained in 
part by PVN neuroinflammatory mechanisms that drive and maintain sympathoexcitation. 
 
Females rats lacking central Gαi2 proteins maintain sympathoinhibition and an anti-
inflammatory neural environment on HS diet  
As we have previously demonstrated in male rats (Carmichael et al., 2020; Kapusta 
et al., 2013; Moreira et al., 2019), salt-resistant female SD rats receiving a control SCR 
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ODN infusion, which does not impact Gαi2 proteins levels, maintained normotension and 
exhibited sympathoexcitation and sodium balance during a 7-day HS intake. Extending our 
prior findings in male SD rats in which we report high dietary salt-evoked up-regulation of 
PVN Gαi2 proteins (Carmichael et al., 2020; Kapusta et al., 2013; Kapusta et al., 2012) we 
observed HS evoked up regulation of PVN Gαi2 proteins in female rats. The magnitude of 
the increase in PVN Gαi2 protein expression was lower than that reported in our prior 
studies in male rats (Carmichael et al., 2020; Kapusta et al., 2013; Kapusta et al., 2012) 
however this likely reflects the lower dietary salt intake used in the present study of 4% 
NaCl and further supports our data that the PVN Gαi2 protein response is strongly regulated 
by the amount of dietary salt intake (Kapusta et al., 2012).   
Despite observing dietary sodium evoked upregulation of PVN Gαi2 proteins, as 
seen in male SD rats, ODN mediated down regulation of central Gαi2 proteins resulted in 
different responses in female SD rats compared to those observed in male rats.  While 
female SD rats developed an increase in MAP following 7-days HS intake the magnitude 
of elevation was greater than 3-fold less than that observed in male SD rats and in contrast 
to the robust prolonged renal sodium retention observed in male rats there was only a 
transient increase in sodium balance in female SD rats. These data demonstrate that there 
is a significant sex difference in the degree to which PVN Gαi2 proteins influence blood 
pressure and renal sodium retention during high salt intake in male versus female rats. 
Further, following HS intake unlike, in Gαi2 ODN infused male rats, which display robust 
sympathoexcitation, we observed the maintenance of global sympathoinhibition and the 
absence of renal sympathoexcitation following HS administration in female rats. We 
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speculate that the observed lack of sympathoexcitation, which is a significant contributor 
to ssHTN in male Gαi2 ODN infused rats, partially accounts for the sex difference observed 
in the magnitude of Gαi2 protein-dependent ssHTN. Given our finding of an absence of 
PVN neuroinflammation assessed as the lack of PVN microglial activation or astrocytic 
reactivity in female Gαi2 ODN infused rats, we hypothesize this contributes to the failure 
of a HS intake to evoke sympathoexcitation and profound ssHTN as observed in male rats. 
This is supported by our previous finding in male Gαi2 ODN infused SD rats on a HS diet 
that inhibition of PVN microglial activation resulted in abolishment of pro-inflammatory 
cytokine production and sympathoexcitation (Moreira et al., 2019), and a markedly 
attenuated increase in blood pressure.   
Our finding of a sex-difference in the role of central Gαi2 proteins supports the 
growing body of evidence supporting sex-differences in the mechanisms regulating blood 
pressure. It is well established that the risk of developing HTN is lower in females prior to 
menopause (Das Gupta et al., 2020; Everett & Zajacova, 2015).  Of interest to our current 
studies are the known anti-inflammatory and cardioprotective roles of estrogens (Crofton 
& Share, 1997; Hoeg, Willis, & Weinberger, 1977; Packer, Pelaez, & Kramer, 2001; Villa, 
Vegeto, Poletti, & Maggi, 2016).  Our animal model of 3-month-old female SD rats 
represents premenopausal women, and as validated in this study, down-regulation of 
central Gαi2 proteins did not affect the level of plasma estrogen. As such, we speculate that 
following down regulation of central Gαi2 proteins, estrogens, and potentially other female 
sex steroid hormones, drive the observed mechanistic differences in male versus female 
rats during HS intake. There is a robust body of literature demonstrating the anti-
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inflammatory and anti-hypertensive effects of estrogens (Hoeg et al., 1977; Packer et al., 
2001; Villa et al., 2016), therefore, we speculate that female Gαi2 ODN infused SD rats on 
HS exhibit blunted HTN due to the anti-inflammatory effects that estrogens exert on PVN 
microglia and the protective effects they exert on PVN neurons via the highly locally 
expressed estrogen receptor-β in the PVN (Xue et al., 2013).While we provide strong 
evidence for a sex difference in the response of male versus female rats to HS intake 
following central Gαi2 protein downregulation, this study does not directly investigate the 
role(s) of the sex steroid in these responses. Future studies, beyond the scope of the current 
work, are needed to fully delineate the mechanisms accounting for observed differences in 
the inflammatory response and magnitude of HTN seen in female SD rats (e.g. 
ovariectomy, PVN specific estrogen receptor-β antagonism). 
Perspectives 
Collectively, our findings suggest that there is a multi-phasic mechanism whereby 
central downregulation of the Gαi2 protein, in conjunction with a HS intake, evokes the 
development of ssHTN in male SD rats. In both male and female rats following Gαi2 
protein downregulation and administration of HS diet there is initial activation of the 
pressure-natriuresis mechanism to restore and maintain sodium homeostasis. In male rats 
only, which develop significantly higher levels of ssHTN than female rats, activation of 
the pressure-natriuresis mechanism occurs concurrently with PVN microglial-mediated 
neuroinflammation and subsequent sustained elevations in sympathetic outflow. These 
data highlight novel sex-specific inflammatory and sympathetic mechanisms contributing 
to the development of male but not female Gαi2 protein dependent ssHTN. Prior studies 
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have shown that single nucleotide polymorphisms in the human GNAI2 gene associate 
with essential HTN in the UK BioBank (Carmichael et al., 2020) and the salt-sensitivity of 
blood pressure in the GenSalt study (X. Zhang et al., 2018). We speculate that the sex-
specific mechanisms observed in our animal studies potentially represent future sex-





CHAPTER FIVE: Altered Balance of Excitatory-Inhibitory Neurotransmission in 
Gαi2 Protein-Dependent Salt-Sensitive Hypertension 
Introduction 
Hypertension (HTN) is the leading global cause of mortality, estimated to account 
for 10.4 million deaths per year (Unger et al., 2020). Additionally, the salt sensitivity of 
blood pressure, an exaggerated pressor response to elevated dietary salt intake, is estimated 
to impact 50% of hypertensive and 25% of normotensive individuals (Kotchen, Cowley, 
& Frohlich, 2013). With the average American consuming three times the daily sodium 
intake recommended by the American Heart Association (Writing Group et al., 2016), it is 
becoming increasingly important to identify the mechanisms responsible for propagating 
hypertensive responses to excess dietary sodium intake.  
Our laboratory has previously characterized the role of Hypothalamic 
Paraventricular Nucleus (PVN) G-Protein Coupled Receptor (GPCR)-coupled α-i2 (Gαi2) 
subunit proteins in mediating normotensive responses to elevated dietary sodium intake in 
salt resistant rats (Carmichael et al., 2020; Kapusta et al., 2013; Moreira et al., 2019; 
Wainford et al., 2015). We have demonstrated that a chronic high sodium diet results in 
site-specific upregulation of Gαi2 proteins and resultant decreases in measures of global 
and renal sympathetic tone, ultimately facilitating normotension (Carmichael et al., 2020; 
Kapusta et al., 2013; Wainford et al., 2015). Additionally, when the Gαi2 protein is present 
there is notable dietary sodium-evoked induction of Fos in the parvocellular PVN, a marker 
of neuronal activation. In contrast, in salt-sensitive animals such as the Dahl Salt-Sensitive 
(DSS) rat which fails to upregulate these proteins, and in salt-resistant animals in which 
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these Gαi2 proteins are experimentally downregulated, a high salt diet evokes 
sympathoexcitation, sodium retention, and ultimately the development of salt-sensitive 
HTN (ssHTN).  
Previous studies from our laboratory have demonstrated a robust induction of PVN 
Fos staining in response to both acute (Carmichael et al., 2016) and chronic (Carmichael 
et al., 2020) challenges to fluid and electrolyte homeostasis in salt-resistant rats. Moreover, 
a recent study from our laboratory has demonstrated significant co-expression of Gnai2 
mRNA with Gad1 mRNA in the parvocellular PVN of naïve male and female SD rats 
(Chaudhary & Wainford, 2021), suggesting a potential impact of PVN Gαi2 proteins on 
GABAergic signaling. Additionally, there is evidence that the neural pathways mediating 
normal control of blood pressure involve coordinated signaling through Gamma-amino 
butyric acid (GABA) B receptors (Li & Pan, 2010; Takenaka et al., 1996) and that 
GABA(B)  receptors facilitate signal transduction via the Gi/o inhibitory class of Gα-subunit 
proteins (Cheng et al., 2014; Yudin & Rohacs, 2018).  
As it has been shown that the delicate balance between inhibitory GABAergic 
signaling and excitatory glutamatergic signaling in the central nervous system is disrupted 
in models of HTN, favoring excitation (Ferreira-Junior et al., 2019; Korpal et al., 2017; Z. 
Shen, Weng, Zhang, Wang, & Yang, 2018), we elected to investigate the balance of 
GABAergic and glutamatergic signaling in rats with and without PVN Gαi2 proteins.  We 
performed in-vivo GABAergic and glutamatergic receptor antagonist studies as well as in-
situ hybridization studies in male Sprague-Dawley rats infused with either scrambled 
control (SCR) or targeted Gαi2 oligodeoxynucleotides and challenged with a 7-day normal 
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or high salt dietary sodium intake.  
Methods 
Animals 
Male SD rats weighing 275-299 g (approximately 3 months of age) were purchased 
from Envigo (Indianapolis, IN, USA). All rats were pair-housed prior to intervention and 
single-housed post-intervention. Rats were continuously housed in a temperature-
controlled (20–26°C) and humidity-controlled (30-70%) facility under a 12-hour light-dark 
cycle. Tap water and standard normal salt rodent diet (NS, Teklad Global Diet No. 2918, 
18% protein, 5% crude fat, 5% fiber, total potassium (K+) content 0.6%, total NaCl content 
0.6% [174 mEq Na+/kg], Envigo, Indianapolis, IN, USA) or experimental high sodium 
diet (HS, Teklad Global Diet No. TD.03095, 19% protein, 5% crude fat, 3% fiber, total K+ 
content 0.8%, total NaCl content 4% [678 mEq Na+ /kg], Envigo, Indianapolis, IN, USA) 
were allotted ad libitum. All rats were randomly assigned to experimental groups. All 
animal protocols were approved by the Institutional Animal Care and Use Committee in 
accordance with the guidelines of the Boston University School of Medicine and the 
National Institutes of Health Guide for the Care and Use of Laboratory Animals (8th 
edition). 
Surgical Procedures 
PVN Bilateral Cannula and Subcutaneous Osmotic Minipump Implantation 
To achieve PVN Gαi2 protein downregulation and the ability to perform subsequent 
PVN microinjections, animals were anesthetized with intraperitoneal (IP) 
Ketamine/Xylazine (Ketamine 30 mg/kg IP + Xylazine 3 mg/kg IP). Animals were then 
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stereotaxically instrumented with a bilateral stainless steel cannula (P1 Technologies, 
Roanoke, VA, USA) into the PVN utilizing coordinates from Paxinos and Watson The Rat 
Brain atlas (AP -1.8 mm from bregma, ML ±0.5 mm from bregma, DV -8.0 mm from the 
skull surface) (Paxinos & Watson, 2007). The cannulas were then each connected via 
silastic tubing to one of two subcutaneous osmotic minipumps, each with an infusion rate 
of 3.6 μL/day and a max fill volume of approximately 150 μL (Model 2006; Alzet, 
Cupertino, CA, USA) to infuse rats at a rate of 300 ng/ side/ day with either control 
scrambled (SCR) (sequence: 5′‐GGGCGAAGTAGGTCTTGG‐3′) or targeted Gαi2  
(sequence: : 5′‐CTTGTCGATCATCTTAGA‐3’) oligodeoxynucleotides (ODN) as 
previously described (Carmichael et al., 2020). Cannulation site was confirmed at the end 
of the study when microinjections of L-glutamate (15 nmol/side) were made into the PVN 
to elicit a pressor response. Animals lacking the pressor response were considered mis-
cannulations (Carmichael et al., 2020) and not used.  
ICV Cannula and Subcutaneous Osmotic Minipump Implantation 
To achieve CNS Gαi2 protein downregulation in PVN in-situ hybridization studies 
in which a PVN-specific cannula would have led to destruction of PVN microarchitecture 
needed for histological studies of neuronal phenotypes, animals were anesthetized with 
intraperitoneal (IP) Ketamine/Xylazine (Ketamine 30 mg/kg IP + Xylazine 3 mg/kg IP). 
Animals were then stereotaxically instrumented with a stainless steel cannula (P1 
Technologies, Roanoke, VA, USA) into the right lateral cerebral ventricle according to 
Paxinos and Watson The Rat Brain atlas (AP -0.3 mm from bregma, ML +1.3 mm from 
bregma, DV -4.5 mm from the skull surface) (Moreira et al., 2019; Wainford et al., 2015). 
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The cannula was connected via silastic tubing to a single subcutaneous osmotic minipump 
(Model 2004; Alzet, Cupertino, CA, USA) to infuse rats at a rate of 25μg/ 6 μL/ day with 
either control SCR or targeted Gαi2  ODNs with the same sequences as described above.  
Acute Femoral Artery and Vein Cannulation 
 On day 7 of the normal or high salt dietary challenge, subgroups of animals were 
anesthetized with IP Sodium Brevital (Sodium Brevital 20 mg/kg IP + 10 mg/kg IV as 
needed). The left femoral vein was cannulated using a PE50 cannula for the delivery of IV 
drugs and normal saline, and the left femoral artery was cannulated using a PE50 cannula 
connected to a BIOPAC transducer to record blood pressure as previously described 
(Carmichael et al., 2016; Carmichael et al., 2020; Frame, Carmichael, et al., 2019). 
Following cannulation, rats were placed in a plexiglass rat holder and an isotonic infusion 
of saline (20 μL/min IV) was given over a 2-hour recovery period allowing rats to return 
to full consciousness and stable renal and cardiovascular function. Mean arterial pressure 
(MAP) was recorded continuously via the femoral artery cannula using computer driven 
BIOPAC data acquisition software (MP150 and AcqKnowledge 3.8.2; BIOPAC Systems 
In., Goleta, CA, USA) connected to an external pressure transducer (P23XL; Viggo 
Spectramed Inc., Oxnard, CA, USA). 
Transcardial Perfusion 
 Subgroups of rats used for in-situ hybridization studies in the brain were deeply 
anesthetized using IP ketamine/xylazine (Ketamine 30 mg/g IP + Xylazine 3 mg/kg IP) 
and perfused through the heart with ice cold 0.1M phosphate buffered saline PBS until the 
liver and kidneys cleared, and then with ice cold 4% paraformaldehyde in 0.1M PBS until 
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fully fixed. Brains were then extracted and post-fixed in 4% paraformaldehyde for 48 hours 
and sealed in 30% sucrose in 0.1M PBS for 72 hours before tissue processing.  
In-vivo Procedures 
PVN Microinjection Studies 
 Following femoral artery and vein cannulation and 2-hour recovery, animals 
underwent a PVN microinjection study utilizing GABA(B) antagonist CGP52432 (3nmol/ 
side) and glutamatergic antagonist kynurenate (1.4μg/side) to determine basal activity of 
both glutamatergic (NMDA, AMPA, Kainate) and GABA(B) receptors. First, MAP was 
recorded for a 20-minute baseline. After that, injections were performed, and MAP 
responses were recorded for 60 minutes following injections.  
Experimental Protocols 
In-situ Hybridization 
 For the co-localization of the Gnai2 mRNA with vGlut2 and Gad1 in the PVN to 
determine the percent distribution of neuronal phenotypes expressing the Gαi2 protein and 
to determine the comparative abundance of GABAergic neurons and glutamatergic 
neurons, in-situ hybridization was performed as described by our laboratory (Chaudhary 
& Wainford, 2021). Coronal sections of fixed brains were cut on a cryostat at 20 μm and 
stored in cryoprotectant until tissue processing. In situ hybridization was performed using 
the RNAscope Assay Fluorescent multiplex kit (ACD 32850, Hayward, CA, USA). 
Controls for each probe were previously validated by our laboratory and are available in a 
repository open access at https://doi.org/10.6084/m9.figshare.c.5136317.v1. First, sections 
were rinsed with 1X PBS and mounted on superfrost plus slides (Fisher 1255015, Fisher 
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Scientific, Waltham, MA, USA). Slides were then washed in RNase free water (Fisher 10-
977-015, Fisher Scientific, Waltham, MA, USA) for 5 minutes and dehydrated through 
serial ascending concentrations of ethanol, air dried, washed in hydrogen peroxide (ACD 
322335, Hayward, CA, USA) to block endogenous peroxidase activity and permeabilized 
in protease III (ACD 322337, Hayward, CA, USA). Slices were then hybridized using 
specific target probes for 2 hours at 40°C. Readily available C2 probes Gad1 (ACD 
316401-C2, Hayward, CA, USA) and Slc17a6(vGLUT2, ACD 317011-C2, Hayward, CA, 
USA) were used along with a custom-designed targeted C1 Gnai2 probe (NPR-0001497; 
ACD 805201) detecting specific Gai2 target RNA. The custom probe was designed using 
the National Center for Biotechnology Information Gene ID 81664 for Rattus norvegicus 
Gnai2, and matches our targeted ODN sequence which has been previously validated to be 
specific to the Gnai2 mRNA. For hybridization, the C2 probes (provided at 50X) were 
diluted at 1:50 in the C1 probe (provided at 1X).  
Following probe hybridization, tissue section slides were rinsed twice with 1X 
wash buffer (ACD 310091; 50X diluted in RNase free water, Hayward, CA, USA) at room 
temperature for 2 minutes each time. The signal amplification was performed using an 
RNA scope set of amplifiers (ACD 320851, Hayward, CA, USA) (Amp 1, 30 minutes at 
40°C; Amp 2, 15 minutes at 40°C; Amp 3, 30 minutes at 40°C; and Amp 4A, 15 min at 
40°C). Washing steps with 1X wash buffer (2 minutes at room temperature x2) were 
included between Amplification steps. Slides were then coverslipped using Prolong 
Diamond anti-fade mounting media (Fisher-P36961) to preserve fluorescent signals and 
stored in the dark in slide cases. 
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Imaging and Analysis of Neuronal Phenotypic Markers via RNAScope In-situ 
Hybridization 
 For in-situ hybridization studies on brain slices, slides were imaged utilizing the 
GFP filter for green stains and Texas Red filter for red stains at 10X and 20X under similar 
exposures. To determine positive RNA puncta staining compared to background, the 
brightness setting was enhanced linearly to an equal degree with respect to the background 
in all images to allow small puncta to become visible. Contrast was also enhanced equally 
and linearly in all images to enable signal detection and discrimination from background. 
To ensure background was identifiable, negative control probes and positive control probes 
commercially available from Advanced Cell Technology/BioTechne were employed. After 
image capture, colocalization of Gad1 and Gnai2 or vGlut2 and Gnai2 was determined 
using ImageJ/FIJI software from the NIH. On blinded images, a 300 μm x 300 μm box was 
drawn over the medial parvocellular region of the PVN. This region in specific was chosen 
for neuronal phenotyping as the large majority (~80%) of Gnai2-positive cells were 
localized here, in addition to the medial parvocellular region being the site of cannula 
implantation in PVN-cannulated rats, and the site where we previously identified the 
largest Gαi2 ODN-induced deficit in Fos-positive cells following IV hypertonic saline 
bolus (Carmichael et al., 2016) and 7-day HS diet (Carmichael et al., 2020). Cells were 
then counted using the cell counter plugin available on ImageJ/FIJI. A cell was determined 
to be positive for the respective mRNA if it contained >5 punctate dots in that foci, and 
colocalization was determined to be those foci with a distinct yellow/orange signal, as well 
as those foci which are not yellow but which possess both red and green foci together in 
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non-overlapping close proximity. Quantifications of each slice were then used to determine 
percent of Gnai2-expressing neurons that were GABAergic or Glutamatergic, as well as 
percent of GABAergic neurons containing Gnai2 and percent of glutamatergic neurons 
containing Gnai2.  
Statistical Analyses 
All data are expressed as mean ± SD. The magnitude of change in MAP at different 
time points in response to microinjections was compared with the mean group control value 
obtained over the first 20 minutes of recording by a one-way repeated-measures analysis 
of variance (ANOVA) with subsequent Dunnett’s test. Group differences in neuronal 
phenotype abundance and colocalization were assessed via two-way ANOVA with one 
fixed effect being ODN infusion and the other fixed effect being dietary sodium intake, 
with the interactions included. Post-hoc multiple comparison analysis was performed using 






PVN-specific Gαi2 ODN infusion in male SD rats on HS diet results in the 
development of ssHTN 
As we have previously demonstrated (Carmichael et al., 2020), administration of a 
7-day HS diet in PVN SCR ODN infused male rats fails to elicit increases in MAP (SCR 
ODN NS baseline MAP, mmHg, 126 ± 4 vs SCR ODN HS baseline MAP 126 ± 6, p>0.05) 
(Figure 1). In contrast, a 7-day HS diet in PVN Gαi2 ODN-infused male rats elicits the 
development of ssHTN (Gαi2 ODN NS baseline MAP, mmHg, 125 ± 4 vs Gαi2 ODN HS 
baseline MAP 146 ± 6) (Figure 1).  
PVN GABA(B) receptor antagonism produces a pressor effect in SCR ODN-infused 
male SD rats on a high salt diet  
 While microinjection of GABA(B) antagonist CGP52432 (3nmol/ side) into the 
PVN induced no change in MAP in both SCR and Gαi2 ODN-infused male rats on NS diet, 
there was a significant pressor effect of GABA(B) antagonism on SCR ODN-infused rats 
on HS diet compared to baseline (SCR ODN HS peak ΔMAP to CGP52432 +17 mmHg at 
20 minutes post-injection, p<0.05) (Figure 1). This effect was absent in Gαi2 ODN-infused 
male rats on HS diet, as this group displayed sustained HTN throughout the study.  
PVN Glutamatergic receptor antagonism produces a depressor effect in Gαi2 ODN-
infused male SD rats on a high salt diet 
 In SCR ODN-infused male SD rats, there was no impact of microinjecting the 
glutamatergic antagonist Kynurenate (1.4μg/side) on MAP regardless of 7-day dietary 
sodium intake. Additionally, glutamate antagonism does not impact MAP in Gαi2 ODN-
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infused male rats on NS diet, but significantly reduces MAP in Gαi2 ODN-infused male 
rats on HS diet (Gαi2 ODN HS peak ΔMAP to Kynurenate -12 mmHg at 20 minutes post-
injection, p<0.05) (Figure 5.1).  
 
 
Figure 5.1: Impact of GABA(B) Receptor and Glutamate Receptor Antagonism on MAP in 
PVN SCR or Gαi2 ODN-Infused Male SD Rats. 
Impact of microinjection of (A) CGP52432 (GABA(B) receptor antagonist, 3nmol/side) or (B) 
Kynurenate (glutamatergic antagonist, 1.4 μg/side) on Mean Arterial Pressure (MAP) in 
Paraventricular Nucleus (PVN) control scrambled (SCR) or targeted Gαi2 oligodeoxynucleotide 
(ODN) infused (300 ng/ side/ day) male Sprague-Dawley rats in conjunction with 7-day normal 
(NS; 0.6% NaCl) or high (4% NaCl) salt diet (*p<0.05 vs respective group baseline value, 
n=6/group, one-way repeated measures analysis of variance (ANOVA)).   
 
Gαi2 ODN infusion and HS diet evoke PVN neuronal plasticity with enhanced 
glutamatergic and suppressed GABAergic neuronal transcripts  
 In both SCR and Gαi2 ODN-infused male SD rats, an HS diet did not evoke changes 
in the proportion of neurons in level 2 of the PVN that expressed the Gnai2 gene nor the 
subregion of the PVN that the majority of expression was localized to, counted as neurons 
positively fluoresced with targeted Gnai2 RNAScope probes (Figure 2). Moreover, there 
were no dietary sodium-evoked changes in the total number of GABAergic neurons (Figure 




SCR ODN-infused male SD rats, nor the percent of either type of neuron that colocalized 
to Gnai2-positive cells. In contrast, an HS diet in conjunction with Gαi2 ODN infusion 
evoked a significant decrease in the abundance of Gad1-positive neurons (average number 
positive neurons per sample area Gαi2 ODN NS 89 ± 8 vs Gαi2 ODN HS 77 ± 5, p<0.05) 
(Figure 3) and a significant increase in the abundance of vGlut2-positive neurons (average 
number positive neurons per sample area Gαi2 ODN NS 77 ± 8 vs Gαi2 ODN HS 95 ± 8 
p<0.05) (Figure 4) in the medial parvocellular region of the PVN. Additionally, HS diet 
and Gαi2 ODN infusion evoked a significant decrease in the colocalization of Gad1 to 
Gnai2-positive cells (percent cells positive for Gnai2 also positive for Gad1 in sample area 
Gαi2 ODN NS 89% ± 7% vs Gαi2 ODN HS 76% ± 3%, p<0.05) (Figure 3) and a significant 
increase in the colocalization of vGlut2 to Gnai2-positive cells (percent cells positive for 
Gnai2 also positive for vGlut2 in sample area Gαi2 ODN NS 78% ± 5% vs Gαi2 ODN HS 







Figure 5.2: Distribution of Gnai2 positive cells across PVN subnuclei at level 2 in SCR or 






Representative photomicrographs of impact of control scrambled (SCR, A-B) or targeted Gαi2 (C-
D) intracerebroventricular oligodeoxynucleotide (ODN) infusion (25 μg / 6 μL/ day) in conjunction 
with normal (0.6% NaCl NS) or high (4% NaCl) salt diet on Gnai2 fluorescent staining in level 2 
of the Paraventricular Nucleus (PVN) and (E) group quantifications by PVN subnuclear region 
(Photos captured at 10X, scale bar = 100 μm, n=6/group).    
 
         
 
                
Figure 5.3: Expression of PVN Gad1 and Colocalization of Gad1-Gnai2 positive cells at level 
2 in SCR or Gαi2 ODN-Infused Male SD Rats. 
Representative photomicrographs of impact of control scrambled (SCR, A-B) or targeted Gαi2 (C-
D) intracerebroventricular oligodeoxynucleotide (ODN) infusion (25 μg / 6 μL/ day) in conjunction 
with normal (0.6% NaCl NS) or high (4% NaCl) salt diet on Gad1 and Gnai2 fluorescent staining 
and colocalization in level 2 of the Paraventricular Nucleus (PVN) and (E-F) quantifications of (E) 
Gad1 abundance and (F) coexpression of Gad-1 by Gnai2-positive cells (*p<0.05 vs. respective 
NS control value, photos captured at 20X, scale bar = 100 μm, green is Gnai2, red is Gad1, 





















Figure 5.4: Expression of PVN vGlut2 and Colocalization of vGlut2-Gnai2 positive cells at 
level 2 in SCR or Gαi2 ODN-Infused Male SD Rats. 
Representative photomicrographs of impact of control scrambled (SCR, A-B) or targeted Gαi2 (C-
D) intracerebroventricular oligodeoxynucleotide (ODN) infusion (25 μg / 6 μL/ day) in conjunction 
with normal (0.6% NaCl NS) or high (4% NaCl) salt diet on vGlut2 and Gnai2 fluorescent staining 
and colocalization in level 2 of the Paraventricular Nucleus (PVN) and (E-F) quantifications of (E) 
vGlut21 abundance and (F) coexpression of vGlut2 by Gnai2-positive cells (*p<0.05 vs. respective 
NS control value, photos captured at 20X, scale bar = 100 μm, green is Gnai2, red is vGlut2, 








 These studies were designed to test the hypothesis that downregulation of PVN 
Gαi2 proteins results in altered neuronal receptor activity and phenotypic abundance, which 
contributes to the sustained sodium-dependent increase in MAP in Gαi2 protein-dependent 
ssHTN in male SD rats. Significantly, we found that downregulation of PVN Gαi2 proteins 
results in loss of HS diet-induced tonic GABA(B) receptor signaling and gain of HS diet-
induced glutamatergic signaling. Additionally, we found that central downregulation of 
Gαi2 proteins results in alterations to PVN parvocellular neuronal phenotypes, with medial 
parvocellular neurons displaying plasticity towards an enhanced abundance of 
glutamatergic neurons and reduced abundance of GABAergic neurons.  
 
Tonic PVN GABA(B) receptor signaling is involved in the maintenance of 
normotension in male SD rats on HS diet 
 Previous work from our laboratory has identified a critical role of PVN neurons in 
the sympathoinhibitory, normotensive responses to acute challenges to fluid and electrolyte 
homeostasis (Carmichael et al., 2016)  as well as chronic elevations in dietary sodium 
intake (Carmichael et al., 2020). In these prior studies, we have found that SCR ODN 
infused male SD rats display a robust PVN Fos protein induction in response to these acute 
and chronic challenges, suggestive of neuronal activation, and that these challenges 
repeatedly result in sympathoinhibition as well as the elimination of excess sodium and 
water, ultimately facilitating normotension. In contrast, our prior studies have 
demonstrated that in male SD rats, Gαi2 ODN infusion attenuates both acute and chronic 
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PVN Fos protein induction, sympathoinhibition, natriuretic responses, and elicits a 
prolongation of elevated MAP in the acute setting and the development of sustained ssHTN 
with chronic high sodium intake, suggesting the critical role of PVN Gαi2 proteins in the 
neural signal transduction pathways regulating sodium and water balance. 
This work extends our prior findings suggesting PVN neuronal activation as an 
effector of the normotensive responses to elevated sodium intake by delineating some of 
the receptor signaling pathways that are activated in response to elevated sodium intake in 
salt-resistance, and describing how those pathways appear to change in salt-sensitive HTN. 
Our current finding that PVN GABA(B) receptor antagonism in male SCR ODN-infused 
SD rats on HS diet elicits a significant hypertensive response signifies that tonic PVN 
GABA(B) receptor activity may be playing a critical role in the maintenance of the 
previously identified sympathoinhibitory, normotensive signaling elicited by chronic HS 
intake (Carmichael et al., 2020; Kapusta et al., 2013; Moreira et al., 2019). Moreover, this 
finding corroborates previous findings in the spontaneously hypertensive rat that HTN is 
attenuated by enhanced GABA(B) receptor activity (Li & Pan, 2006, 2007). In addition, 
we believe that there is a significant role of the Gαi2 protein in facilitating tonic PVN 
GABA(B) receptor signaling as in Gαi2 ODN-infused male rats on HS diet, which display 
robust HTN, there is an absence of a PVN GABA(B) receptor antagonism-induced 
hypertensive response. We believe that in the absence of the Gαi2 protein, through which 
GABA(B) receptors have been demonstrated to potentially signal (Straiker, Borden, & 
Sullivan, 2002), there is a loss of HS-induced tonic GABA(B) receptor signaling, thus 
contributing to the failure to remain normotensive. While the synaptic localization of the 
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GABA(B) receptor remains unclear, it is possible that this receptor contributes to both 
presynaptic inhibition of excitatory neurotransmitter release, and slow-wave postsynaptic 
hyperpolarization to ultimately facilitate PVN sympathoinhibitory responses to HS.  
Tonic PVN glutamatergic receptor signaling is enhanced in Gαi2 ODN-infused male 
SD rats on HS diet 
 Our previous studies characterizing Gαi2 protein-dependent ssHTN have not only 
identified a failure to suppress sympathetic outflow in response to HS in these hypertensive 
rats, but also a significant exacerbation of sympathetic outflow, known as 
sympathoexcitation (Carmichael et al., 2020; Kapusta et al., 2013; Moreira et al., 2019). 
Extending these findings that not only is sympathoinhibition lost but sympathoexcitation 
gained, our current study demonstrates that while tonic normotensive PVN GABA(B) 
receptor activity is attenuated, there is an enhancement of tonic hypertensive PVN 
glutamatergic signaling. In Gαi2 ODN-infused male rats on HS diet, but not in any other 
group, PVN glutamatergic receptor antagonism elicited a significant depressor response. 
These data also corroborate previous findings by other groups that enhancement of PVN 
glutamatergic signaling promotes HTN and is common in multiple models of HTN (Gabor 
& Leenen, 2012a; Glass et al., 2015; Li & Pan, 2017; Qiao, Zhou, Li, & Pan, 2017), and 
that excessive excitatory PVN signaling correlates with elevations in blood pressure.  
Male SD rats lacking central Gαi2 proteins display robust sodium-dependent PVN 
neuronal plasticity  
 To further understand the context of our pharmacologic data, we used RNAScope 
technology for fluorescent in-situ hybridization to determine the relative abundance of 
135 
 
Gnai2-expressing neurons in the various subnuclei of the PVN, and the proportions of 
Gad1- and vGlut2-Gnai2 colocalized neurons in the medial parvocellular PVN where 
Gnai2 is the most abundant, per our previous finding (Chaudhary & Wainford, 2021). We 
show here that in the medial parvocellular subnucleus of the PVN at level 2, there is the 
highest abundance of Gnai2 transcripts, and this relative proportionality remains 
unchanged regardless of OND infusion or HS intake.  Moreover, we see that with respect 
to parvocellular neurons, there is a significant Gαi2 ODN and HS-induced reduction in 
Gad1 total expression and Gad1-Gnai2 colocalization, and an increase in vGlut2 total 
expression and vGlut2-Gnai2 colocalization. These data provide new evidence of 
transcriptional-level neuronal phenotypic plasticity in ssHTN, and provide evidence that 
not only do functional changes occur in receptor signaling, but possibly reorganization of 
the abundance of neuronal phenotypes occurs in ssHTN.   
 As mentioned above, it has been demonstrated in several models of HTN that there 
is prohypertensive glutamatergic tone (Dampney et al., 2018; Glass et al., 2015; Li & Pan, 
2017; Qiao et al., 2017) and antihypertensive GABAergic tone (Badr, Rao, & Manee, 2021; 
Li & Pan, 2006, 2007). What is not clear, however, is the mechanism whereby actual 
synaptic reorganization occurs facilitating enhanced glutamatergic PVN input and reduced 
GABAergic input. Of the few reports detailing this phenomenon, Biancardi et al 
(Biancardi, Campos, & Stern, 2010) describe significant reorganization of PVN-rostral 
ventrolateral medulla-projecting neurons in renovascular HTN, favoring glutamatergic 
inputs over GABAergic inputs at the immunohistochemical level. Their data, in 
conjunction with our novel data demonstrating mRNA-level alterations in the markers of 
136 
 
neuronal phenotypes, suggest a broad phenomenon whereby alterations in neuronal 
signaling are correlated with, and possibly exacerbated by, an overall reduction in 
antihypertensive GABAergic neurons and enhancement of prohypertensive glutamatergic 
neurons through which to signal. 
With respect to the multiple pathways that may potentially impact neuronal 
transcription of neurotransmitter-related genes, significant consideration may be given to 
PVN inflammation and the impact of microglial-derived cytokines on neuronal signaling. 
Studies, including from our laboratory, have shown that multiple models of HTN feature 
robust neuroinflammation (Moreira et al., 2019; Sharma et al., 2019; P. Shi et al., 2010; 
Worker et al., 2020). Additionally, it has been demonstrated that cytokines can have a 
direct impact on neuronal firing and signaling (Clarkson et al., 2017; Galic et al., 2012; 
Hadjilambreva, Mix, Rolfs, Muller, & Strauss, 2005; Riazi, Galic, & Pittman, 2010). These 
findings together suggest a possible mechanism whereby HS intake-induced PVN 
inflammation may exacerbate the enhancement seen in prohypertensive glutamatergic 
signaling in Gαi2 protein-dependent ssHTN. Future studies may utilize a minocycline-
ODN co-infusion strategy as previously described (Moreira et al., 2019) to delineate a 
potential role of microglial-mediated PNV inflammation in the aforementioned neuronal 
plasticity.  
Conclusions 
 We have demonstrated here that following PVN Gαi2 ODN infusion, an elevated 
dietary sodium intake evokes the development of ssHTN featuring enhanced glutamatergic 
tone and abundance of parvocellular glutamatergic neurons, loss of tonic GABA(B) 
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receptor signaling and reductions in the abundance of PVN parvocellular GABAergic 
neurons. These data provide additional mechanistic insight into the role of the Gαi2 protein 
in the maintenance of normotension and salt-resistance in male SD rats, and may lead to 




CHAPTER SIX: Overall Discussion 
 The importance of understanding the integrated central neural mechanisms 
involved in the regulation of sodium homeostasis and blood pressure in health and disease 
is underscored by the multitude of human diseases that feature sodium and fluid 
dysregulation, such as salt-sensitive hypertension (ssHTN) (Bayorh et al., 1998; 
Kammerlander, 2019). The work contained in this dissertation sought to provide an 
enhanced understanding of the central neural and inflammatory mechanisms which 
regulate sodium balance and blood pressure, and the pathophysiological processes which 
contribute to the development of ssHTN. Our novel data demonstrate a critical role for 
central Gαi2 proteins in the regulation of central sympathetic outflow in response to a 
chronic challenge to sodium homeostasis in the form of elevated dietary sodium intake.  
First, we have demonstrated that in the absence of central Gαi2 proteins, male but 
not female SD rats develop robust PVN-specific microglial-mediated neuroinflammation, 
which correlates with increased sympathetic outflow and an elevated magnitude of ssHTN. 
These data suggest that central Gαi2 proteins plays both an anti-inflammatory and 
sympathoinhibitory central role in the response to a high salt diet. Moreover, we have 
shown that this male-specific PVN inflammation develops rapidly following high sodium 
intake and precedes the development of sympathoexcitation in the absence of Gαi2 
proteins, but develops concurrently with pressure-natriuresis induced elevations in blood 
pressure, suggesting altogether a sex-dependent multi-phasic mechanism whereby high salt 
diet induces the development of Gαi2 protein-dependent ssHTN. Lastly, we have shown 
that significant PVN neuronal plasticity following Gαi2 protein downregulation contributes 
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to the sodium-dependent enhancement in blood pressure, featuring reductions in tonic 
GABA(B) receptor signaling and enhancement of glutamatergic signaling, disrupting 
proper excitation-inhibition coupling in the PVN intended to regulate blood pressure.  
The Potential Integration of a High Salt Diet, Neuronal Signaling Alterations, and 
PVN Inflammation  
 As described above, this work highlights both an anti-inflammatory and GABA(B) 
receptor-mediated inhibitory role of PVN Gi2 proteins in the maintenance of salt-
resistance. What remains unclear, however, is the potential link that exists between these 
phenomena directly and between these phenomena and an elevated dietary sodium intake. 
With respect to PVN inflammation, as described in Chapter 4, it appears that as soon as 24 
hours following HS dietary intake and Gi2 ODN infusion, male SD rats develop robust 
PVN neuroinflammation. This occurrence suggests the possibility that elevated dietary 
sodium intake directly evokes microglial reactivity and is congruent with other literature 
suggesting a role for salt in inducing pro-inflammatory microglial activity (T. Zhang et al., 
2020). Due to the fact that the PVN is close in proximity to the 3rd ventricle, it is quite 
possible that acute elevations in cerebrospinal fluid sodium concentrations due to HS 
intake, as described in by several laboratories (Gomes et al., 2017; Zera, Nowinski, Segiet, 
& Smykiewicz, 2019), act locally to enhance microglial reactivity.  
Moreover, it is likely that uncoupling of excitation and inhibition contributes to the 
development of PVN inflammation as well. As reported by our laboratory, signaling via 
the afferent renal nerves in SD rats is necessary to facilitate sympathoinhibitory and 
normotensive responses to a HS diet (Frame, Carmichael, et al., 2019). This afferent renal 
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nerve signaling, which was shown to evoke PVN cFos activation via 
immunohistochemistry, may represent the mechanism whereby PVN GABAergic 
pathways, shown to be important for maintaining normotension in this thesis, are activated 
in response to a HS diet. With respect to the downregulation of PVN Gαi2 proteins, it may 
be that the afferent renal nerves send a signal which is unable to be synaptically received, 
thus uncoupling inhibition from excitatory signaling. This failure to inhibit via a loss of the 
Gαi2 protein, and resultant excitation-inhibition uncoupling with excessive excitatory 
signaling, may then go on to result in excitotoxicity to some PVN neurons, ultimately 
leading to neuronal stress signaling and the induction of additional pro-inflammatory 
microglial reactivity.  
This multifaceted mechanism possibly inducing the microglial reactivity seen 
following Gαi2 ODN infusion and HS diet, may additionally help explain the apparent PVN 
site-specificity of microglial activation, as it appears that only in the PVN are multiple 
insults occurring that combine to create a pro-inflammatory environment, which our 
minocycline infusion data in Chapter 3 demonstrate is directly related to the magnitude of 
ssHTN. It thus appears that there may be a plethora of mechanisms, some even 
undiscovered yet, contributing to the development of ssHTN, including a bidirectional 
relationship between HS diet and neuronal excitotoxicity-evoked induction of microglial 
activation and the influence of microglial-mediated cytokine production on sympathetic 
outflow likely via actions on local presympathetic neuronal circuits which are already 
disrupted via loss of HS-diet induced tonic GABA(B) receptor signaling.  
Together, our work supports a PVN-specific Gαi2 protein-gated signal transduction 
141 
 
pathway that regulates inflammatory signaling, as well as facilitates enhanced GABA(B) 
receptor signaling in response to chronic elevations in sodium intake to maintain a salt-
resistant phenotype. The identification of these neural mechanisms promoted by PVN Gαi2 
protein upregulation in salt-resistance may enhance mechanistic understanding of the 
development of ssHTN.       
Future Directions 
 First, future studies in the laboratory will be aimed at understanding the 
electrophysiological impacts of Gαi2 proteins on PVN neuronal firing. While the studies 
described in this dissertation provide insight into the phenotypes of neurons possibly 
participating in the altered sympathetic outflow observed in HTN, as well as the receptor 
types through which signaling may be altered, future studies may utilize whole-cell patch 
clamp techniques, in addition to microelectrode array technology to identify the impact of 
Gαi2 proteins downregulation on individual neuronal firing rates as well as intra-nuclear 
synaptic signaling between local inhibitory and excitatory neurons. Moreover, tracer 
studies may be utilized to help identify the populations of neurons which project to 
sympathetic nuclei in the brain stem and spinal cord as described by other groups 
(Biancardi et al., 2010).  
 In addition to electrophysiology studies, our laboratory may investigate the impact 
of the loss of GPCR-coupled Gαi2 protein signal transduction on the spatial transcriptomics 
of PVN neurons. As described here, the loss of Gαi2 protein signal transduction appears to 
be correlated with an alteration on the abundance of both vGlut2 and Gad1 transcripts, 
suggesting an impact of Gαi2 protein signal transduction on transcriptional regulation of 
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PVN neuronal phenotypes. Additionally, it is possible that inflammation-related cytokine 
receptor signaling, as seen described in animals lacking Gαi2 proteins on HS diet, may 
result in changes to neuronal activity as well as altered transcripts as cytokine receptors 
have been well-characterized to influence neuronal excitability (Vezzani & Viviani, 2015) 
and to activate a host of transcription factors, including those related to the JAK-STAT 
(Villarino, Kanno, Ferdinand, & O'Shea, 2015) and ERK (E. K. Kim & Choi, 2010) 
pathway.  
 Finally, owing to our recent identification of correlations in distinct single 
nucleotide polymorphisms (SNPs) in the human GNAI2 gene and the salt sensitivity of 
blood pressure in the GenSalt study (X. Zhang et al., 2018) and essential HTN in subjects 
from the UK BioBank (Carmichael et al., 2020), future studies from our laboratory may 
further attempt to identify the utility of GNAI2 SNPs as a biomarker used to predict HTN 
risk, investigating possible correlations between SNPs in GNAI2 and physiological factors 
such as blood pressure, circulating catecholamines, and estimates of renal function. With 
respect to these SNPs and the work contained in this thesis, it is quite possible that 
impairments in human GNAI2 transcriptional regulation, as described in Menzaghi et al. 
(Menzaghi et al., 2006), contribute to the inability to effectively signal through brain Gi2 
proteins, resulting in elevations in sympathetic outflow that promote the previously 
described salt-sensitivity and essential HTN in humans via the mechanistic changes 
described in Chapters 3-5. Namely, it is possible that the impairment in human Gi2 protein 
signaling dysregulates excitation-inhibition coupling and promotes a sex-dependent 




Strengths and Limitations 
 With respect to the studies described in this dissertation, there are several 
advantages to our approach. First, utilizing an ODN-mediated downregulation technique 
in a salt-resistant rat model (the SD rat) enhances our ability to isolate the impact of central 
Gαi2 proteins on the response to elevated dietary sodium intake in salt-resistance and how 
Gαi2 protein absence facilitates the development of ssHTN. Second, our use of the young 
SD rat prevents the confounding that occurs when animals develop age-related HTN. Last, 
these studies are strengthened by our ability to target the Gαi2 protein in just the PVN 
utilizing PVN-specific ODN infusions as performed in subsets of animals in Chapter 5, 
isolating the impact of PVN-specific Gαi2 protein expression on blood pressure regulation.  
Limitations do exist, however. While these studies provide insight into the ways in 
which a failure to upregulate Gi2 proteins results in ssHTN, they do not identify the 
mechanisms whereby salt-resistant SD rats facilitate PVN-specific upregulation of Gi2 
proteins in response to HS diet. Additionally, we are unsure why exactly GNAI2 SNPs 
correlate with the salt-sensitivity of blood pressure or HTN. We speculate that, at least in 
a subset of individuals with GNAI2 SNPs, as described by Menzaghi et al., correlations in 
GNAI2 polymorphisms and HTN exist due to an impact on the transcriptional regulation 
of the GNAI2 gene owing to the polymorphism existing at a transcription factor binding 
site (Menzaghi et al., 2006). This impairment in GNAI2 transcription may underlie the 
inability of salt-sensitive humans to regulate sodium appropriately, and the potential lack 
of  Gi2 protein expression in these individuals may contribute to the development of HTN 
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in a manner similar to our studies described herein, with a loss of control over neuronal 
circuitry normally responsible for sympathoinhibition. 
Moreover, while our studies identified sex differences in the magnitude of ssHTN 
following HS diet, our approach did not investigate the impacts of female sex steroid 
hormones on HTN. Human and animal studies have suggested that premenopausal females 
receive cardio-protection from estrogens such as 17β-estradiol. Our studies in the future 
may utilize ovariectomy-based approaches to determine if the robust sex differences 
observed in this dissertation were the result of estrogens or some other unidentified 
factor(s). Lastly, our studies are not able to currently identify whether the implicated 
GABA(B) receptor which appears to be tonically active in salt-resistant SD rats on HS diet 
exerts its sympathoinhibitory effects in a presynaptic or postsynaptic manner. This may be 
clarified using electrophysiologic methods as described in the future directions section, 
where whole-cell patch clamping may be able to delineate a more specific role of these 
inhibitory receptors.  
Perspectives 
 The identification of novel mechanisms, and potential therapeutic targets, driving 
the development and maintenance of ssHTN remains critically important in the 21st 
century. With antihypertensive drug development having been virtually unmoving for over 
a decade (Shah & Stafford, 2017), and HTN contributing to an estimated 10.4 million 
deaths worldwide per year (Unger et al., 2020), we hope that our work to identify novel 
central signal transduction pathways involved in the regulation of sympathetic outflow will 
help provide new therapeutic targets for future pharmaceutical research in HTN.  
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The importance of our basic science work to delineate the neural mechanisms 
contributing to the development of ssHTN is underscored by 1) The significant correlations 
our laboratory has identified between those with GNAI2 SNPs and essential HTN 
(Carmichael et al., 2020) and the salt-sensitivity of blood pressure (X. Zhang et al., 2018), 
both in fairly large proportions of their respective populations, 2) the excess of dietary 
sodium consumed worldwide (Appel et al., 2011) and 3) the findings in the recent SPRINT 
trial (Group et al., 2015), amongst many other blood pressure reduction randomized clinical 
trials conducted since the mid-20th century which have been reviewed extensively through 
large-scale meta analyses (Zanchetti, Thomopoulos, & Parati, 2015) noting significant 
benefits of reducing blood pressure. We believe our work will help achieve the goal of 
having a population with well-controlled blood pressure through the provision of an 
enhanced understanding of central mechanisms dysregulating sympathetic outflow, 
supporting the identification of novel potential therapeutic targets, such that individuals 
may be treated in a personalized, mechanism and genotype-based way that enhances the 
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